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Chapter 1 
Introduction 
It has been nearly sixty years since Albright, Smith, and Richardson (1941) 
first described the relationship between menopause and osteoporosis in adult 
women, yet this disease continues to be problematic for modern day 
researchers.  It is currently estimated that one-third of all postmenopausal 
women, particularly Caucasian women, will experience an osteoporotic fracture 
within their lifetime (Chrischilles, Shireman, & Wallace, 1994). Moreover,  it is 
anticipated that over 5.2 million hip, spine, and forearm fractures will occur in the 
next decade (Chrischilles, et al., 1994; Kleerekoper & Avioli, 1993). 
Osteoporosis which "represents the most common form of metabolic  bone 
disease" (Genant, 1993, p. 229) is "characterized by low bone mass and 
structural deterioration of bone tissue, leading to bone fragility and an increased 
susceptibility to fractures.." (National Osteoporosis Foundation, 1996,  p. 2). The 
occurrence of these fractures can be attributed to the loss of bone mineral 
density (BMD) experienced by older adults (Melton, 1993). 
Generally, after the third decade of life, BMD slowly declines in the healthy 
individual (Kleerkoper & Avioli, 1993). For women, this decline is accelerated 
during the first five years of menopause as levels of estrogen are drastically 
reduced (Birkenhager-Frenkel, Courpron, & Hupscher, 1988;  Snow-Harter & 2 
Marcus, 1991). Because of low estrogen which accompanies menopause, and 
to a lesser extent aging (Richelson, Wahner, Melton, & Riggs, 1984), women 
lose approximately 35 percent of cortical and 50 percent of trabecular bone over 
their lifetime; conversely, men lose approximately two-thirds of these amounts 
(Aisenbrey & DePaepe, 1992; Richelson, Wahner, Melton, & Riggs, 1984). 
Estrogen and age are not the only factors which influence bone 
remodeling. Mechanical stresses, medications, health status, physiological 
stress/function, race, gender, body weight and composition, family history, and 
alcohol and tobacco use also alter BMD. For example, it has been established 
that the use of glucocorticoid medications increases renal calcium exertion 
(Nielsen, Thomsen, Eriksen, Charles, Storm, & Mosekilde, 1988). As a result, 
individuals using these and other selected medications are at greater risk of 
increasing bone resorption, reducing bone formation, and inducing osteoporosis 
(Lukert & Raisz, 1990). 
In recent years, there has been increased attention on the bone health of 
pre- and postmenopausal women (Notelovitz, et al., 1991; Pruitt, Jackson, 
Bartels, & Lehnhard, 1992; Sinaki & Mikkelson, 1984), amenorrheic and 
eumenorrheic athletes (Risser, Lee, LeBlanc, Poindexter, Risser, & Schneider, 
1990; Robinson, Snow-Harter, Taaffe, Gillis, Shaw, & Marcus, 1995; Snow-
Harter, 1994), children and adolescents (Bonjour, Theintz, Buchs, Slosman & 
Rizzo li, 1991; McCulloch, Bailey, Whalen, Houston, Faulkner, & Craven, 1992), 
and the influence of medications (Weiss, Ure, Ballard, Williams, & Da ling, 1980), 3 
diet (Aloia, Vaswani, Yeh, Ross, Flaster, & Dilmanian, 1994; Riggs, Wahner, 
Melton, Richelson, Judd, & O'Fallen, 1988), and physical activity (Cavanaugh & 
Cann, 1988; Smidt, Lin, O'Dwyer, & Blampied, 1992; Snow-Harter, Bouxsein, 
Lewis, Carter, & Marcus, 1992). The need for this research is underscored by the 
fact that the annual cost of treating bone related complications, such as 
osteoporosis, has reached $20 billion within the United States (Praemer, Furner, 
& Rice, 1992) and is expected to increase as Americans live longer (Melton, 
1993). 
One group that has not received adequate attention to their bone health is 
individuals with mental retardation (MR). This group accounts for nearly three 
percent of the U.S. population (Eichstaedt & Lavay, 1992), of which  over sixty-
thousand reside within state developmental centers (Lakin, Prouty, Smith, & 
Braddock, 1996). Furthermore, Eyman, Grossman, Tarjan, and Miller (1987) 
suggest with the trend toward deinstitutionalization throughout the United States, 
large state-operated facilities are caring for fewer individuals with mild MR and 
more individuals with severe/profound MR than previously. As a result, 
individuals with a greater degree of disability are admitted to or remain within 
these facilities. Concurrently, these same individuals may be at increased risk of 
bone fracture due to disuse osteoporosis and the use of osteodynamic 
pharmaceuticals (e.g., anticonvulsant medications). 
While there is limited information on the bone health of individuals with MR 
(Felix, 1993), Stamp, Round, Rowe, and Haddad (1972) suggest that the single 4 
most costly medical problem in adults residing in state developmental centers 
may be the treatment of pathologic fractures due to demineralized bone. This 
may be compounded by the fact there has been a decline in mortality within 
large developmental centers as well as an increase in the age of the population 
(O'Brien, Tate, & Zaharia, 1991). 
Statement of the Problem 
Frequently, individuals with severe mental retardation (SMR) have 
physical limitations that restrict independent ambulation resulting in a reduction 
of weightbearing activities. Many are limited to the use of assistive devices such 
as wheelchairs for transportation and/or rely on the assistance of trained staff or 
volunteers to assist with movement. That is, staff may "transfer" the individual 
from the bed to a wheelchair, from wheelchair to shower, and so forth, thereby 
decreasing the likelihood that the individual will participate in any weightbearing 
activity throughout each day. If individuals are limited in their participation of 
weightbearing activities (load) BMD will be compromised (Issekutz, Blizzard, 
Birkhead, & Rodahl, 1965; Stewart, Alder, Byers, Segre, & Broadus, 1982). This 
may be particularly evident in individuals with limited motor abilities who reside in 
continuous care settings, such as board and care homes or state developmental 
centers, where the severity of mental and/or physical impairment diminish 
opportunities to participate in weightbearing activities. 5 
In addition to limited data on the bone mass of individuals with MR, little 
information is currently available on the occurrence of bone fractures among 
individuals with SMR residing in state developmental centers. The inadequacies 
of these data may be due to several factors. First, while a central governmental 
agency (i.e., Health Care Financing Administration) is responsible for compiling a 
repository of data on all hospital discharges, there is no federal agency 
responsible for compiling data from state developmental centers. That is,  no 
national reporting requirements exist. As a result, data on fracture injuries for 
individuals with MR residing in continuous care facilities within the United States 
are not available. Secondly, there is only a limited number of published studies 
investigating the bone health of individuals with MR. The few studies which  have 
been done are primarily descriptive in nature. As a result, it was believed 
essential to conduct a pilot study prior to the onset of this investigation. 
The pilot study was designed to answer the question: do ambulatory and 
non-ambulatory adults with SMR residing in a state developmental center have 
similar femoral neck, hip, and mid-shaft femur BMD values, and how do these 
values compare to their non-disabled ambulatory peers? The basic research 
question was: were individuals with SMR residing in a state developmental 
center at higher risk of developing an osteoporotic fracture compared with their 
non-disabled peers? 
In the Spring of 1995, sixty-one ambulatory and nonambulatory males and 
premenopausal females adults with SMR were transported to the Bone 6 
Research Lab at Oregon State University for femoral neck, hip, and mid-shaft 
femur BMD measurements. Following familiarization, subjects were scanned for 
BMD using dual energy x-ray absorptiometry (DXA) (Ho logic QDR-1000/W). All 
subjects had been on anticonvulsant therapy longer than 10 years and all were 
below the age of 45. Results from this preliminary investigation 
demonstrated that ambulatory adults had significantly higher BMD values at all 
sites compared with nonambulatory individuals. Furthermore, the results 
suggested that all individuals had significantly lower BMD values for all sites 
compared with their non-disabled peers indicating a greater risk of osteoporotic 
fracture. 
As a result of the pilot study, it was determined that subjects were at higher 
risk of spontaneous fractures due to lower BMD values at all sites compared with 
their gender- and aged-matched peers without disabilities. Due to these findings, 
and the lack of empirical data about this population, a retrospective investigation 
on the epidemiology of fractures among adults with SMR residing in a state 
developmental center was justified. 
Purpose 
The purpose of this study was to investigate the five-year incidence, 
characteristics, and risk factors of bone fractures among adults with SMR 
residing in a state developmental center. The goal of this investigation was to 
provide information which may be used to establish procedures to reduce the 7 
frequency and severity of such fractures and to minimize these consequences. 
The specific aims of this study were to: (1) determine the five-year incidence of 
fractures among adults with SMR residing in a state developmental center, 
(2) determine the distribution of type of fractures, and (3) identify risk factors 
(e.g., body mass index) associated with bone fractures  among individuals with 
MR residing in a state developmental center. 
This study provides documentation on the magnitude and importance of 
bone fracture as a significant medical concern in a state developmental center 
located in the Western United States. Data obtained in this study also provide 
information useful in: (1) identifying individuals at risk, (2) identifying  risk factors 
for bone fracture, and (3) developing effective preventive programs. In addition, 
this study may encourage further research investigations into the epidemiology 
of bone fracture within this group. Lastly, this study utilizes methodology 
(collection, treatment, and analysis) which could be useful for interpreting 
fracture data among individuals residing in state developmental centers 
nationwide. 
Research Hypotheses 
Specific alternative hypotheses to be tested specific to the SMR population 
in this investigation include: 8 
(1) Females who reside in a state developmental center will have a 
significantly greater five-year cumulative incidence rate of bone fractures than 
males with SMR who reside in a state developmental center. 
(2) Postmenopausal females who reside in a state developmental center 
will have a significantly greater five-year cumulative incidence rate of bone 
fractures than premenopausal females with SMR who reside in a state 
developmental center. 
(3) Individuals with SMR who reside in a state developmental center and 
take anticonvulsant medications will have a significantly greater five-year 
cumulative incidence rate of bone fractures than individuals with SMR who do 
not take anticonvulsant medications and reside in a state developmental center. 
(4) Individuals with SMR who reside in a state developmental center with a 
BMI value greater than 25 will have a significantly lower five-year cumulative 
incidence rate of bone fractures compared to those individuals with SMR  and a 
BMI value less than 20 who reside in a state developmental center. 
(5) Individuals with SMR who reside in a state developmental center and 
are not capable of independently ambulating (immobile or immobile/assisted 
standing group) will have a significantly greater five-year cumulative incidence 
rate of bone fractures than individuals with SMR who ambulate independently 
(with or without an assistive device, e.g., cane) and reside in  a state 
developmental center. 9 
(6) Individuals requiring any level of assistance to eat meals will have a 
significantly greater five-year cumulative incidence rate of bone fractures than 
those individuals with SMR who require no assistance with feeding and reside in 
a state developmental center. 
Delimitations 
This retrospective five-year study includes male and female clients with 
SMR who resided in a state developmental center located in the Western United 
States between April 1, 1991 through March 31, 1996. All subjects continuously 
resided during this five year period in a developmental center or left this cohort 
due to fracture, deinstitutionalization, or death. Furthermore,  every individual 
included in this study was 20 years old or greater on April 1, 1991. 
Limitations 
Several factors may limit the extent to which the findings can be 
generalized. These include: 
(1) All participants with SMR are from one training center located in the 
Western United States. 
(2) There was no control on subjects for factors that influence bone health 
such as: (a) heredity, (b) diet, (c) unmonitored physical activity, and (d) smoking. 
(3) The health and physical fitness level of each subject varied greatly. 
(4) The type, duration of usage and combination of medications varied 
greatly between subjects. 10 
(5) The length of time that individuals were ambulatory or nonambulatory 
varied greatly. 
(6) The status of menstrual functioning varied greatly between female 
subjects. 
(7) The medical records obtained from the state development center 
may not accurately reflect client data. 11 
Chapter 2
 
Review of Literature
 
While considerable research has focused on the prevention and treatment 
of osteoporotic fractures among the elderly, few studies have examined the bone 
health of individuals with MR. Therefore, this chapter will provide an overview of 
pertinent topics as they relate to the bone status of this population. Specifically, 
a review of literature on osteology, and the influences of nutrition, immobilization, 
and pharmacological agents common to individuals with MR, their collective 
effects on bone health and the risk of bone fracture among this population. 
Osteology: An Overview 
The human skeleton consists of 206 bones of various lengths, shapes, and 
sizes serving very specific functions. These include: (1) providing protection for 
the vital organs (e.g., brain), (2) support of soft tissue and organs, (3) 
hemopoiesis functions, (4) locomotion via bones acting as levers and attachment 
sites for muscles, and (5) mineral storage (Junqueira, Carneiro, & Kelly, 1992). 
As skeletal bones are structurally and functionally different, so to is their 
composition. Each skeletal bone is composed of a combination of cortical and 
trabecular bone. The proportions of the two types of bone vary throughout the 
different regions of the body. For example, cortical (compact) bone 
compromises approximately 80 percent of all skeletal bone, forms the shafts of 
long bones, the outer shell of other bones, and accounts for approximately 75 12 
percent of the femoral neck, 50 percent of the femur, and approximately 30 
percent of the vertebral bodies (Riggs, 1982; Ward law, 1993). Found to a lesser 
extent, trabecular (cancellous) bone is porous and found primarily at the end of 
long bones, throughout the pelvis and vertebrae, and is metabolically more 
active than cortical bone (Ward law, 1993). As a result, trabecular bone is 
predominantly associated with metabolic functions whereas cortical bone is 
primarily responsible for mechanical functions. (Baron, 1993). 
The internal structure of the bone or matrix is composed of calcium and 
phosphorous, and to a lesser extent bicarbonate, citrate, potassium, and sodium. 
Approximately 99% of the body's store of calcium is found within bone in the 
form of hydroxyapatite as is 90% of phosphorous (Junqueira, Carneira, & Kelley, 
1992). In addition to providing rigidity to bone, calcium and phosphorous are 
needed for other physiological functions including muscle contraction and blood 
clotting. 
As calcium intake and uptake is a vital part of bone formation during 
childhood growth and the replacement of bone cells during adulthood, it has a 
critical role in the prevention of osteoporosis (Schaafsma, 1992). As a result, it is 
instrumental that calcium blood levels be regulated at optimal levels by different 
hormonal agents. Specifically, the release of parathyroid hormone (PTH), 
calcitonin, and vitamin D ensure blood calcium levels are adequately maintained, 
calcium reserves are stored, or calcium excretion is stimulated as needed 
(Hedge, 1987). For instance, if blood calcium levels are low (e.g., during 13 
pregnancy), calcium is absorbed from bones and used to maintain desirable 
levels. Several factors are suggested to interact with bone maintenance and 
turnover, including, but not limited to, physical activity (mechanical loading), 
nutritional practices, pharmacological influences, genetic and lifestyle factors 
(Ward law, 1993). 
Selected Factors Influencing Calcium Metabolism 
The association between calcium intake and bone health has been well 
established, however, there are a number of factors which may positively or 
negatively influence normal calcium metabolism even with a desirable daily 
intake of calcium. Two factors of primary concern for adults with SMR which  can 
influence calcium metabolism include the influence of diet and different 
pharmacological agents. 
The Role of Protein 
To illustrate the prominent role of diet and its relationship to calcium 
metabolism, numerous investigators have examined the role of a high dietary 
protein intake and urinary calcium. For example, Heaney and Recker (1982) and 
others, have suggested that high dietary protein intakes, specifically sulfur-
containing amino acids (Ward law, 1993), enhance bone resorption as it induces 
hypercalciuria. More specifically, Hegsted and Linkswiler (1981) investigated the 
long-term effect (sixty continuous days) of either a 46 g or 123 g/day protein diet 
on the urinary calcium excretion of six females. Results indicate that urinary 14 
calcium held constant on the lower protein diet but doubled when the higher diet 
was consumed. They concluded that the increase in urinary calcium found with 
the high protein diet caused a significant negative calcium balance which could 
have deleterious effects on BMD. 
In a similar study, Hegsted, Schuette, Zemel, and Linkswiler (1981) 
examined the effects of two levels of each dietary protein and phosphorous with 
eight males for 51 continuous days. They reported that when phosphorous 
intake was increased during the protein diets, urinary calcium decreased from 
156 to 93 mg/day and from 334 to 200 mg/day for the low and high diet, 
respectively. Simultaneous increases in protein and phosphorous caused a 28% 
increase in urinary calcium, whereas, protein intake alone caused a 115% 
increase. They concluded that to maintain bone mineral equilibrium, an increase 
in dietary protein necessitates a simultaneous increase in dietary phosphorous. 
Attempting to identify the exact mechanism involved in the protein-induced 
hypercalciuria phenomenon, Allen, Oddoye, and Margen (1979) conducted a 95­
day metabolic study with six adult males who received either 12 g or 36 g of 
nitrogen and 1400 mg of calcium per day. Urinary calcium levels were found to 
increase significantly from a mean of 191 mg/day on 12 g/day nitrogen diet, to 
277 mg/day on the 36 g diet. No significant difference in the absorption of 
calcium consuming the high protein diet were found. They concluded that a 
decrease in the fractional reabsorption of calcium by the kidney appeared to be 15 
the most likely cause of the protein-induce hypercalciuria and that consumption 
of high calcium diet is unlikely to prevent negative balance. 
More recently, Metz, Anderson, and Gallagher (1993), conducted a cross-
sectional study of 38 Caucasian women to identify associations between 
physical activity levels, dietary factors and radial bone mineral density (RBMD). 
The results of a multiple regression analysis revealed that both protein and 
phosphorous intake were negatively associated with RBMD (p < 0.05), whereas, 
physical activity level and LBM were positively associated. They suggested that 
dietary protein and phosphorous intakes greater than suggested RDA values 
were adverse for BMD. 
From a practical standpoint, Schaafsma (1992) has stated that calcium 
absorption decreases with advancing age and that a limitation on dietary protein 
and sodium consumption is recommended to prevent a negative calcium balance 
situation. Current RDA guidelines suggest that adults over the age of 51, 
consume approximately 0.45 g/kg of body weight. However, this may vary 
greatly in the elderly. Nevertheless, Tkatch and associates (1992) have 
suggested that individuals not getting adequate dietary protein may be at greater 
risk of hip fracture. 
Tkatch et al (1992) examined the effects of two different dietary 
supplements with different protein contents on sixty-two patients who were 
admitted into a orthopedic ward for a proximal femur fracture. One group (30 
females, 5 males; 83.2 ± 1.3 years) received 250 ml/day of an oral protein 16 
containing supplement, while a control group (24 females, 5 males; 81.3 ± 1.6 
years) received the same supplement but with no protein. They found that the 
median hospital stay was significantly lower (p < 0.05) in the protein supplement 
group (69 v. 102 days). Seven months following fracture, there were no 
significant BMD differences between groups, however, the number of patients 
showing a significant decrease in FBMD was lower in the protein supplemented 
group (p < 0.05). They concluded that elderly adults who had experienced a 
femoral neck fracture and received an oral protein supplement showed more 
favorable outcome after fracture. 
The findings of Tkatch et al suggest a need for protein supplementation 
following fracture. Yet, data from Pinchcofsky-Devin and Kaminski (1987) 
suggest that individuals residing in nursing homes may not be receiving 
adequate levels of dietary protein. Data were collected from two nursing homes 
with a total of 225 patients (72.2 ± 21 years). Assessment included biochemical 
(e.g., serum albumin) and anthropometric measurements (skinfold & 
circumference). Evaluation of the data indicated a 52% incidence of malnutrition, 
including 24% hypoalbuminemic nutrition and 76% of individuals were anemic. 
They concluded that the incidence of malnutrition to be much greater than 
previously reported for this population. 
Most recently, Feskanich, Willett, Stampfer, and Colditz (1996) investigated 
the association between dietary protein and bone fractures in a cohort of 85,900 
women between the ages of 35 and 59 years old. During 931,512 person-years 17 
at follow-up, over 200 hip and 1,600 forearm fractures were identified during a 
twelve year period. They found that while animal protein intake was associated 
with an increased risk of forearm fracture in women who consumed more than 95 
g per day versus women with consumption less than 68 g per day (RR = 1.22, 
95% CI 1.04-1.43, p = .01), vegetable protein intake was not associated with 
bone fracture. Similarly, no association was found between dietary protein 
(vegetable or animal) and the occurrence of hip fracture. 
The Influence of Steroidal Medications 
The use glucocorticoid and other steroidal medications has been shown to 
produce bone loss in healthy young adults (Godschalk & Downs, 1988; Nielsen, 
et al., 1988), elderly men (Mitchell, Jackson, & Lyles, 1991), and asthmatics 
(Adinoff & Hollister, 1983). Specifically, these types of drugs alter bone 
remodeling (Lukert & Raisz, 1990; Mitchell & Lyles, 1990) by decreasing bone 
formation (Klein, Arnaud, Gallagher, Deluca, & Riggs, 1977), intestinal calcium 
absorption (Kimberg, Baerg, Gershon, & Graudusius, 1971), increasing renal 
calcium exertion (Nielsen, et al, 1988), and altering gonadal functioning (Luton, 
Thieblot, Valcke, Mahoudeau, & Bricaire, 1977). 
Traditionally, glucocorticoid medications have been used to treat conditions 
such as asthma and rheumatic disorders, however, studies which examined the 
efficacy of glucocorticoids on BMD bone have been with healthy adults. For 
example, Mitchell and colleagues (1991) investigated the short-term effects of 
glucocortoid use on seven Caucasian males (68.6 ± 5.3 yrs.) to determine their 18 
influence on the serum levels of BGP (a biochemical marker of bone 
metabolism), calcium, phosphorous, PTH, and alkaline phosphatase. Following 
baseline serum measurements, subjects were given 40 mg of prednisone orally 
on five consecutive days. Blood samples were obtained on days 7 through 11, 
13, 15, and 17 after the completion of prednisone. Subjects served as their own 
controls. Mitchell et al. reported that within 24 hours of the first dosage of 
prednisone, serum BGP levels were diminished. Furthermore, after five 
continuous days of treatment, BGP levels dropped an average of 78%, which 
was found to be significantly different than baseline values (p = 0.004). 
However, within 24 hours of completing the medication routine, serum BGP 
values were not significantly different than baseline values obtained. 
The Influence of Anticonvulsant Medication 
Antiepileptics, also known as antiseizure or anticonvulsant medications are 
widely prescribed for the treatment of seizure disorders such as epilepsy which is 
commonly found among individuals with SMR. For instance, Tannenbaum, 
Lipworth, and Baker (1989) report that 80% of individuals with MR residing in an 
intermediate care facility were using one or more anticonvulsant medications to 
control seizures. Moreover, Cunningham and Mueller (1987) suggested 
anticonvulsant drugs to be one of the most frequently prescribed medications for 
this population. While anticonvulsant medications are often the first choice in the 
treatment of seizure disorders, only 80% of seizure disorders are controlled by 
medications which are prescribed based upon the severity of the disorder as well 19 
as the possible side effects associated with these drugs (Coulter, 1991). 
Unfortunately, one such long term side effect of selected anticonvulsant usage 
includes bone mineral loss (Eadie, 1984). 
Anticonvulsant medications have been documented to have a determential 
effect on BMD and calcium absorption in the gut (Hahn, 1976; Hunter, Maxwell, 
Stewart, Parsons & Williams, 1971; liavainen & Savolainen, 1983; Mosekilde & 
Melsen, 1976; Tolman, Jubiz, Sannella, & Madsen, 1975). Three such studies 
examined the bone status of nonambulatory individuals residing in state 
institutions with MR on anticonvulsant therapy. Specifically, Lee and Lyne 
(1990), Lee, Lyne, Kleerekoper, Logan, and Belfi (1989), and Fischer, Adkins, 
Leibl, VanCalcar, and Mar lett (1988) report that anticonvulsants are partially 
responsible for the osteopenia which occurs in children and young adults with 
multihandicaps. However, therapeutic interventions to help prevent the negative 
influences of anticonvulsant medications have been encouraging with this 
population. For instance, using photon absorptiometry, Fischer, Adkins, Liebi, 
VanCalcar, and Mar lett (1988) investigated the effects of vitamin D therapy on 
the BMC and bone mineral density (BMD) of youngsters with profound MR 
concurrently taking anticonvulsant medications and residing in a state 
developmental center. Eleven nonambulant youngsters between 7 and 17 years 
old (six males, mean age = 14.3 and five females, mean age = 10.6), with 
profound MR were given vitamin D therapy at a dosage of 4,000 IU/m2 body 
surface area/day for 6 continuous months. Seven of the eleven subjects were on 20 
at least two anticonvulsant therapies, including two individuals taking four 
different types. Single photon absorptiometry BMC and BMD measurements 
were obtained at baseline, three- and six- months of vitamin D therapy. The 
results of the study indicated a significant increase (p < 0.01) in the BMC values 
for 9 of the 11 clients with one client showing a decrease in BMC. Fischer et al. 
concluded that supplementation of vitamin D therapy for nonambulant 
youngsters with profound MR taking anticonvulsant medications can improve 
BMC values. However, the authors made no mention of a control group and it is 
uncertain if BMC changes were strictly due to Vitamin D therapy alone or as the 
result of developmental progression. 
Immobilization and BMD 
Since the late 1800's it has been known that bone cells, like muscle tissue, 
are dynamic in nature and ever changing in response to the mechanical forces 
placed on them (Wolff, 1986 {Translation }). These bone cells (osteoblasts, 
osteoclasts, & osteocytes) are in a constant flux between dissolution (resorption) 
and formation (absorption). Collectively, this cycle known as remodeling 
continues throughout adult life (Frost, 1993). 
While the remodeling process is a complex series of physiological events 
not fully elucidated, it is known that different types of cells take part in the 
remodeling process. Mainly, osteoclast, the bone-dissolving cells, and 
osteoblasts, bone rebuilding cells, respond to different stimuli. For example, the 
presence and utilization of such systemic hormones as thyroxine, estrogen, and 21 
insulin; local factors (prostaglandin's), growth factors (insulin-like), mechanical 
loading (type, duration, intensity of physical activity), lifestyle factors (smoking, 
diet), and pharmacological therapies all can influence the remodeling process 
(Toss, 1992; Ward law, 1993). 
While osteoclast and osteoblast respond to varied stimuli, including physical 
activity, what is not known is the exact mechanism necessary to positively 
influence bone absorption within humans (Lanyon, 1992). More specifically, the 
type, intensity, frequency, or duration of physical activity necessary to stimulate 
absorption and/or decrease resportion (loss) (Heinonen, Oja, Kannus, Sievanen, 
Haapasalo, Manttari, & Vuori, 1995). 
Empirical investigations have examined the influence of weightlessness, 
prolonged bed rest, immobilization, and physical activity on the effects of BMD 
through a variety of qualitative and quantitative judgments (Lanyon, 1987). For 
example, quantitatively, strain gauges have been attached internally to the limbs 
(in vivo) of turkeys (Lanyon & Rubin, 1984), sheep (Churches, Howlett, Waldron 
& Ward, 1980; O'Connor, Lanyon, & Mac Fie, 1984), and roosters (Rubin & 
Lanyon, 1984) including the only in vivo human study (Lanyon, Hampson, 
Goodship, & Shah, 1975) to determine the extent of mechanical loading on 
bones during various activities and its influence on bone modeling. Conversely, 
qualitative investigations have examined the effects of athletic participation, 
medications, and nutrition on changes in BMC. 22 
It is widely known that mechanical loading through weightbearing activities 
(LeVeau & Bernhardt, 1984), is positively related to BMD (American College of 
Sports Medicine, 1995). Yet, investigators continue to explore different 
interventions and treatment strategies that will prevent and/or reverse the onset 
of osteoporosis and minimize the occurrence of fracture. Chesnut (1991) 
suggests that the determinants of osteoporosis include: (1) obtaining optimal 
peak bone mass, (2) peak bone maintenance, and (3) minimizing the rate of 
bone mass loss. To illustrate the importance of each of these factors, it is useful 
to examine data from human exposure to weightlessness where rapid changes 
in BMD are found. 
Residence in the weightless environment of space appears to influence 
BMD in a manner comparable to that which has been seen in disuse 
osteoporosis due to immobilization (Lutwak, Whedon, La Chance, Reid, & 
Lipscomb, 1969; Turner & Szukalski, 1985). Specifically, human bed-rest studies 
comparing pre- and post-bone biopsy samples (Vico, et al., 1987) and animal 
immobilization studies using osseous tetracycline staining (Landry & Fleisch, 
1964) have shown increased bone resportion to occur during disuse. As a 
result, during extended duration spaceflights or long periods of immobilization, 
BMD losses may reach detrimental levels and seriously increase susceptibility to 
fracture. 
Progressive bone loss seen with exposure to weightlessness has been 
mainly due to the removal of mechanical stresses produced by earth's gravity 23 
from the weight-bearing bones of the body (Donaldson, Hulley, Vogel, Hattner, 
Bayers, & McMillan, 1970; Issekutz, Blizzard, Birkhead, & Rodahl, 1965). 
Therefore, zero-gravity induced bone loss is of concern for individuals due to 
long-duration spaceflights or, for the purposes of this study, for individuals who 
are not capable of weightbearing due to physical and/or mental impairment. 
While Turner (1995) reports that inhibition of periosteal bone formation in 
young rats was not present on a four-day spaceflight, photon absorptiometric 
measurements taken on Gemini and Apollo crewmembers indicate that bone 
losses occur on even relatively short spaceflights (Mack, La Chance, Vose, & 
Vogt, 1967; Mack & Vogt, 1971). However, due to species and skeletal 
configuration differences in spaceflight experiments, and environmental 
differences (e.g., mechanical loads) between bed-rest or immobilization and 
spaceflight, no conclusive statements can be made at this time as to the precise 
mechanisms of human bone loss during prolonged periods of weightlessness. 
Yet, there has been a tremendous need to address this issue as demonstrated in 
the field of rehabilitation medicine. 
Prior to the known effects of space travel on bone mineral, the return of 
thousands of soldiers with disabilities following the end of the Second World War 
initiated interest on the influence of prolonged periods of immobilization on BMD. 
Studies such as Howard, Parson, and Bigham (1945), and Dunning and Plum 
(1957), confirmed, that in fact, extended bed rest/immobilization was detrimental 
to BMD in humans. As a result, numerous investigators began exploring 24 
different therapeutic interventions to minimize and/or reverse these deleterious 
effects, including the use of ambulation (Abramson, 1948), an oscillating bed 
(Whedon, Deitrich, & Shorr, 1949; Whedon & Shorr, 1957), standing (Freeman, 
1949), heavy resistance exercise (Clark, Watkins, Tonning & Bauer, 1954), and 
tilt table (Wyse & Pattee, 1954). 
Perhaps most noteworthy of these studies is the work of Issekutz, Blizzard, 
Birkhead, and Rodahl (1965) who investigated the effects of prolonged bed rest 
and physical activity on the urinary excretion of calcium. Fourteen males 
between the ages of 18 and 21 years participated in twenty different 
experimental conditions, including: (a) complete bed rest for 18-42 continuous 
days with no physical activity, and/or (b) one hour exercise (supine or sitting 
bicycle ergometer) and 23 hours bed rest daily, (c) complete bed rest for 18 
continuous days followed by 2 hours of daily supine exercise for 13 days, (d) 
sitting for 8 hours followed by bed rest the remaining 16 hours each day, (e) 18 
days complete bed rest followed by 24 days with 3 hours of daily standing, (f) 40 
days of continuous bed rest followed by a standing program, and (g) complete 
bed rest for 32 days followed by 15 days of 8 hr/day sitting or 15 days. Baseline 
urinary calcium excretion levels averaged 218 mg/day for subjects prior to the 
onset of bed rest. Following 18-42 days of continuous bed rest, urinary calcium 
excretion increased an average of 157 mg/day for all subjects. After a minimum 
of 18 continuous days of bed rest, there were no significant decreases in urinary 
calcium excretion following participation in the one, two, or four hour daily sitting 25 
or supine exercise programs. However, calcium output started to decline 
following the return of normal weightbearing activities. Interestingly, while four 
hours of daily recumbent cycling did not positively influence calcium excretion 
during bedrest, a passive standing program did. One of two subjects who stood 
two hours per day showed a decline in urinary calcium excretion while four of five 
subjects who stood three hours per day also displayed this same trend. The 
authors concluded that "the increase in urinary calcium output in prolonged 
horizontal positions is due to the absence of longitudinal pressure 
(weightbearing) on the bones rather than the physical inactivity during bed rest " 
(p. 1013). Unfortunately, statistical analyses were not performed for any of the 
experimental conditions and the sample size was small. 
If weightbearing alone is responsible for declining the urinary calcium output 
as Issekutz et al. (1965) and others (Donaldson, et al., 1970; Schneider & 
McDonald, 1984) have suggested, it would therefore seem beneficial for 
nonambulatory subjects to stand each day to help prevent calcium losses. This 
may be particularly significant for subjects who are unable to ambulate 
independently and need supervised therapeutic sessions in order to establish 
weightbearing positions. Yet, researchers do not agree on the benefits of 
passive standing for the prevention of osteoporosis. This includes the use of 
assisted standing programs with individuals who have experienced spinal cord 
injuries (SCI), older adults with idiopathic osteoporosis, children or adults with 
other orthopedic and/or mental impairments. However, it has been suggested 26 
since 1929 (Cuthberson, 1929), and is now widely accepted, that a lack of 
physical activity is a contributing factor in the development of osteoporosis 
(Lindsay, 1993). 
Abramson (1948) investigated bone disturbances in ambulatory and 
nonambulatory adults with SCI several years post-injury. After 
roentengographical analysis, Abramson found that twenty-five of thirty 
nonambulators had osteoporosis in varying degree. Conversely, seven of eight 
ambulators showed no signs of osteoporosis. Unfortunately, Abramson did not 
report how osteoporosis was determined, the site of the roentengograph, or the 
duration after injury in which the measurements were obtained. However, as a 
result of his findings, Abramson concluded that ambulation may prevent urinary 
calculi which in turn may influence bone status. 
Freeman (1949) also suggested that ambulation and standing reduced 
calcium loss. Similar findings were reported by Whedon and Shorr (1957) while 
using a rocking bed for immobilized healthy men but not found in individuals with 
poliomyelitis. Likewise, Wyse and Pattee (1954) did not find rocking or standing 
beneficial to a group of adults with paraplegia. 
In a study to investigate different therapeutic intervention strategies on the 
intensity and duration of hypercalciuria, Plum and Dunning (1958) studied the 
effects of rocking, sitting, standing, underwater therapy, and crutch-walking in 
thirty-seven subjects paralyzed by poliomyelitis. Plum and Dunning further 
classified individuals by the extent of limb involvement due to paralysis. Seven 27 
males and nine females were identified with quadriplegia. From the clinical onset 
of poliomyelitis, the authors followed subjects throughout the rehabilitation 
process and at later follow-up. They reported that none of the therapeutic 
interventions were effective in reducing calcium output in poliomyelitis patients 
and that hypercalciuria continued for an average of 11 to 12 months after 
diagnosis of poliomyelitis. Likewise, in a group of twenty patients with paraplegia 
and "moderate paralysis", there was found to be no reduction in calcium 
excretion as a result of the intervention. However, the authors reported one 
patient who could ambulate with canes did show a reduction in calcium output 
and that other patients who ambulated independently returned to normal calcium 
excretion levels. Plum and Dunning concluded that the force applied to bone as 
a result of the muscular capacity to do so and not the ability to ambulate is the 
most effective means of preventing disuse osteoporosis. Similarly, Abramson 
and Delagi (1961) suggested that muscle action is the most effective stress upon 
bone preventing disuse osteoporosis and further suggested that while 
weightbearing is less effective, it probably has value in preventing osteoporosis. 
Yet recent investigations on the BMD of collegiate swimmers do not fully 
support these conclusions (Taaffe, Snow-Harter, Connolly, Robinson, Brown, & 
Marcus, 1995). Fehling, Alekel, Clasey, Rector, and Stillman (1995) compared 
the lumbar spine (LSBMD), proximal femur (PFBMD), and WBMD, including 
regional analyses for both arms and legs, torso, and pelvis (specific sites were 28 
not provided) among Caucasian collegiate female swimmers (n = 7), volleyball 
players (n = 8), and gymnasts (n = 13).  In addition, a non-active control group 
(n = 17) was also compared using DXA. After controlling for differences in height 
and weight between subjects and groups, Fehling et al reported that the higher 
loading groups (volleyballers and gymnasts) had significantly greater WBMD 
(including legs and pelvis), LSBMD, and FBMD values compared to both the 
swimming and control groups. Furthermore, Fehling et al reported no significant 
difference in BMD measurements obtained at any site between the swimming 
group and the control group, yet the swimmers were reported to have 
significantly greater (p < .05) lean body mass (LBM). They concluded that 
collegiate females who participated in high impact sports (volleyball and 
gymnastics) have greater BMD values than those who do not participate in these 
sports. Furthermore, as participation in a non-loading sport (swimming) yielded 
similar BMD values compared with a group of non-active woman, these results 
suggest that the muscular forces generated during swimming do not provide 
significant forces (loads) to positively influence BMD. These findings are 
consistent with those of Risser, Lee, LeBlanc, Poindexter, Risser, and Schneider 
(1990) who compared lumbar spine and calcaneal BMD among 29 Caucasian 
female collegiate athletes competing at a Division I University in the sports of 
volleyball (n = 12), basketball (n = 9), and swimming (n = 10). Additionally, a 
non-active control group of thirteen college-aged females was also compared in 
the study. After adjusting for height and weight, swimmers were found to have 29 
significantly lower LSBMD values compared to all other groups, including the 
non-active control group. In addition, the swimmers and the non-active group 
had significantly lower calcaneal BMD values (p < 0.05) compared to the 
volleyball and basketball groups. When comparing the volleyball and basketball 
groups, no significant BMD differences were found for calcaneous or lumbar 
spine. Furthermore, volleyball players had significantly greater (p < 0.05) 
LSBMD values than the non-active group. Like the findings of Fehling et al., 
swimmers were found to have equivalent or lower BMD values when compared 
to non-active females of similar age, and significantly lower than females 
participating in high impact sports including volleyball, basketball, and 
gymnastics. 
One such group which has difficulty with weightbearing activities, including 
an increased risk of demineralization due to disuse are individuals with SCI. 
Previous researchers have suggested that individuals with paraplegia are at 
greater risk of spontaneous fractures as a result of disuse osteoporosis (Comarr, 
Hutchinson, & Bors, 1962; Drennan & Freehafer, 1971; Ohry, Shemesh, Zak, & 
Herzberg, 1980; Rafii, Firooznia, Golimbu, & Sokolow, 1982; Ragnarsson & Sell, 
1981). However, recent investigations have found that while hip BMD values 
were found to be significantly lower in men and women with SCI, lumbar spine 
and forearm BMD values were at or near normal values (Biering-Sorensen, Bohr, 
& Schaadt, 1988, 1990; Eddins, et al.,1995; Leslie & Nance,1993). For instance, 
using DXA, Biering-Sorensen, Bohr, and Schaadt (1990) investigated the 30 
change in lumbar spine, femoral neck and shaft, distal forearm, and proximal 
tibia bone mineral content (BMC) in six men and two women between the ages 
of 18 and 49 years. BMC data were obtained an average of 43 days post-injury 
(range 9-167 days) and subjects were followed up to 53 months after-injury 
(average 41 months). All individuals with SCI had complete lesions ranging from 
C7 to L1. The authors reported that while proximal tibia and femoral neck values 
reached between 40-50% and 60-70% of normal values respectively, lumbar 
spine and distal forearm BMC were virtually unchanged. Beiring-Sorensen, 
Bohr, and Schaadt concluded that normal muscle function is necessary to 
prevent BMC losses and that unchanged lumbar spine BMC may be due to the 
continuous weightbearing to the trunk required with wheelchair use. 
Using Compton gamma ray scattering technique, Gross, Roberts, Foster, 
Shankardass, and Webber (1987) conducted an investigation of the calcaneal 
bone density in twenty-six males and twenty-three females with restricted 
mobility due to such factors as: multiple sclerosis (n = 20), cerebral palsy 
(n = 4), traumatic brain injury (n = 10), and SCI (n = 8). The investigators 
reported that mobility had been restricted from 1.5 to 43 years prior to bone 
density measurement. Using forward stepwise multiple regression analysis, 
Gross et al examined the influence of disease diagnosis, lower limb muscle tone, 
gender, and years after condition onset to determine if bone density was related 
to these variables. They reported that while 57% (n = 28) of subjects tested had 
bone density values one standard deviation or more below predicted normal 31 
density, none of the variables included in the forward stepwise regression 
analysis were significant predictors on calcaneal bone density. Gross et al 
concluded that the low calcaneal values obtained were probably a result of 
restricted weightbearing activity and a reduction in their participation in  physical 
activities. 
Kunkel, Scremin, Eisenberg, Garcia, Roberts, and Martinez (1993) 
investigated the effects of standing on BMD, spasticity, and contactures of six 
wheelchair dependent (average 19 years in chair) adults, including five 
individuals with SCI. Following pre-testing and familiarization with the standing 
apparatus, six men (mean age 49 years) were asked to stand 45 minutes  twice 
per day for five months in a specialized standing frame. Femoral neck and 
lumbar spine BMD measurements were obtained using DXA.  Upon completion 
of the five month protocol, subjects had averaged standing 144  hours over 135 
days. The results of standing did not influence femoral neck or lumbar BMD, 
contractures, or spasticity values. Kunkel et al (1993) reported that femoral neck 
values were not significantly different as a result of the standing but were found 
to be significantly lower than that of healthy men. Like previous researchers 
(Biering-Sorensen, Bohr, and Schaadt 1988, 1990; Leslie and Nance,1993), 
Kunkel et al also reported that lumbar spine BMD values, while unchanged due 
to the standing protocol, were in the normal range compared to healthy men. 
Lastly, while standing did not improve BMD values, subjects reported improved 
psychological well-being as a result of being able to stand daily. 32 
While the use of assisted standing remains unfounded in reversing the 
effects of disuse osteoporosis, researchers have attempted to identify other 
therapeutic modalities to help minimize or reverse the effects of osteoporosis. 
For example, in a group of men with quadriplegia, Leeds et al (1990) 
investigated the influence of a functional electrical stimulation (FES), cycle 
ergometry training on proximal femur BMD. Six men with quadriplegia between 
the ages of 18 and 27 years trained three days per week for seven months on a 
FES cycle ergometer. After initial familiarization and training, subjects trained for 
30 minutes each session. Pre- and post-training proximal femur measurements 
(femoral neck, Ward triangle, and trochanter) were obtained using DXA. 
Expressed as a percentage of healthy men, Leeds and colleagues reported that 
BMD data were 65, 52, and 46 percent of normal for the femoral neck, Ward's 
triangle and trochanter, respectively. Following seven months of training, there 
was no significant difference in BMD values for any of the three sites. Leeds et al 
concluded that FES cycle ergometry was not effective in producing positive BMD 
changes in the proximal femur for men with quadriplegia. However, these 
findings are not limited to adults with disabilities. For instance, Schneider and 
McDonald (1984) studied the effects of 5 to 36 weeks of continuous bed rest on 
90 healthy men (mean age = 25 years). In an attempt to minimize bone mineral 
loss, a variety of different interventions were investigated including the use of: (1) 
calcium supplementation, (2) physical activity, (3) skeletal compression, (4) 
vitamin D therapy, and (5) hydrostatic pressure to the legs. In spite of the 33 
different interventions, urinary calcium was found to increase substantially and 
monthly calcaneal bone mineral losses of 5% were reported. Like Issekutz et al 
(1965) and others, the authors concluded that prolonged periods of 
immobilization and the lack of weightbearing activity causes skeletal loss. 
Schneider and McDonald concluded that despite the intervention strategies of 
physical activity, calcium and vitamin D supplementation, the lack of 
compressive and impactive forces were responsible for calcaneal bone loss. 
At this time, there remains a paucity of information on the most effective 
strategies for minimizing the adverse effects of nonambulation among children 
and adults. There has been numerous descriptive investigations on the bone 
health of individuals with SCI, yet little information remains for individuals with 
other disabilities. While FES has been shown to reverse the effects of muscular 
atrophy and enhanced quadricep blood flow of individuals with SCI (Taylor, et al., 
1993), there has been no proof that this can maintain or improve BMD in 
nonambulatory children or adults. As a result, modern researchers continue to 
seek definitive answers on how best to treat disuse osteoporosis among children 
and adults with and without disabilities. 
BMD and Mental Retardation 
Until recently, there has been no information available on the BMD of 
children or adults with MR (Kao, Chen, Wang, & Yeh, 1992). However, three 
recent investigations have examined this issue among younger adults with mild 
and SMR. 34 
Using DXA, Sepulveda and colleagues (1995) compared the arm, leg, 
pelvic, and spinal BMD of a group of males (n = 11) and females (n = 4) with 
Down syndrome (DS) (28.8 ± 9.71 years) to a group of males (n=12) and 
females (n =13) without MR (31.24 ± 9.49 years). Unfortunately, specific BMD 
measurement sites were not provided by the authors (e.g., femoral neck rather 
than "leg"). Body composition values, including percent body fat, fat mass, and 
LBM, were also obtained using DXA. Control subjects were selected due to their 
similarity with individuals with DS on age, height, and weight but not matched 
one-to-one. No mention was made of ambulatory ability, activity level, dietary 
differences or status of other factors which may have differentiated the two 
groups (e.g., tobacco use). Sepulveda et al reported no significant differences 
between groups among age, weight, LBM, percent body fat, or fat mass, 
however, a significant difference existed between groups in height. Arm and leg 
BMD values, while lower in the DS group, were not significantly different from the 
control group. Pelvic and spine BMD values were both significantly greater (p = 
.001) in the control group compared to the group with DS. After adjustment for 
covariates, the percentage difference between the two groups for pelvic and 
spine BMD values was 11.1% and 13.9%, respectively. The results of this study 
should be noted with caution, as neither the control or DS group were 
homogeneous in terms of ethnicity. Specifically, the control group included 
twelve non-Caucasians, including five African-Americans and no mention was 
made if subjects were matched on ethnic background. This may be problematic 35 
when comparing the results as it is well documented that African-Americans 
have greater BMD values and fewer fractures compared to Caucasians (Farmer, 
White, Brody, & Bailey, 1984; Karagas, Lu-Yao, Barrett, Beach, & Baron, 1996). 
In another comparative study, Felix (1993) investigated the BMD of 
premenopausal women with and without mild MR between the ages of 19 and 45 
years old. All subjects were able to ambulate independently, were free of any 
known life-threatening diseases, and did not take any medications which were 
known to effect bone metabolism other than oral contraceptives. Subjects were 
matched on age, menopausal status, body mass index (BMI), and oral 
contraceptive usage. In addition, subjects were evaluated for health and level of 
physical activity (questionnaire), muscular strength, and body composition. Felix 
reported no significant differences between groups among age, weight, and BMI. 
However, like Sepulveda et al, Felix (1993) reported a significant difference 
between groups in height. Furthermore, he reported that while the average 
FBMD and WBMD were lower for women with MR, these values were not 
significantly different than values obtained for their non-retarded peers. Lastly, a 
stepwise regression analysis revealed that lean muscle mass (LMM) was the 
best predictor of FBMD and WBMD in women with MR. In women without MR, 
biceps strength was the best predictor of FBMD while LMM and quadriceps 
strength were the best predictors of WBMD. 
Most recently, Downs, McCubbin, Snow, Baylor, and Whitney (1996) 
investigated the FBMD and mid-shaft femur BMD (MFBMD) of sixty-one 36 
ambulatory and nonambulatory males and premenopausal females with SMR 
who: (1) were between the ages of 25 and 45 years old, (2) were full-time 
continuous developmental center residents during the previous five years, (3) 
were on anticonvulsant therapy continuously for ten or more years, (4) had no 
history of a fracture in the long bones of one leg, and (5) had no history of 
metabolic and/or bone disease. Subjects were divided into three groups: (1) 
Ambulatory (13 males, 8 females; 35.52 ± 5.6 years) nonambulatory 
weightbearers (tilt table standers) (16 males, 12 females; 35.04 ± 5.6 years), or 
(3) nonambulatory, nonweightbears (no tilt table standing) (6 males, 6 females; 
35.08 ± 5.1 years). Results of the study found that ambulators had significantly 
greater (p < .01) FBMD and MFBMD compared with both nonambulatory groups. 
Also, MFBMD was higher and there was a trend toward greater BMD in all sites 
in nonambulatory weightbearers compared with the nonweightbearing­
nonambulatory group, suggesting tilt table standing positively influenced bone 
mass. While the results of this study would suggest the advantages of tilt-table 
standing for nonambulatory adults, Downs et at reported a number of limitations. 
First, there was no way to control subjects for factors that influence BMD such 
as: (a) diet, (b) unmonitored physical activity, (c) heredity, and (d) smoking 
behavior. Secondly, the health and physical activity level; type, duration of 
usage and combination of medications; and the length of time that individuals 
had been nonambulatory varied greatly between subjects. Thirdly, the amount of 
weightbearing which did occur during tilt table standing was not monitored.  It 37 
was unknown if 100% of clients body weight was applied to the base of the tilt 
table during each session or if the straps which held the client onto the table 
reduce the clients applied body weight to less than 100%. In addition, it is 
unclear if clients weight was distributed equally on both limbs. Finally, there is no 
way of knowing whether subjects who were eligible for the tilt table protocol had 
greater BMD values prior to tilt table standing. As a result, Downs et al 
suggested that future research be undertaken to examine the influence of 
assisted standing on nonambulatory adults with SMR who are at greater risk of 
disuse osteoporosis and spontaneous fracture with the development of a safe 
and appropriate weightbearing protocol. 
Compared with the results of Sepulveda and colleagues (1995) and Downs 
et al (1996) the results of the Felix (1993) study did not suggest that individuals 
with MR were at greater risk of osteoporosis. Yet, many individuals with MR 
have secondary conditions which may directly or indirectly influence bone 
mineral status. While MR may not cause osteoporosis, common secondary 
medical conditions, and lack of individual understanding, opportunity, 
participation or information about healthy lifestyle factors may influence bone 
health. 
One such medical condition which has been investigated is the 
prevalence of hypothyroidism in individuals with DS. Either congenital or 
acquired in nature, hypothyroidism is common among individuals with MR, 
particularly those with DS (Baxter, Larkins, Martin, Heyma, Myles, & Ryan, 1975; 38 
Murdoch, Ratcliffe, McCarty, Rodger, & Ratcliffe, 1977). For instance, cretinism 
is one such congenital endocrine disorder characterized by a deficiency of 
thyroid hormone causing MR (Luckasson, et al., 1992). Hypothyroidism, 
particularly in children, may result in abnormal skeletal growth (Perry, 1989). 
While hypothyroidism has actually been shown to increase calcium absorption 
within the gut, the calcium is not deposited within the bones; rather than storing 
the excessive calcium, a hypercalciuria state resulting in negative calcium 
balance is achieved (Krane, Brownell, Stanburg, & Corrigan, 1956; Lekkerkerker 
& Doorenbos, 1973). 
In an attempt to determine the presence of hypothyroidism in a group of 
adults with DS, Mani (1988) examined fifty-five individuals residing in a state 
developmental center for the presence of thyroid dysfunction as determined by 
both clinical (e.g., lethargy, reflexes), and biochemical features (e.g., elevated 
TSH, low T4). Of the thirty-two males and twenty-three females with DS 
examined, twenty-eight exhibited clinical signs suggestive of hypothyroidism. 
Upon further examination via biochemical analyses, twelve were found to have 
hypothyroidism. Mani concluded that while 50% of individuals with DS exhibited 
clinical signs of hypothyroidism, approximately 20% (n = 12) of those individuals 
with DS examined had biochemical results indicative of hypothyroidism 
compared to a reported population average of approximately 1.1%. 
Frequently, hypothyroidism is treated with thyroxin, a form of thyroid 
hormone. Jancar (1990) examined the presence of osteoporosis in 39 
institutionalized adults with SMR on thyroxine treatment for hypothyroidism. 
Nineteen subjects, including fourteen females (mean age = 63.3 years) and five 
males (mean age = 54 years) were examined. Females had been on thyroxine 
treatment an average of 11.4 years, males 11.2. The results of the investigation 
found that nine of the fourteen females (64%) and one of the five males (20%) 
showed signs of either osteoporosis or had a related bone fracture. 
Unfortunately, Jancar did not report on the menopausal status of the females, 
the ambulatory/activity levels of either groups, or how signs of osteoporosis were 
determined, thus it is difficult to suggest that thyroxine treatment is implicated in 
causing bone fragility in this study. While Jancar concluded the need for further 
study of the effects of thyroxine therapy for individuals with MR being treated for 
hypothyroidism, previous investigators suggested individuals undergoing such 
treatment are at risk for developing osteoporosis (Cooper, 1988; Paul, Kerrigan, 
Kelly, Braverman, & Baran, 1988). 
Menopause & Hormone Replacement Therapies 
Produced mainly by the ovaries, estrogen is circulated via the blood to 
many of the tissues and organs of the body. At the onset of menopause, 
decreased ovarian function results in a loss of estrogen (Nordin, Aaron, Speed, 
& Crilly, 1981). There are several physiological mechanisms whereby estrogen 
exerts an effect on BMD (Marks & Popoff, 1988). First, estrogen deficiency 
indirectly leads to greater osteoclastic activity by diminishing osteoblastic activity 
within the bones. Secondly, estrogen promotes the synthesis of calcitonin which 40 
inhibits bone resorption. Lastly, estrogen enhances the active metabolite of 
Vitamin D, 1, 25-dihyroxyvitamin D3, which increases absorption of calcium at 
the intestine. As a result of decreased estrogen production at menopause, BMD 
declines rapidly, particularly during the first five years of menopause (Snow-
Harter & Marcus, 1991). 
The importance of estrogen function can be demonstrated when a young 
women has had the surgical removal of her ovaries. Following oophorectomy, a 
rapid phase of bone loss occurs attributed to the loss of estrogen (Fogelman, 
Poser, Smith, Hart, & Bevan, 1984). Similarly, this pattern of bone loss occurs 
during menopause which parallels the age-related, gradual decrease in bone 
loss after peak bone mass attained during the third decade of life (Sinaki, 1989). 
The accelerated bone loss seen in women in the first five years of 
menopause can be prevented by hormone replacement therapy (HRT) 
(Horsman, Gallagher, Simpson, & Nordin, 1977; Lindsay, et al., 1976). Perhaps 
due to the wide variation in methodologies and populations studied, neither 
physical activity nor calcium supplementation alone or in combination have 
repeatedly shown positive effects on BMD in postmenopausal women (AGSM, 
1995). 
While Aloia and colleagues (1994) reported that calcium augmentation 
(1700 mg/day) alone significantly reduced bone loss in 118 postmenopausal 
Caucasian women followed over a three year period, it was significantly less 
effective than estrogen-progesterone-calcium supplementation given to a similar 41 
group of women. Unfortunately, there was no estrogen-progesterone only group 
in this design. 
The efficacy of HRT in preventing postmenopausal bone loss has been 
widely documented in both retrospective and prospective studies and at a 
number of skeletal sites, including the femoral neck and spine (Christiansen & 
Riis, 1990; Cititelli et al., 1988; Stevenson, et al., 1990). In addition, some of 
these studies have demonstrated an increase in bone mass in response to 
estrogen replacement therapy (ERT) or HRT. Stevenson and colleagues (1990) 
have shown in a prospective study that transdermal estradiol increased BMD in 
the spine and proximal femur in postmenopausal women and cross-sectional 
data suggest similar results (Savvas, et al., 1988). 
A number of studies have shown that ERT/HRT use is associated with a 
reduction in fracture risk in the hip, spine, and radius (Ettinger, Genant, & Cann, 
1985, 1988; Kiel, Felson, Anderson, Wilson & Moskowitz, 1987; Naessen, 
Person, Adami, Bergstrom, Bergkvist, 1990). More recently, Tuppurainen et at 
(1995) reported HRT use had a protective effect (odds ratio 0.70, 95% CI 0.50 ­
0.96) against fractures in a cohort of 3,140 women (53.4 years ± 2.8 years) 
followed for an average of 2.4 years. The protective effect against hip fractures 
is considerable, most studies indicating an overall risk reduction of 50-75% in 
ERT/HRT users. Felson, Zhang, Hannan, Kiel, Wilson, and Anderson (1993), 
investigated the influence of ERT on the femoral, vertebral, mid-shaft and distal 
radius BMD in a cohort of 670 Caucasian women (mean age 76 years). From 42 
the entire cohort, 212 women (approximately 32%) had continuously taken ERT. 
After adjusting for age, weight, height, smoking behavior, age at menopause, and 
physical activity level, the researchers concluded that women below the age of 
75 years who had taken ERT for seven or more years had on average, 11.2 
percent greater BMD (all sites) than women who had never taken ERT. Similarly, 
women 75 years or older had 3.2 percent greater BMD values at all sites 
compared to their same-age peers who did not take ERT. Felson and colleagues 
reported that women who had taken ERT a minimum of seven years since 
menopause had significantly greater (p < 0.05) femoral and spinal BMD values 
and those on ERT for 10 or more years had significantly greater (p <0.05) BMD 
values at all sites except the spine. The authors concluded that women should 
take ERT at least seven years after menopause for the preservation of BMD. 
While the minimum duration of ERT use required for protection against 
fractures has not been firmly established, two studies report a period of five or 
more years is required (Paganini-Hill, et al., 1981; Weiss, Ure, Ballard, Williams, 
& Dahling, 1980). These findings would support those of Nguyen, Jones, 
Sambrook, White, Kelly, and Eisman (1995). In a cohort of 1091 women 
(70 ± 7.2 years old), they reported that ERT users of more than five years had 
significantly greater (p < 0.001) lumbar spine and femoral neck BMD values 
compared with a similar group of women who had used ERT less than five years 
or not at all. 43 
In light of the perceived benefits of HRT administration for peri- and 
postmenopausal women, their usage is based on consideration of risks versus 
benefits. While there are considerable protective effects against fracture with 
HRT use, there is also widespread evidence of a significantly greater RR for 
endometrial (Ettinger, Goldtich, & Friedman, 1988), uterine (Rubin, Peterson, 
Lee, Maes, Wingo, & Becker, 1990; Shapiro, Kelly, & Rosenberg, 1985), and 
breast cancers (Bergkvist, Adami, Persson, Hoover, & Schairer, 1989; Colditz et 
al., 1991). As Langer and Barrett-Connor (1994) have suggested, women and 
their medical practitioners thus need to be clear about their main reasons for use 
of HRT: whether for short term relief of symptoms or for longer term prophylaxis 
since the potential risk-benefit balance associated with different modes of 
administration, formulations, and duration of use differ. 
Summary 
The human skeleton, composed of 206 bones of various lengths, shapes, 
and sizes is constantly undergoing transformation. Composed of both cortical 
and trabecular bone in different proportions each skeletal bone has a very 
specific function. One such role is the storage of calcium. There are a number of 
factors which influence calcium metabolism including, but not limited to: diet, 
medications, ambulatory and menopausal status, gender, and age. 
Diet plays a critical role in calcium metabolism and thus bone health. For 
example, excessive dietary animal protein intake has been identified as potential 
risk factor for forearm fractures among females who consume more than 95 g 44 
per day (Feskanich et al, 1996) and yet a necessary oral supplement following 
femoral fracture (Tkatch et al, 1992). Calcium, phosphorous, and vitamin D 
supplementation have yielded mixed results in regards to positively influencing 
bone health. 
Medications, including steroidals and glucorticoids have consistently 
demonstarted a deleterious effect on bone remodeling (Luken & Raisz, 1990; 
Mitchell & Lyles, 1990). Similarly, anticonvulsant medications, which are widely 
prescribed for individuals with SMR, negatively influence BMD and calcium 
absorption (Cunningham & Mueller, 1987; liavainen & Savolainen, 1980). 
With the exception of genetics, the greatest single factor which may 
influence BMD is ambulatory status. That is, are individuals capable of 
participating in weightbearing activities which stimulate osteoblastic responses. 
Numerous bedrest, spaceflight, and studies with nonambulatory (e.g., spinal cord 
injured) children and adults have consistently shown the positive influence of 
mechanical loading through weightbearing activities (Lindsay, 1993). 
Unfortunately, many adults with SMR are not capable of participating in 
weightbearing activities which stimulate bone absorption. 
Due to population differences, no definitive statements can be made about 
the risk of osteoporosis associated with having MR. Data, while limited, suggest 
that nonambulatory children and adults with MR are at greater risk of fracture 
(Downs et al, 1996; Lee & Lyne, 1990; Sepulveda et al, 1995) but females with 45 
DS may not (Felix, 1993). More studies are needed with this population of 
children and adults before conclusive statements can be established. 
Menopausal status is widely known to influence bone health (Sinaki, 1989). 
The older an individual, the greater risk of fracture, particularly among 
postmenopausal females. However, the use of HRT/ERT has been successfully 
used to maintain and/or increase BMD values among postmenopausal females 
(Christiansen & Riis, 1990; Felson et al., 1993; Stevenson et al., 1990 ). 
Unfortunately, usage of these pharameticutical therapies are not without risk, 
including a higher incidence of some forms of cancer (Ettinger et al., 1988; Rubin 
et al., 1990). 46 
Chapter 3
 
Methodology and Procedures
 
The methodology and procedures used within this study are described 
within this section. This includes a description of the cohort, the methodology 
employed to gain client data, and those statistical methods used in data analysis. 
Cohort Definition 
The primary purpose of this five-year retrospective study was to examine 
the incidence, causes, and the risk factors of bone fracture in a population of 
individuals with severe mental retardation who resided in a state developmental 
center located in the Western United States between April 1, 1991 through 
March 31, 1996.  It was estimated that over 500 individuals were eligible for 
study participation. For each individual, study years began when the following 
criteria were met: residence in the state developmental center on April 1, 1991 
and diagnosed with severe mental retardation'. 
Risk of fracture ended on the first of the following dates: first fracture of that 
type, residence outside of the developmental center longer than 14 continuous 
days, death, or the end of the study period (March 31, 1996). 
Classification based on 1992 AAMR Definition from Mental Retardation: Definition, classification, and systems of 
support (9th ed.), by R. Luckasson, D. Coulter, E. Polloway, S.Deiss, R. Schalock, M. Snell, D. Spitalnik,& J. 
Stark, 1992, Washington, DC: American Association on Mental Retardation. 
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Methodology 
Permission to conduct this study was obtained from the Institutional Review 
Boards at the state developmental center located in the Western United States 
(Appendix A), Oregon State University (Appendix B) and the parents/legal 
guardians of subjects (Appendix C & D). Each individual meeting the study 
criteria was eligible for inclusion within this study as identified by the medical 
director of the state developmental center. 
After individuals were identified, a manual review of radiographical records 
including the original roentgenogram was undertaken to identify those individuals 
who have experienced a fracture for the period between April 1, 1991 and March 
31, 1996. The date of the radiographical procedure which positively determined 
the presence of a fracture served as the reference date for the incident unless 
otherwise noted within the client medical records. Once clients had been 
identified as having experienced a fracture, the primary investigator with the 
assistance of developmental center nursing personnel, filled-out a medical 
questionnaire (Appendix E) for each client based on the following information 
from their medical and nursing records: identification number (assigned by 
developmental center), age, gender, race, cottage of residence, medication(s) 
and dosage(s), body height and weight, ambulatory status, smoking status, 
calcium and vitamin D supplementation, years residing in a state developmental 
center, amount of assistance needed to eat meals (e.g., total assistance, 
independent), fracture site, type, date, and etiology. 48 
A separate questionnaire for those clients who were identified as eligible for 
inclusion within the study but did not experience any fracture during the study 
period was completed by the investigator and a team of nursing staff from the 
state developmental center. The questionnaire included except fracture data 
information. 
All subjects and families/guardians were assured of confidentiality as each 
individual was identified by their developmental center issued identification 
number rather than name. 
Treatment of the Data 
Upon the completion of the medical questionnaire, information was entered 
manually into a Alpha IV database system to ensure the accuracy of data input. 
Data were then downloaded to an Microsoft Excel 5.0 for Windows (Microsoft, 
1993) file by the principal investigator. Analysis was conducted on Epi Info 6.0 
(Centers for Disease Control and Prevention, 1995) and SPSS Advanced 
Statistics 6.1 for Windows (Norusis, 1994). 
The outcome variable was the occurrence or non-occurrence of bone 
fracture. Fracture occurrence measured by cumulative incidence (CI) as 
calculated by dividing the number of fractures by total cases with stratification by 
age, gender, ambulatory ability, medication usage, and calcium and vitamin D 
supplementation. Relative risk of fractures including construction of confidence 
intervals (95% CI) for all estimates was undertaken (Hennekens & Buring, 1987) 49 
for: age, gender, BMI, ambulatory ability, supplemental calcium and vitamin D, 
smoking, menopausal status, and medication usage (Tables 38  125). 
Chi-square (x2) contingency table analysis was employed for unadjusted 
tests for detecting significant associations between fracture occurrence and 
characteristics of clients (Page, Cole, & Timmreck, 1995). Mantel-Haenszel 
methods were used for variables with multi-levels of classifications (e.g., 
medication dosage) and for stratified data. To assess the degree of association 
between a risk factor of interest and an outcome event (fracture), relative risk 
ratios (RR) were obtained. Confidence intervals for those effect estimates were 
also computed. For variables with more than two categories, logistic regression 
methods were used to identify possible trends in fracture risk by such variables. 
The significance of a trend was tested by the Wald test (Hosmer & Lemeshow, 
1989). A p-value of ..0.05 was considered statistically significant. 
Variables found to be important (at oc = 0.25 level) and logically plausible in 
previous univariate analysis were then considered for multivariate analysis. 
Logistic regression was used to perform multivariate analysis on the relationship 
between fracture and the important risk factors in order to examine significant 
fracture predictors or variables that might be important in explaining fracture 
occurrence. Stepwise procedures were employed for inclusion or exclusion of 
variables. The multivariate model was fit after verifying the importance of each 
variable in the model based on the likelihood ratio test and Wald statistics 
(Hosmer & Lemeshow, 1989). The regression coefficients were used to estimate 50 
odds ratios (Hosmer and Lemeshow, 1989). The goodness of fit of the model 
was assessed by evaluating Pearson residuals and deviance residuals. 51 
Chapter 4 
Results 
Data presented within this chapter are the result of a retrospective 
epidemiological study on the occurrence of bone fracture among a cohort of 
adults with severe mental retardation. Medical records were reviewed for 518 
adults residing in a state developmental center on April 1, 1991 and followed 
through March 31, 1996. 
As expected from a group of individuals who reside in a state 
developmental center, there was considerable variability between and within age 
and gender groups on the variables of interest. Therefore, for the purposes of 
simplification, data will be organized into four categories. First, the general 
characteristics of the study population will be presented. This includes gender, 
age group, height, weight, BMI, anticonvulsant and different medication usage, 
ambulatory and self-feeding ability, and other descriptive data. Secondly, the 
results of epidemiological data analyses, including cumulative incidence and 
relative risk ratios (RR) across strata will be provided. Third, as the primary 
question of interest is the occurrence or non-occurrence of bone fracture, the 
outcome of six alternative hypotheses will be presented which focus on those 
factors associated with fracture outcome. The last section, logistic regression 
analysis, will provide evidence of those factors which best predict the occurrence 
or non-occurrence of bone fracture and assist in the identification of individuals 
at greatest risk of future bone fracture. 52 
General Characteristics 
Age and Gender 
Table 1 describes the age and gender specific distribution of all clients in 
this investigation. More than half of the entire cohort of adults were males 
(n = 271, 52.3%) who ranged in age from 23 to 65 years old (± 11.08 years). 
With the exception of the 60-and-over age category, there were more males than 
females within each of the five 10-year age groups (e.g., 30 39 years old). 
While females accounted for less than half of the entire cohort (n = 247, 47.7%), 
they comprised 66% (n = 39) of those individuals over the age of sixty and 
ranged in age from 23 to 72 years old (± 12.62 years). 
As a group, the 30 to 39 year olds accounted for the largest proportion of 
adults (n = 175, 33.8%) and conversely those 60 years and older (n = 59, 11.3%) 
comprised the smallest group. Due to the recent trend of deinstitutionalization 
which has occurred within this and other state developmental centers throughout 
the country, fewer children have been placed within these facilities in recent 
years (Lakin, Braddock, & Smith, 1995). As a result, there were no individuals 
under the age of 23 in residence at the state developmental center and the 20 to 
29 year old age group represented only 15.1% (n = 78) of the entire population. 
The lack of younger individuals residing within the state developmental center is 
further demonstrated by the fact that on the last day of data collection the 
youngest subject was 28 years old and had been residing at the state 
developmental center for 15 years. 53 
Table 1. 
Age and Gender of Adults Residing in a State Developmental Center. 
Age Group  Males (%)  Females ( %)  Total ( %) 
20 to 29  41 (7.9)  37 (7.1)  78 (15.1) 
30 to 39  94 (18.1)  81 (15.6)  175 (33.8) 
40 to 49  69 (13.3)  57 (11.0)  126 (24.3) 
50 to 59  47 (9.1)  33 (6.4)  80 (15.5) 
60 & Above  20 (3.9)  39 (7.5)  59 (11.3) 
Total  271 (52.3)  247 (47.7)  518 (100.0) 
Height. Weight. and Body Mass Index 
The specific group and gender related anthropometric characteristics of this 
cohort are found in Table 2. This includes mean and standard deviation values 
by gender and age group for the cohort by height (cm), weight (kg), and BMI 
(weight in kg/height in meters2). Subjects weight ranged from a low of 31 kg and 
33 kg for females and males respectively to a high of 70 kg for females and 116 
kg for males. As a group, males averaged 57.68 kg (± 12.86 kg), well over 9 kg 
more than the female cohort (48.18 ± 9.31 kg). Males were also on average 11 
cm taller than females. Males ranged from a low of 137 cm to a high of 185 cm 
(± 11.43 cm) in height. Conversely, females ranged from 112 cm to 175 cm 
(± 11.39 cm). As the formula for BMI is a function of height and weight, as 54 
expected, male BMI values were slightly greater than females (22.39 ± 4.73 
v. 21.60 ± 3.52). 
Table 2. 
Characteristics of Adults by Age Groups for Height. Weight and Body Mass 
Index (BMI). (Means and Standard Deviations) 
Age Group  Height  Weight
 
(Yrs.)  Frequency  (cm)  (kg)  BMI
 
Group 
20 to 29  78  154.90 (11.32)  53.49 (14.11)  22.15 (4.46) 
30 to 39  175  155.36 (12.68)  53.85 (13.06)  22.22 (4.23) 
40 to 49  126  157.04 (12.05)  52.81 (11.29)  21.40 (3.88) 
50 to 59  80  156.88 (14.31)  54.77 (11.50)  22.38 (4.50) 
> 60  59  149.81 (12.63)  49.17 (9.28)  22.03 (4.06) 
Males 
20 to 29  41  159.58 (10.33)  59.81 (14.96)  23.43 (4.74) 
30 to 39  94  161.03 (11.41)  59.70 (13.43)  23.08 (4.98) 
40 to 49  69  161.04 (11.25)  54.63 (12.20)  21.08 (4.37) 
50 to 59  47  162.98 (11.84)  58.64 (11.00)  22.27 (4.69) 
> 60  20  154.98 (10.51)  52.11 (8.53)  21.82 (3.98) 
Females 
20 to 29  37  149.70 (8.88)  46.50 (9.01)  20.74 (3.71) 
30 to 39  81  148.78 (10.79)  47.07 (8.65)  21.22 (2.87) 
40 to 49  57  152.19 (11.28)  50.62 (9.74)  21.78 (3.18) 
50 to 59  33  148.19 (13.09)  49.25 (9.96)  22.52 (4.28) 
> 60  39  147.16 (13.01)  47.66 (9.39)  22.14 (4.15) 
Race 
An overwhelming majority of clients were Caucasian (n = 444, 86.7%) 
compared with the race of the remaining sixty-nine clients. Of the non­55 
Caucasians, Native Americans comprised the second largest group (n = 25, 
4.8%) (Table 3). Hispanic American (n = 19, 3.7%), African American (n = 15, 
2.9%), and Asian American (n = 10, 1.9%) comprised the balance of adults 
residing in the developmental center. 
Table 3. 
Racial Background of Adults Residing in a State Developmental Center. 
Racial Background  Frequency  Percentage 
Caucasian  449  86.7 
Native American  25  4.8 
Hispanic American  19  3.7 
African American  15  2.9 
Asian American  10  1.9 
Total  518  100.0 
Residency at Developmental Center 
Upon the onset of the study, individuals had been residing within state 
developmental centers an average of 38.6 years (± 12.56 years) with the longest 
resident having been within developmental centers for 71 years. The client with 
the shortest residence at developmental centers had been there 8 years. From 
the onset of the study (April 1, 1991) until the study endpoint (March 31, 1996), 56 
144 (27.8%) of the 518 individuals were no longer residing at the developmental 
center. Most adults had been placed in other full-time care residences, with 
families and siblings, or were deceased. Individual follow-up upon leaving the 
developmental center was not conducted. 
Ambulation Ability 
Of particular interest to the outcome variable on the occurrence of bone 
fractures was the ambulatory ability of clients. As it is well documented that non­
weightbearing activity contributes to diminished bone health, the ambulatory 
status of all individuals was documented. 
Working with developmental center personnel, ambulatory status was 
identified on a four-point Likert scale. With a range from immobile (incapable of 
performing assisted standing) to independent ambulation, it was felt a four-point 
Likert scale would account for the ambulatory ability of all developmental center 
clients. 
For the purposes of this study, the final ambulatory characteristics of the 
subjects noted in Table 4 are reflective of their ambulatory status at the time of 
fracture if any, upon the last day of the study if subjects did not fracture, or upon 
subjects last day at the developmental center (other than last day of the study). 
Those identified as immobile were separated into one of two groups: (a) those 
who could participate in assisted standing (immobile/assisted standing), and (b) 
those who could not physically stand on a tilt table/prone stander (immobile). 
The greatest number of clients were identified to be in the immobile/assisted 57 
standing group (n = 190, 36.7%) followed by those individuals (n = 161, 31.1%)
 
who could ambulate with an assistive device (e.g., walker, crutch, cane). Those
 
individuals who could ambulate independently, even with orthothic devises (e.g.,
 
ankle-foot orthotics/AFO's) but without the use of any other devise were
 
identified as ambulatory (n = 89, 17.2%). The group with the least number of
 
adults were those identified as immobile and incapable of participating in an
 
assisted standing protocol (n = 78, 15.1%).
 
Table 4.
 
Ambulatory Ability of Adults Residing in a State Developmental Center.
 
Ambulatory Ability  Frequency  Percentage 
Immobile / Assisted Standing  190  36.7
 
Use Assistive Devisee  161  31.1
 
Ambulatory  89  17.2
 
Immobile3  78  15.1
 
Total  518  100.0 
'Includes individuals who can use tilt table or other assistive devise to maintain stationary 
standing position. 
2lncludes such devises as walkers, crutches, braces, and canes 
3lndividuals are physically unable to participate in assisted standing 
Feeding Ability 
The ability to feed oneself was recorded on a five point Likert Scale 
reflecting the amount of personal care assistance necessary to consume meals. 58 
Approximately 83% (n = 430) of subjects needed some level of assistance during 
meals. This included 28 individuals who were fed by either an oral or abdominal 
tube. Table 5 depicts the range of feeding abilities from the lowest level (Tube 
Fed) to highest level of self-feeding (No Assistance). 
Table 5. 
Self-Feeding Ability of Adults Residing in a State Developmental Center. 
Self-Feeding Ability  Frequency  Percentage 
Total Assistance  164  31.7 
Mostly Assistance  120  23.2 
Minimal Assistance  118  22.8 
No Assistance  88  17.0 
Tube Fed  28  5.4 
Total  518  100.0 
One hundred and sixty-four adults (31.7%) required total assistance 
during meals. Conversely, only 88 (17.0%) were capable of independently 
eating without any assistance. Collectively, the minimal assistance (n = 118, 
22.8%) and mostly assistance (n = 120, 23.2%) groups accounted for 46% of the 
cohort. In addition to feeding ability, it was possible to document the prescribed 
supplemental calcium and Vitamin D provided to individuals in addition to 59 
medications of interest. Recognizing the need for supplemental calcium, 473 
(91%) clients received 500 600 mg of calcium daily. Similarly, every client on 
anticonvulsant therapy (n = 438, 84.6%) received 600 800 iu of supplemental 
vitamin D daily. 
Reproductive Status 
The reproductive status of females is provided in Table 6. This includes 
classification of females as either pre- or postmenopausal and their history of 
hysterectomy or oophorectomy. 
Women who had bilateral oophorectomies (n = 17, 6.9%) were included in 
the postmenopausal group. Conversely, women with hysterectomies (n = 39, 
15.8%) and were not known to be postmenopausal were included in the 
premenopausal group. Due to the difficulty of establishing, the developmental 
center did not systematically record peri-menopausal status, and this group of 
women was included in the postmenopausal group. Almost equally distributed, 
of the 247 females in the cohort slightly over half (n = 128, 51.8%) were 
postmenopausal an average of 8.29 years (± 5.24 years). The remainder of 
women (n = 119, 48.2%) were identified as premenopausal. 60 
48.2 
Table 6. 
Reproductive Status of Females Residing in a State Developmental Center. 
Reproductive Status  Frequency  Percentage' 
Pre-Menopausal  119 
Post-Menopausal  128  51.8 
Hysterectomy  39  15.8 
Oophorectomy  17  6.9 
1 
Based on 247 Female Adults 
Medications 
Anticonvulsant, oral contraceptive, glucocorticoid, and hypothyrodial 
medication usage among adults is summarized in Table 7. Of those medications 
of interest, anticonvulsants were prescribed most frequently (n = 438, 84.6%). 
Specifically, there were six different anticonvulsants which were widely 
prescribed to individuals (Table 8). These included Phenytoin (n = 353, 80.6%), 
Phenobarbital (n = 234, 53.4%), Valproic Acid (n = 166, 37.9%), Carbamazpine 
(n = 101, 23.1%), Primidone (n = 61, 13.9%), and Ethosuximide (n = 35, 8.0%). 61 
Table 7. 
Medication Usage Among Adults Residing in a State Developmental Center. 
Medication Type  Frequency  Percentage' 
Anticonvulsants  438  84.6 
Oral Contraceptives  34  6.6 
Glucocorticoids  21  4.1 
Hypothyrodial  9  1.7 
1 
Based upon 518 Adults 
Table 8. 
Anticonvulsant Medication Usage Among Adults Residing in a State 
Developmental Center 
Medication Type  Frequency  Percentage2 
Phenytoin  353  80.6 
Phenobarbital  234  53.4 
Valproic Acid  166  37.9 
Carbamazepine  101  23.1 
Primidone  61  13.9 
Ethosuximide  35  8.0 
2
Based on 438 adults taking one or more anticonvulsant medications 62 
Of the 518 individuals within the cohort, 84.6% (n = 438) were on one or 
more anticonvulsant medications including nearly 75% (n = 380) who were taking 
two or more types of anticonvulsants (Table 9). Frequencies of other 
medications of interest were as follows: oral contraceptives for females (n = 34, 
13.8% of women), glucocorticoids (n = 21, 4.1%), and hypothyrodial medications 
(n = 9, 1.7%). No hormone or estrogen replacement therapies were prescribed 
for females. 
Table 9. 
Number of Anticonvulsant Medications Taken Concurrently Among Adults 
Residing in a State Developmental Center. 
Number of Anticonvulsants 
Concurrently Taking  Frequency  Percentage 
0  80  15.4 
1  58  11.2 
2  259  50.0 
3  112  21.6 
4  9  1.7 
Total  518  100.0 
Fractures 
Based on the case definitions of this study, 229 individuals (44.2%) 
experienced 291 fractures during this five year retrospective period (Table 10). 63 
Of those who experienced a fracture, 168 (73.3%) had one fracture, 43 (18.8%) 
had two, 15 (6.6%) fractured three times, and only 3 (1.3%) had four fractures. 
There were no individuals who had more than four fractures to areas of the body 
defined in this study (e.g., mid-shaft femur). 
Table10. 
Five-Year Cumulative Incidence of Fractures Among Adults Residing in a 
State Developmental Center 
Fractures or  People at  Cumulative
 
Type  Fractured  Risk  Incidence
 
Incidence'  291  518  .560 
Incidence2  229  518  .440 
1 
Based on the number of incident fractures occurring on/between April 1, 1991 and 
March 31, 1996 
2
Based on the number of individuals experiencing a fracture on/between April 1, 1991 
and March 31, 1996 
Of these 291 fractures, 120 (41.2%) were idiopathic in nature. That is, 
according to the medical records, developmental center personnel were 
uncertain of the cause of the fracture. The cause of ninety-five fractures (32.6%) 
were classified as Other, which usually included minimal trauma due to accidents 
other than falls (e.g., subject being struck by another subject) or more commonly, 
were documented to occur during a seizure (e.g., striking object during the 
course of the seizure). Fracture causation which occurred with less frequency 64 
were due to falls (n = 46, 15.8%) and transfers (n = 30, 10.3%). Unfortunately, 
there are a number of limitations when examining causation. Individual fractures 
were often not discovered until hours or days after the event seemed to occur, 
thus the etiology was recorded as unknown. Secondly, the reported causes are 
assumed to be honest and accurate. Therefore, medical personnel bias or 
uncertainty may prevent accurate recording of the cumulative incidence of 
causation (Table 11). 
Table 11. 
Documented Causes of Fractures Among Adults Residing in a State 
Developmental Center. 
Cause of Fracture  Frequency  Percentage 
Unknown  120  41.2 
Other'  95  32.6 
Falls  46  15.8 
Transfers  30  10.3 
Total  291  100.0 
1 
Includes such items as accidents and seizure related incidents 
In regards to site of fracture (Table 12), three areas, ribs (n = 49, 16.8%), 
femur (n = 46, 15.8%), and radius (n = 41, 14.1%), accounted for 46.7% of all 
fractures sites. Other locations with ten or more fractures included the thoracic 
vertebrae (n = 38, 13.1%), humerus (n = 26, 8.9%), clavicle (n = 22, 7.6%), fibula 65 
(n = 18, 6.2%), hip (n = 15, 5.2%), and ulna (n = 13, 4.5%). Five additional 
locations accounted for 23 (7.9%) fractures. 
Table 12.
 
Site of Fracture Among Adults Residing in a State Developmental Center
 
(April 1. 1991 to March 31, 1996) 
Site of Fracture 
Ribs 
Femur 
Radius 
Thoracic Vertebrae 
Humerus 
Clavicle 
Fibula 
Hip (Proximal Femur) 
Ulna 
Pelvis 
Lumbar Vertebrae 
Cervical Vertebrae 
Tibia 
Skull 
Sacrum 
Total 
Frequency
 
49
 
46
 
41
 
38
 
26
 
22
 
18
 
15
 
13
 
8
 
5
 
5
 
3
 
2
 
0
 
291
 
Percentage 
16.8 
15.8 
14.1 
13.1 
8.9 
7.6 
6.2 
5.2 
4.5 
2.7 
1.7 
1.7 
1.0 
< 1.0 
0.0 
100.0 66 
Cumulative Incidence of Fractures 
Age and Gender Data 
The cumulative incidence of fractures among males was 35.4% with a 
relative risk of .658 (95% CI = .342 - .669, p < .001). Conversely, females had a 
cumulative incidence of 53.8% with a relative risk of 1.540 (p = <.001, 95% CI for 
RR = 1.521  4.213) (Table 13). Even though many of the relative risk estimates 
were not found to be statistically significant, two groups of males (Table 14) and 
two groups of females (Table 15) were found to be at greater risk of fracture. The 
40 - 49 year old male group was found to be at 21% greater risk of fracture 
(p = .298, 95% CI for RR = .843 - 2.362) and 50 to 59 year olds had a 42% 
greater risk among males (p = .073, 95% CI for RR = 1.059  3.374). Likewise, 
40 - 49 year old females also were at increased risk (6%) (p = .689, 95% CI for 
RR = .675  2.047) as were 20 - 29 year old females (p = .704, 95% CI for RR = 
.693 - 2.324). The lowest relative risk for males was found in 20 - 29 year olds 
(RR = .652, p = .107, 95% CI for RR = .332 - 1.157) and the 60 69 year old 
female group (RR = .944, p = .726, 95% CI for RR = .509  1.756). 
As a group (Table 16) there was an increase in RR with increasing age from 
a low RR of .883 (p = .390, 95% CI for RR = .559 - 1.317) for the 20 - 29 year 
olds to a peak RR of 1.124 (p = .373, 95% CI for RR = .847  2.002) for the 50 ­
59 year olds. Curiously, the exception of this trend was the 60 years and older 
group with a RR of 1.040 (p = .803, 95% CI for RR = .710  1.851). When 
gender specific age groups were combined (Table 17), males  50 years old had 67 
a RR of 1.318 (p = .121, 95% CI for RR = .969  2.746) while females < 40 years 
had a RR of 1.014 (p = .849, 95% CI for RR = .645  1.701). The only 
statistically significant RR found among the males, females, or the entire cohort 
by gender was a protective effect for men younger than 40 years old with a RR 
of .689 (p = .029, 95% CI for RR = .362  .933). Table 13. 
Relationship Between Gender and Cumulative Incidence of Fractures 
Gender  Cases  Controls 
Cumulative 
Incidence 
Relative 
Risk (RR) 
95% CI 
For RR  p-value 
Males 
Females 
96 
133 
175 
114 
.354 
.538 
.658 
1.540 
.342 
1.521 
.669 
4.213 
<.001 
<.001 
Total  229  289 Table 14. 
Relationship Between Age and Cumulative Incidence of Fractures for Males 
Age 
(Males)  Cases  Controls 
Cumulative 
Incidence 
Relative 
Risk (RR) 
95% CI 
For RR  p-value 
20 to 29 
30 to 39 
40 to 49 
50 to 59 
60 & above 
10 
29 
28 
22 
7 
31 
65 
41 
25 
13 
.244 
.309 
.401 
.468 
.350 
.652 
.815 
1.205 
1.417 
.987 
.332 - 1.157 
.473  1.248 
.843 - 2.362 
1.059 - 3.374 
.520  2.547 
.107 
.250 
.298 
.073 
.682 
Total  96  175 Table 15.
 
Relationship Between Age and Cumulative Incidence of Fractures for Females
 
Age  Cumulative  Relative  95% CI 
(Females)  Cases  Controls  Incidence  Risk (RR)  For RR  p-value 
20 to 29  21  16  .568  1.064  .693  2.324  .704 
30 to 39  43  38  .531  .979  .596 - 1.628  .865 
40 to 49  32  25  .561  1.056  .675  2.047  .689 
50 to 59  17  16  .515  .950  .500 - 1.871  .772 
60 & above  20  19  .513  .944  .509 - 1.756  .726 
Total  133  114 Table 16.
 
Relationship Between Age and Cumulative Incidence of Fractures
 
Age  Cumulative  Relative  95% CI 
Group  Cases  Controls  Incidence  Risk (RR)  For RR  p-value 
20 to 29  31  47  .397  .883  .559 - 1.317  .390 
30 to 39  72  103  .411  .899  .604  1.197  .317 
40 to 49  60  66  .476  1.105  .854  1.795  .379 
50 to 59  39  41  .488  1.124  .847  2.002  .373 
60 & above  27  32  .458  1.040  .710  1.851  .803 
Total  229  289 Table 17.
 
Relationship Between Age and Cumulative Incidence of Fractures for Males and Females
 
Age 
Group  Cases  Controls 
Cumulative 
Incidence 
Relative 
Risk (RR) 
95% CI 
For RR  p-value 
Males 
< 40 yrs old  39  96  .289  .689  .362  .933  .029 
?_ 50 yrs old 
Females 
29  38  .433  1.318  .969  2.746  .121 
< 40 yrs old 
50 yrs old 
64 
37 
54 
35 
.542 
.514 
1.014 
.937 
.645 - 1.701 
.540 - 1.508 
.849 
.617 73 
Body Mass Index Data 
Unlike age and gender data, BMI data yielded numerous statistically 
significant relative risks (Table 18). Specifically, when male and female data 
were combined, those with BMI values less than 20 were found to be at 242% 
greater risk (RR = 2.416) of fracture (p < .001, 95% CI for RR = 1.906  4.978). 
Conversely, individuals with BMI values between 20 and 25 only had a RR of 
.771 (p = .013, 95% CI for RR = .465  .908) and those with a BMI greater than 
25 had the lowest RR value (RR = .505, p < .001, 95% CI for RR = .247  .536). 
With the exception of the female 20 - 25 BMI group, this trend was consistent 
across gender. Interestingly, the male BMI group less than 20 was at the 
greatest risk of fracture among all groups (RR = 3.633, p < .001, 95% CI for RR 
= 3.021 - 10.641). Males with a BMI greater than 25 were at the least risk of all 
groups (RR = .373, p < .001, 95% CI for RR = .166  .501). Table 18.
 
Relationship Between Body Mass Index (BMI) and Cumulative Incidence of Fractures
 
Cumulative  Relative  95% CI 
Body Mass Index  Cases  Controls  Incidence  Risk (RR)  For RR  p-value 
Group 
< 20  123  73  .628  2.416  1.906  4.978  <.001 
20 to 25  76  127  .374  .771  .465  .908  .013 
> 25  30  89  .252  .505  .247  .536  <.001 
Males 
< 20  62  40  .608  3.633  3.021 -10.641  <.001 
20 to 25  22  72  .234  .560  .277  .747  .003 
> 25  12  63  .160  .373  .166 ­ .501  <.001 
Females 
< 20  61  33  .649  1.379  1.266  3.532  .007 
20 to 25  54  55  .545  .865  .462  1.215  .215 
> 25  18  26  .409  .722  .320  1.027  .057 75 
Race Data 
As the cohort was predominately Caucasian, the RR estimates required that 
all non-Caucasian adults be grouped for analysis (Table 19). While neither the 
Caucasian or non-Caucasian group had a statistically significant RR value, non-
Caucasians were found to be at a 6% greater risk of fracture (RR = 1.057, 
p = .697, 95% CI for RR = .746  1.840). 
Ambulation Ability Data 
Group analyses of RR by ambulatory ability yielded several significant 
findings (Table 20). For example, the assisted standing group was at the 
greatest risk of fracture (RR = 1.386, p < .001, 95% CI for RR = 1.317 - 2.634) 
compared with the other three groups, including the immobile group (RR = .950, 
p = .711, 95% CI for RR = .630 - 1.486). The only group which was statistically 
protected from fracture included the Ambulatory group who had a RR of .461 
(p < .001, 95% CI for RR = .220  .520). When immobile groups were combined, 
overall they had a 34% greater chance of fracture (p = .004, 95% CI for 
RR = 1.207  2.392) compared with the assistive device and ambulatory group 
(RR = .746, p = .004, 95% CI for RR = .433 - .843). When gender specific 
ambulatory groups were examined (Table 21), ambulatory males (RR = .356, 
p < .001, 95% CI for RR = .159  .580) were at the lowest risk of fracture overall 
but ambulatory females also had a decreased chance of fracture (RR = .559, 
p = .003, 95% CI for RR = .211 - .709). Women in the assistive device group 
were at greatest risk of fracture among females (RR = 1.348, p = .016, 95% CI 76 
for RR = 1.195 - 3.684) as were assisted standing men for their respective 
gender (RR = 1.687, p < .001, 95% CI for RR = 1.454  3.968). Table 19.
 
Relationship Between Race and Cumulative Incidence of Fractures
 
Cumulative  Relative  95% CI 
Race  Cases  Controls  Incidence  Risk (RR)  For RR  p-value 
Caucasian  197  252  .439  .919  .512 - 1.431  .549 
Non-Caucasian  32  46  .410  1.057  .746 - 1.840  .697 
Total  229  298 Table 20.
 
Relationship Between Ambulatory Ability and Cumulative Incidence of Fractures
 
Ambulatory 
Ability  Cases  Controls 
Cumulative 
Incidence 
Relative 
Risk (RR) 
95% CI 
For RR  p-value 
Group 
Immobile  33  45  .423  .950  .630  1.486  .711 
Assisted Standing  102  88  .537  1.386  1.317 - 2.634  <.001 
Assistive Device  74  87  .460  1.059  .802  1.612  .589 
Ambulatory  20  69  .225  .461  .220  .520  <.001 
Combined Groups 
Immobile & 
Assisted Standing  135  133  .504  1.340  1.207 - 2.392  .004 
Assistive Device & 
Ambulatory  94  156  .376  .746  .433 - .843  .004 Table 21.
 
Relationship Between Ambulatory Ability. Gender and Cumulative Incidence of Fractures
 
Ambulatory  Cumulative  Relative  95% CI 
Ability  Cases  Controls  Incidence  Risk (RR)  For RR  p-value 
Males 
Immobile  16  23  .410  1.190  .778 - 2.645  .430 
Assisted Standing  43  45  .489  1.687  1.454  3.968  <.001 
Assistive Device  30  65  .842  .842  .496 - 1.307  .330 
Ambulatory  7  42  .143  .356  .159  .580  <.001 
Females 
Immobile  17  22  .436  .782  .361  1.222  .162 
Assisted Standing  59  43  .578  1.126  .809 - 2.163  .298 
Assistive Device  44  22  .666  1.348  1.195 - 3.684  .016 
Ambulatory  13  27  .325  .559  .211  .709  .003 
Total  229  289 80 
Self-Feeding Ability 
There was a progressive decrease in risk of fracture as self-feeding ability 
increased (Table 22). Tube Fed individuals had a 68% greater risk of fracture 
(p = .003, 95% CI for RR = 1.623 - 7.784) followed by those who required total 
assistance (RR = 1.347, p = .003, 95% CI for RR = 1.250  2.542). Also at 
increased fracture risk, but not statistically significant, was the mostly assisted 
group (RR = 1.102, p = .095, 95% CI for RR = .999 - 1.204). Like the mostly 
assisted group, findings from the minimal assist group were not statistically 
significant but nevertheless, indicated a decreased risk of fracture (RR = .829, 
p = .131, 95% CI for RR = .521 - 1.102). The independent self-feeding group 
(No Assistance) was found to have a significant lower risk of fracture (RR = .343, 
p < .001, .150  .373). When groups were combined, those which required tube, 
total, and mostly assistance were at 99% greater risk of fracture (p < .001, 95% 
CI for RR = 1.860 4.181) while those who were capable of feeding with minimal 
or no assistance demonstrated a significant lower risk of fracture (RR = .506, 
p < .001, 95% CI for RR = .256  .538). Table 22.
 
Relationship Between Self-Feeding Ability and Cumulative Incidence of Fractures
 
Self-Feeding  Cumulative  Relative  95% CI 
Ability  Cases  Controls  Incidence  Risk (RR)  For RR  p-value 
Group 
Tube Fed  20  8  .714  1.675  1.623  7.784  .003 
Total Assistance  88  76  .537  1.347  1.250  2.542  .003 
Mostly Assist  61  59  .508  1.204  .999 - 2.132  .095 
Minimal Assistance  45  73  .381  .829  .521  - 1.102  .131 
No Assistance  15  73  .170  .343  .150 ­ .373  <.001 
Combined Groups 
Tube/Total/Mostly 
Assistance  169  143  .542  1.994  1.860  4.181  <.001 
Minimal & No 
Assistance  60  146  .291  .506  .256 - .538  <.001 82 
Reproductive Status 
There were no reproductive factors which yielded a statistically greater or 
lesser risk of fracture (Table 23). Postmenopausal women had a slightly higher 
(7%) risk of fracture (p = .582, 95% CI for RR = .712 - 1.954) than 
premenopausal women (RR = .935, p = .582, 95% CI for RR = .521 - 1.456). 
While the cumulative incidence of fracture was slightly greater among women 10 
or more years postmenopausal (.576) versus women less than 10 years 
postmenopausal (.554), they had slightly reduced risk of fracture (RR = .961, 
p = .818, 95% CI for RR = .394  2.179) than women less than 10 years 
postmenopausal (RR = 1.040, p = .818, 95% CI for RR = .495  2.610). 
The surgical procedures which may influence the outcome of fracture risk of 
pre- and postmenopausal women included hysterectomies and oophorectomies. 
While there was a limited number of women who had bilateral oophorectomies (n 
= 17), they were found to be at 10% greater risk of fracture 
(p = .667, RR = 1.100, 95% CI for RR = .556  3.380). Women who had 
experienced a hysterectomy had a lower risk of fracture, but it was not found to 
be significant (RR = .782, p = .165, 95% CI for RR = .361  - 1.222). Table 23.
 
Relationship Between Reproductive Status and Cumulative Incidence of Fractures in Females
 
Reproductive 
Status  Cases  Controls 
Cumulative 
Incidence 
Relative 
Risk (RR) 
95% CI 
For RR  p-value 
Pre Menopausal' 
Post-Menopausal2 
Hysterectomy 
Oophorectomy 
83 
50 
17 
10 
75 
39 
22 
7 
.525 
.562 
.436 
.588 
.935 
1.069 
.782 
1.100 
.521  1.456 
.712 - 1.954 
.361 - 1.222 
.556  3.380 
.582 
.582 
.165 
.667 
1 Pre-menopausal group includes women with hysterectomies 
2 Post-menopausal group includes women with bilateral oophorectomies 84 
Medications 
Medications identified for analysis of this cohort were chosen based on their 
probability of negatively influencing bone health. These included oral 
contraceptives, hypothydrodial, glucocorticoid, and anticonvulsant medications. 
With the exception of oral contraceptive usage, there was a greater risk of 
fracture for usage associated with the other medications (Table 24). In 
descending order by fracture risk, these included anticonvulsants, (RR = 1.167, 
p = .285, 95% CI for RR = .803  2.124), glucocorticoids (RR = 1.081, p = .749, 
95% CI for RR = .614 - 2.768), and thyroxine (RR = 1.005, p = .889, 95% CI for 
RR = .409 - 3.807). While none of the medications achieved significance for 
fracture risk, oral contraceptive usage, which was limited to certain ambulatory 
women at the developmental center (n = 34), was approaching significance as a 
decreased risk of fracture (RR = .821, p = .059, 95% CI for RR = .366 - 1.393). 
Examination of each of the six different anticonvulsant medications 
commonly prescribed to adults yielded only one agent which approached a 
significant lower risk effect (valproic acid); the remaining five medications all 
yielded a greater risk of fracture (Table 25). For example, the greatest risk 
(17%) was found among individuals taking primidone (p = .246, 95% CI for 
RR = .885 - 2.309) whereas carbamazepine yielded a 3.8% greater risk 
(p = .757, 95% CI for RR = .752  1.656). As 73.4% of the entire cohort was 
taking two or more anticonvulsants, analysis was undertaken to investigate the 
presence of any combination or dosage effects with the different medications. 85 
Only one combination of medications was found to reach significance. 
Phenytoin (Dilantin) and valporic acid (Depakane) yielded a significant 
decreased risk of fracture among the 94 individuals on this pharmaceutical 
combination (RR = .759, p = .050, 95% CI for RR = .447 - 1.002). As no other 
combination of medications was found to produce either a increased or 
decreased risk among subjects, analysis was conducted strictly by the number of 
anticonvulsant medications concurrently taken (Table 26). 
Regardless of medication type, there were no significant values found for 
any number of anticonvulsant medications taken at the same time. The greatest 
risk of fracture (24%) was found among subjects taking four anticonvulsants 
(p = .529, 95% CI for RR = .557  5.775) followed by individuals taking two 
medications (RR = 1.019, p = .857, CI for RR = .719 - 1.519). When the number 
of medications were combined, neither the two or less anticonvulsant group, nor 
the three or more anticonvulsant group yielded any significant risk of fracture. Table 24.
 
Relationship Between Different Medications and Cumulative Incidence of Fractures
 
Cumulative  Relative  95% CI 
Medication  Cases  Controls  Incidence  Risk (RR)  For RR  p-value 
Oral Contraceptives  16  18  .471  .821  .366 - 1.393  .059 
Thyroxine  4  5  .444  1.005  .409 - 3.807  .889 
Glucocorticoids  10  11  .476  1.081  .614 - 2.768  .749 
Anticonvulsants  198  240  .452  1.167  .803 - 2.124  .285 
Total  228  274 Table 25.
 
Relationship Between Anticonvulsant Medications and Cumulative Incidence of Fractures
 
Anticonvulsant  Cumulative  Relative  95% CI 
Medication  Cases  Controls  Incidence  Risk (RR)  For RR  p-value 
Medication 
Phenytoin  160  192  .455  1.094  .814 - 1.702  .407 
Valproic Acid  65  101  .392  .840  .539 - 1.074  .114 
Carbamazepine  46  55  .455  1.038  .752 - 1.656  .757 
Phenobarbital  112  122  .498  1.162  .949  1.858  .131 
Primidone  31  30  .501  1.173  .885 - 2.309  .246 
Ethosuximide  17  18  .486  1.107  .723 - 2.400  .596 
Combined Medications' 
Phenytoin & 
Valporic Acid  33  61  .351  .759  .447  1.002  .050 
1 Only combination of medications found to be significant at 0.05 level Table 26.
 
Relationship Between the Number of Anticonvulsant  Medications Taken and Cumulative Incidence of Fractures
 
Number of  Cumulative  Relative  95% CI 
Anticonvulsants  Cases  Controls  Incidence  Risk (RR)  For RR  p-value 
None  31  49  .388  .857  .534  1.249  .285 
One  25  33  .431  .947  .595 - 1.584  .726 
Two  118  141  .456  1.019  .719  1.519  .857 
Three  50  62  .446  .983  .677 - 1.494  .889 
Four  5  4  .555  1.235  .557 - 5.775  .529 
One or Two  143  174  .451  .992  .653  1.502  .952 
Three or more  55  66  .455  1.008  .710 - 1.545  .952 89 
Hypotheses Testing 
The results of six alternative hypothesis are presented in order as they 
appear in Chapter 1. Chi square (x2) contingency tables were constructed to test 
each of the six working hypothesis with an alpha set at .05 level for acceptance. 
The first hypothesis suggested that females would have a significantly 
greater five-year cumulative incidence of fractures than males. With an 
incidence rate of .442 for the entire cohort, 120 males were expected to 
experience at least one fracture as were 109 females (Table 27). Contrary to the 
expected results based on the incidence rate, 96 males and 133 females 
experienced one or more fractures. With analysis, these data revealed that 
females had a significantly greater (x2 = 17.51, p < .001) cumulative incidence of 
fractures than did males and the alternative hypothesis was not rejected. 
As females were expected to have significantly more fractures than males, 
the second hypothesis was established to test if postmenopausal women had a 
fracture cumulative incidence which was significantly greater than 
premenopausal women. With a cohort fracture incidence rate of .538 for 
females, and with consideration given for the distribution of the cohort by 
menopausal status, it was expected that premenopausal women would have 85 
fractures compared with 48 for postmenopausal women. The results of data 
analysis revealed that premenopausal women had 83 fractures while 
postmenopausal women experienced 50 fractures (Table 28). As a result of 90 
contingency table analysis, postmenopausal women did not have a significantly 
greater cumulative incidence of fractures compared to premenopausal women 
(x2 = .230, p > .10), and the working hypothesis was rejected. 
Table 27. 
Chi Square Contingency Table Analysis of Fracture Incidence Between 
Males and Females 
Fracture
 
Status  Males  Females  Total
 
Fracture
 
Observed  96  133
 
Expected  120  109  229 
No Fracture 
Observed  175  114 
Expected  151  138  289 
Total  271  247  518 
Cumulative Incidence for cohort = (229/518) = .442 
x Statistic = 17.51 
df = 1 
p  value = < .001 91 
Table 28. 
Chi Square Contingency Table Analysis of Fracture Incidence Between 
Pre - and Post-Menopausal Females 
Fracture  Pre- Post-

Status  Menopausal  Menopausal  Total
 
Fracture
 
Observed  83  50
 
Expected  85  48  133
 
No Fracture
 
Observed  75  39
 
Expected  73  41  114
 
Total  158  89  247
 
Cumulative Incidence for cohort = (133/247) = .538
 
x Statistic = .230
 
df = 1
 
p  value = > .10
 
As anticonvulsant usage among adults residing in the State developmental 
center approached 85%, and it is documented that these medications may 
negatively influence bone health, it was hypothesized that individuals taking 
anticonvulsant medications would have a significantly greater five year 
cumulative incidence of fractures than adults who did not take anticonvulsant 92 
medications. The fracture incidence rate for the use or non-use of 
anticonvulsant medications was calculated to be .442 as a result of 229 
individuals fracturing among 518 adults. Contingency table analysis expected 
194 adults on anticonvulsant medication to have experienced a fracture versus 
35 individuals not on these medications. Data analysis (Table 29) found  no 
significant difference in the cumulative incidence of fracture as a result of 
anticonvulsant usage (x2 = 1.11, p > .10) and the working hypothesis was 
rejected. Furthermore, no significant difference in the cumulative incidence of 
fracture was found due to the number of anticonvulsant medications (Table 30) 
concurrently taken (x2 = .004, p > .10). 93 
Table 29. 
Chi Square Contingency Table Analysis of Fracture Incidence Between
 
Anticonvulsant Usage or Non-Usage
 
Fracture  Anticonvulsants
 
Status  Yes
  No  Total 
Fracture
 
Observed  198  31
 
Expected  194  35  229
 
No Fracture
 
Observed  240  49
 
Expected  244  45  289
 
Total  438  80  518
 
Cumulative Incidence for cohort = (229/518) = .442
 
X Statistic = 1.11
 
df = 1
 
p - value = > .10
 94 
Table 30. 
Chi Square Contingency Table Analysis of Fracture Incidence Between 
Number of Anticonvulsant Medications Used 
Fracture  Anticonvulsants
 
Status  1 or 2  3 or 4  Total
 
Fracture
 
Observed  143  55
 
Expected  143  55  198
 
No Fracture
 
Observed  174  66
 
Expected  174  66  240
 
Total  317  121  438
 
Cumulative Incidence for cohort = (198/438) = .442
 
x Statistic = .004 
df = 1
 
p - value = > .10
 
The influence of BMI was identified as a plausible factor which contributes 
to, or helps prevent the occurrence of fracture. Therefore, it was hypothesized 
that individuals with a BMI less than 20 would have a significantly greater 
cumulative incidence of fracture compared with adults with a BMI greater than 
25. The fracture incidence rate for these two groups was calculated to be .477, 95 
which would have resulted in 94 fractures in the BMI < 20 group and 54 fractures 
in the BMI > 25 group. Results of contingency table analysis (Table 31) 
supported the hypothesis that individuals with a BMI value below 20 would have 
a significantly greater cumulative incidence of fractures compared to those with 
BMI values greater than 25 (x2 = 47.55, p < .001). 
Table 31. 
Chi square Contingency Table Analysis of Fracture Incidence Between Body
 
Mass Index Values
 
Fracture  Body Mass Index
 
Status  < 20  > 25
  Total 
Fracture
 
Observed  123  25
 
Expected
  94  54  148 
No Fracture
 
Observed  73  89
 
Expected  102  60  162
 
310 Total  196  114
 
Cumulative Incidence for cohort = (148/310) = .477
 
x Statistic = 47.55
 
df = 1
 
p - value = < .001 96 
The fifth working hypothesis suggested that individuals capable of 
ambulating, either with an assitive device (e.g., walker) or independently, would 
have a significantly lower cumulative incidence of fractures compared  to those 
individuals who could not ambulate (immobile and immobile/assisted standing 
group). Contingency table analysis (Table 32) suggested that the combined 
ambulatory groups would have 111 fractures compared with 118 in the  immobile 
groups. Results of the x2 test supported the hypothesis that ambulators had a 
significantly lower cumulative incidence of fractures compared to the immobile 
groups (x2 = 9.13, p < .005). Further analysis of the combined ambulation 
groups found that independent ambulators had a significantly lower cumulative 
incidence (Table 33) of fracture compared to those individuals who ambulated 
with the use of an assistive device (x2 = 13.46, p < .001). 97 
Table 32. 
Chi Square Contingency Table Analysis of Fracture Incidence Between 
Ambulatory Ability 
Fracture 
Status  Immobile'  Ambulatory2  Total 
Fracture
 
Observed  135  94
 
Expected  118  111  229 
No Fracture
 
Observed  133  156
 
Expected  150  139  289 
Total  268  250  518 
Cumulative Incidence for cohort = (229/518) = .442 
X Statistic = 9.13 
df = 1 
p - value = < .005 
'Immobile group includes: (a) immobile, and (b) immobile/assisted standing groups 
2Ambulatory group includes: (a) assistive device, and (b) ambulatory groups 98 
Table 33. 
Chi Square Contingency Table Analysis of Fracture Incidence Between 
Assistive Device and Ambulation Groups 
Fracture  Group 
Status  Assistive  Ambulatory  Total 
Fracture
 
Observed  74  20
 
Expected  61  33  94 
No Fracture
 
Observed  87  69
 
Expected  100  56  156
 
Total  161
  89  250 
Cumulative Incidence for cohort = (94/250) = .376 
x Statistic = 13.46 
df = 1 
p - value = < .001 
The last hypothesis examined the impact of self-feeding ability on the 
cumulative incidence of fractures (Table 34). Specifically, do individuals 
requiring any level of assistance to eat meals have a significantly greater 
cumulative incidence of fractures than do individuals who need no assistance 
with meals. Theoretically, it was felt that if individuals could eat independently, 99 
they would have more opportunities to purchase (e.g., vending machines) and/or 
consume food than would individuals who rely on some level of assistance to eat 
meals. As a result, individuals who were capable of eating independently might 
weigh more resulting in greater BMI values which would suggest a protective 
effect against fracture. Results of hypothesis testing did accept the hypothesis 
that independent self-feeders were at a significantly lower risk of fracture 
compared with individuals who could not eat meals independently (x2 = 31.71, 
p < .001). 100 
Table 34. 
Chi Square Contingency Table Analysis of Fracture  Incidence Between Self-
Feeding Ability 
Fracture  Self-Feeding Assistance
 
Status  Yes'
  No2  Total 
Fracture
 
Observed  214  15
 
Expected  190  39  229 
No Fracture
 
Observed  216  73
 
Expected  240  49  289
 
Total  430
  88  518 
Cumulative Incidence for cohort = (229/518) = .442 
x Statistic = 31.71 
df = 1 
p value = < .001 
lIncludes all groups which required feeding  assistance: (a) tube, (b) total, (c) mostly, and
(d) minimal. 
2lncludes only those individuals who are independently self-feeding 
Logistic Regression Analysis 
Multivariate logistic regression analysis was employed to examine the 
relationship between bone fracture and a regression model which adequately 
identify variables or "predictors" of fracture outcome. Univariate logistic 101 
regression was employed to assess which variable(s) were appropriate for entry 
into the model. Variables yielding an alpha of at least .25, verified as important 
with use of the Wald statistic to determine the significance of the likelihood ratio 
test, and biologically plausible in univariate analysis were then considered for 
multivariate analysis (Hosmer & Lemeshow, 1989). As a result of this 
preliminary analysis, 13 variables were identified for entry into the multivariate 
model (Table 35). 
The saturated or full model was constructed using a forced entry technique 
where the rank order for variables was established using the degrees of freedom 
from the univariate statistic (variables which met entry a < 0.25). With 
establishment of the saturated model, a reduced model was constructed using 
stepwise techniques with the criteria parameters set at cc = .25 and the backward 
elimination parameters set at cc = .30 (Hosmer & Lemeshow, 1989). Using the 
stepwise procedures the following variables were identified for inclusion within 
the reduced model (Table 36): (1) ambulation ability, (2) use of calcium, (3) body 
weight (kg), (4) self-feeding ability, and (4) body mass index. 
Verification of the model was then employed using the Likelihood ratio test 
(Hosmer & Lemeshow, 1989). This test examines the model likelihood with and 
without variables to test overall significance. The calculated log of the likelihood 
in the full model (546.492) was tested against the calculated log of the likelihood 
in the reduced model (552.072) to determine if they were significantly different. 
The likelihood ratio test resulted in a non-significant difference (p > .05) between 
the full and reduced model. 102 
Finally, to assist with data interpretation, all risk factors found to reach 
significance can be found in Table 37. This includes male, female, and group 
data. 103 
Table 35. 
Variables Identified from Univariate Logistic Regression for Entry into the 
Multivariate Model (Listed Alphabetically with Corresponding p-value). 
Variable  p-values 
Age  .2268 
Ambulation  .0000 
Body Mass Index  .0000 
Calcium  .0111 
Gender  .0000 
Height  .0000 
Menopause Status  .0001 
Oophorectomy  .2191 
Phenobarbital  .1285 
Primidone  .2390 
Self-Feeding  .0000 
Smoking  .0149 
Valporic Acid  .1109 
Vitamin D  .2829 
Weight  .0000 
1p-value obtained from Chi square distribution for the Likelihood Ratio Test 104 
Table 36.
 
Variables Identified for Inclusion into the Reduced Model
 
Variable 
Parameter 
Estimate  Odds Ratio 
Wald (x2) test 
p-value 
Ambulation 
Immobile 
Assisted Standing 
Assistive Device 
Ambulatory 
1.1008 
.  0217 
-.9594 
3.0067 
1.0220 
.3831 
.0001 
.9281 
.0000 
Self-Feeding 
Tube Fed 
Total Assistance 
Mostly Assist 
Minimal Assist 
No Assistance 
-.2857 
-.5592 
-.3037 
.4428 
.7515 
.5717 
.7380 
1.5571 
.0000 
.0292 
.1590 
.1313 
Body Mass Index 
< 20 
20 - 25 
> 25 
.0509 
.2465 
1.0522 
1.2795 
.7756 
.0967 
Body Weight  .1126  1.1192  .0000 
Calcium 
Yes 
No  -.3346  .7156  .1045 105 
Table 37.
 
Summary of Significant Relative Risk Factors
 
Relative 
Variable  Risk  Risk  p-value 
Gender 
Males (M)  .658  Decreased  <.001 
Females (F)  1.540  Increased  <.001 
Males < 40 years  .689  Decreased  .029 
Ambulation Status/Group 
Assisted Standing  1.386  Increased  .007 
Ambulatory  .461  Decreased  <.001 
Ambulation Status/Gender 
Assisted Standing (M)  1.687  Increased  <.001 
Ambulatory (M)  .356  Decreased  <.001 
Ambulatory (F)  .559  Decreased  .003 
Assistive Device (F)  1.348  Increased  .016 
BMI/Group 
< 20  2.416  Increased  <.001 
20-25  .771  Decreased  .013 
> 25  .505  Decreased  <.001 
BMI/Gender 
< 20 (M)  3.633  Increased  <.001 
< 20 (F)  1.379  Increased  .007 
20-25 (M)  .560  Decreased  .003 
> 25 (M)  .373  Decreased  <.001 
Feeding Ability 
Tube  1.675  Increased  .003 
Total Assistance  1.347  Increased  .003 
No Assistance  .343  Decreased  <.001 
Medications 
Phenytoin 
& Valporic Acid  .759  Decreased  .050 106 
Chapter 5
 
Discussion & Recommendations
 
Adults with SMR who reside within state developmental centers may be at 
greater risk of bone fracture due to individual characteristics as well as 
developmental center practices. As fracture data regarding this population is 
limited, this five-year retrospective study enhances the understanding of the 
type, frequency, and site of bone fractures as well as specific risk factors 
associated with fracture outcome. 
In order to facilitate understanding of the current investigation findings, this 
chapter will (1) focus the findings of this research on the results presented in 
Chapter 4 and the interpretation with the current body of knowledge, (2) identify 
the strengths and limitations in conducting retrospective research within a large 
state developmental facility, (3) provide recommendations for similar 
investigations, and (4) summarize the findings of this study. 
Discussion of the Results 
Age. Gender & BMI Data 
The relationship between age, gender, and the cumulative incidence of 
fractures was explored for both males (Table 15) and females (Table 16). As a 
group, males were found to have a significant protective effect against bone 
fracture (Table 13). By age stratification, both the 40-49 and 50-59 year old 
male groups revealed an increased relative risk of fractures. Interestingly, males 107 
60 years of age or older were found to have a slight protective effect against 
fracture (Table 15).  While none of the five age categories among males 
revealed a statistically protective or increased relative risk of fracture, these 
findings are not consistent with the current research base. For example, 
Rudman et al (1989), Gullberg et al (1993), and others have reported a 
significant yearly increase in the cumulative incidence of fractures among males 
after the age of 50 years. More specifically, Melton et al (1992) suggested that 
males older than 50 years have a 13% lifetime risk of hip, spine, or distal forearm 
fracture. 
Perhaps one explanation for the protective relative risk found in those 
males 60 years of age and older was due to the small sample size within this age 
group. While data for 271 males was collected within this study, males 60 years 
and older accounted for less than eight percent (7.3%, n = 20) of the cohort. Of 
these twenty individuals, only seven experienced any fracture. Therefore, as a 
result of the findings for this age group and the small sample size, all males 50 
years and older were pooled for further analysis and the relationship between 
age, gender, and relative risk of fracture was re-evaluated (Table 17). 
Pooling data for all males over 50 years yielded an increased relative risk of 
fractures (RR = 1.318, 95% CI for RR = .969 - 2.746), however, it was not found 
to be statistically significant (p = .121). With the exception of not reaching 
significance, the pooled data for men 50 years and older are consistent with the 
findings of Rudman et al (1989), Gullberg et al (1993) and others. That is, these 108 
data suggest that males over the age of 50 years old with or without SMR 
appear to have an increased risk of bone fracture. Contrary to these findings, 
males 40 years and younger had a significantly lower risk of fracture (p  = .029). 
Unlike the male cohort, females as a group were found to have  a 
significantly greater risk of fracture (p < .001) and experienced a significantly 
greater number of fractures than did the male group (p < .001). However, the 60 
years and older female group, like the same age male group, were also found to 
have a protective effect against the risk of fracture (Table 16). Furthermore,  a 
similar trend was found among the 50-59 year old females. While neither of 
these age groups reached significance, these findings conflict with most, if not 
all, available information on the development of fractures among older females. 
To investigate these results in greater detail, women 50 years and older were 
pooled for further analysis (Table 17). Unlike their male counterparts, females 
50 years and older continued to have a protective, but non-significant, effect (RR 
= .937, 95% CI for RR = .540 - 1.508) against the risk of fracture. These findings 
are particularly interesting, especially with further analysis by age stratification. 
Surprisingly, the greatest risk of fracture among women was found among the 
20-29 year olds. While none of the female age groups yielded a significant 
protective or increased relative risk of fracture, both the 20-29 and 40-49  year 
olds were at greater risk of fracture. These findings are disturbing in light of our 
current understanding on the progression of osteoporosis and the lifetime risk of 
fractures among females. 109 
It is well established that females have less age-specific bone mass and a 
greater number of fractures than males (Karagas, Lu-Yao, Barrett, Beach, & 
Baron, 1996; Mazess, 1982; Melton, Chrischilles, Cooper, Lane, & Riggs, 1992). 
Is there an explanation for younger women with SMR to have a greater risk of 
fracture than those women with SMR over the age of 50 years old? In addition, 
is this trend consistent among all age groups when male and female age-specific 
data are combined? 
To explore these questions, both the male and female age-specific groups 
were combined. Results (Table 14) suggest that with the exception of the 60 
years and older group, there was a progressive increase in the relative risk of 
fracture by age group as expected in this population of adults. Specifically, the 
50-59 year olds had the greatest relative risk of fracture while the 20-29 year old 
group had the least risk.  It would appear from combining gender data that the 
protective effect found among 20-29 year old males positively influenced the 
age-specific data. Yet, this does explain the difference between the cumulative 
incidence of fractures for 20-29 year old males (.244) compared with the same 
age female group (.568). Perhaps 20-29 year old females had a greater level of 
disability than their same-age male peers. Furthermore, how does one interpret 
the findings that females less than 40 years old had a greater cumulative 
incidence of fractures (.542) compared to females 50 years or older (.514)? Why 
were women older than 50 and men less than 40 years old at a lower risk of 110 
fracture? Are there characteristics that these two groups share which yield a 
protective effect against fracture? 
Based on the current information available, regardless of gender, the older 
an individual, the greater the risk of fracture. Could it be that women with SMR 
who are living into their 50's and beyond are healthier with fewer secondary risk 
factors than their younger female peers? Are healthier younger females being 
deinstitutionalized as Eyman et at (1987) suggested? Perhaps women who 
remain within the state developmental centers are more apt to fracture or 
younger females are more active and therefore at greater risk of fracturing. 
One plausible explanation is the influence of body weight and the 
relationship to BMD. In an investigation of 300 healthy Caucasian 
premenopausal females between 20 and 29 years old, Mazess and Barden 
(1991) examined the effects of calcium intake, participation in physical activity, 
smoking behavior, and oral contraceptive usage on spinal, femoral, and distal 
radius BMD. Mazess and Barden reported that while smokers had significantly 
lower SBMD (p < .05), there was no significant influence of calcium intake, 
physical activity participation, or oral contraceptive usage on BMD at any site. 
However, the authors reported that the best predictor of BMD among 
premenopausal women was body weight. Specifically, the greater the body 
weight the greater the BMD values obtained at the spine, femur, and radius. 
Similarly, among 550 male and female adults, Elliot and colleagues (1993) found 
lower spinal and femoral BMD values associated with decreased body weight. 111 
Likewise, Salamone et al (1996), Nagraj et al (1990), Dawson-Hughes, Shipp, 
Sadowski, and Dallal (1987), and Ribot, Tremollieres, Pouilles, Bonneu, 
Germain, and Louvet (1988) have reported high correlations between body 
weight and BMD. 
Other investigators have examined body weight and height individually and 
collectively as BMI (weight in kg/height in meters2) on the relative risk of 
fractures. For instance, among 52,313 middle-aged Norwegian males and 
females between 35 and 49 years old, Meyer, Tverdal, and Falch (1993) 
reported that age-adjusted relative risks of hip fractures increased with height in 
both men (RR = 2.92, 95% CI for RR = 0.94  9.05) and women (RR = 3.62, 95% 
CI for RR = 1.46 - 8.97). In addition, they reported BMI to be inversely related to 
the incidence of hip fractures. Likewise, Greenspan, Meyers, Maitland, Resnick, 
and Hayes (1991) reported that a decrease in BMI of one standard deviation 
increased the odds ratio for the risk of hip fracture by 2.2 (95% CI for RR = 
1.2  3.8, p < 0.01) among ambulatory male and female older adults who 
experienced a fracture due to falling. 
With BMI as a plausible explanation for the greater relative risk among 
younger females, one would then expect the BMI of the 20-29 year old females, 
who are at greater fracture risk, to be significantly different than those women in 
the 60 and over age group who had a lower risk of fracture. However, these 
data do not support this hypothesis. Specifically, while the 20-29 year old 
females had an average BMI value of 20.74 (± 3.71), the 60 and older group, 112 
while slightly greater (22.14 ± 4.15), was not significantly different (Table 2). 
Further descriptive analysis revealed that of the 37 females between the ages of 
20-29, 17 had a BMI value less than 20. Of these, 15 experienced a fracture for 
a cumulative incidence of 0.882. Conversely, of the 39 women over the age of 
60, 15 had BMI values less than 20 and only 7 experienced a fracture for a 
cumulative incidence of 0.466. Somehow the younger females with BMI values 
less than 20 were fracturing at nearly twice the rate as those women over the 
age of 60 with equivalent BMI values. Did these older women once have BMI 
values greater than 20 with concurrent values in BMD and now, in their later 
years, be obtaining BMI values less than 20? Alternatively, could the younger 
women with BMI values less than 20 have never developed optimal BMD values 
at or above the fracture threshold as Chesnut (1991) suggests? If so, are there 
optimal BMI values which could be obtained and maintained for individuals with 
SMR without undue risk to individual health (e.g., obesity)? To further 
investigate, analysis of those women with greater BMI values was undertaken. 
While the sample size is limited, descriptive data revealed of the fifteen females 
with BMI values between 20 and 25, six or approximately 40% experienced one 
(or more) fracture(s) during the study period. Furthermore, five females had BMI 
values greater than 25 and none experienced any fracture. While it is obvious 
there are a number of factors which influence optimal bone health, it would seem 
appropriate to further investigate the interaction between BMI and fracture risk 
among young female adults with SMR. This is particularly important information 113 
as both males and females with BMI values less than 20 were at a significant risk 
of fracture. 
Of all the risk factors investigated throughout this study, none yielded a 
greater risk factor for males than having a BMI less than 20 (RR  = 3.633, 95% CI 
for RR = 3.021  10.641, p < .001). Furthermore, males with BMI values greater 
than 20 had a significant protective effect against fracture as demonstrated in 
both the BMI 20-25 group (RR = .560, 95% CI for RR = .277 - .747, p = .003), 
and those with BMI values greater than 25 (RR = .373, 95% CI for RR = .166 ­
.501, p < .001). These protective effects were not limited to males. While the 
magnitude of the relative risk was not found to be significant for either group, 
females with BMI values between 20 and 25 (RR = .865, 95% CI for RR = 
.462 - 1.215, p = .215) and those with BMI greater than 25 (RR = .722, 95% CI 
for RR = .320 - 1.027, p = .057), both were found to have a protective effect. 
Overall, the gender specific age-groups with the lowest BMI values were the 
20 - 29 year old females (20.74 ± 3.71) and the 40 - 49 year old males (21.08 ± 
4.37). The greatest BMI values obtained for males were found within the 20-29 
year olds (23.43 ± 4.74) and the 50 - 59 year old females (22.52 
± 4.28). 
Race 
It was felt that race might have a significant effect on the findings of this 
study, however, due to the limited number of individuals who were non-
Caucasian, generalizability to a larger group of individuals with SMR is not 114 
possible. Throughout the literature, numerous researchers have reported higher 
incidence and risk of fracture for Caucasian women compared with Caucasian 
and African-American men (Farmer, White, Brody, & Bailey, 1984; Karagas, Lu-
Yao, Barrett, Beach, & Baron, 1996; Mangaroo, Glasser, Roht, & Kapadia, 
1985). With few exceptions (e.g., 95-99 year olds experiencing femoral neck 
fractures), Caucasian women have a greater incidence rate of fractures than 
African-American women (Karagas, Lu-Yao, Barrett, Beach, & Baron, 1996). 
Due to the diversity of ethnicity's among the 78 non-Caucasians within this 
study (15% of sample), and the non-significant relative risk estimates found for 
both non-Caucasians (RR = 1.057, 95% CI for RR = .746  1.840, p = .697) and 
Caucasians (RR = .919, 95% CI for RR = .512 - 1.431, p = .549), inference on 
the relationship between ethnicity and the cumulative incidence of fractures is 
not possible. However, what is clear is the unexpected protective effect found 
among Caucasians (RR = .919) and the 6% greater risk of fracture for non-
Caucasians. These findings are inconsistent with information currently available, 
but the lack of an adequate non-Caucasian sample would seem to restrict 
conclusions. Therefore, a meaningful assessment by ethnicity is not feasible. 
Self-Feeding Ability 
Those groups which were found to require assistance during feeding 
(tube, total, and mostly assistance groups) were found to be at greatest risk of 
fracture when compared to those who required no assistance (independent 
group). One possible explanation is the magnitude of the accompanying 115 
physical disability of each individual. Those requiring total assistance during 
feeding tended to be nonambulatory and had lower BMI values whereas 
individuals who required no assistance tended to be ambulators with greater BMI 
values  Dietary practices also must be considered with regard to nutritional 
status. It is unclear to what extent the diets were similar among individuals of 
different ambulatory abilities. 
Developmental center practices monitor the caloric intake of individuals 
each day with an isocaloric state often the goal. Specifically, equating caloric 
input to match caloric output as demonstrated by changes in body weight, fecal, 
and urinary excretion. Understandably, there are limitations to simply 
establishing a given caloric input each day. That is, will the individual ingest all, 
part, or none of the food and if so, how are these nutrients utilized within and by 
the body. For example, in a 5-year retrospective study of one hundred and fifty-
three (48-96 years old) full-time male residents of a Veterans Administration 
Nursing Home, Rudman et al (1989) identified thirteen attributes associated with 
the occurrence of fracture within this population. After correcting for age, blood 
levels of 25 -OH -D, 1,25-(OH)2-D and somatomedin C were significantly 
associated with fracture occurrence. While there were a number of limitations 
within the study design, Rudman et al suggested that the impaired renal function 
of 1,25-(OH)2-D (vitamin D metabolite) contributed to the occurrence of fracture. 
Furthermore, while Rudman et al investigated the functional abilities of each 
male, including years of residence at the nursing home, they did not find 116 
individuals requiring total assistance (with activities of daily living) to be at 
greater risk of fracture than those with greater functional abilities (e.g., able to 
self-dress). Rudman and colleagues went as far as determining dentition 
(number of teeth) and found no correlation to the occurrence of bone fractures. 
To date, no research studies have investigated the relationship of self-feeding 
ability and the prevalence of osteoporosis or incidence of bone fractures among 
individuals with MR. 
Eyman and Call (1991) investigated mortality rates among individuals with 
(DS) residing within the state of California. Eyman and Call reported that 
inadequate mobility or self-feeding skills were better predictors of mortality than 
the presence of congenital heart difficulties frequently associated with DS. They 
reported that these same individuals also had life-expectancies less than their 
same-aged peers with DS who were capable of self-feeding and independent 
mobility. 
Perhaps directly related to the ability to self-feed is the ability to adequately 
care for ones' teeth.  If individuals with MR, including DS, are not capable of self-
feeding, functionally they probably are not able to brush their own teeth. The 
result might be a greater incidence of problems associated with poor oral 
hygiene. Whyman, Treasure, Brown, and MacFadyen (1995) examined the oral 
health of nearly 200 individuals with MR residing in a state developmental center. 
This group was found to have more teeth missing and decayed than the national 
average of their non-institutionalized peers. Over eighty percent of individuals 117 
required extensive scaling and cleaning while nearly twenty percent of those 
required complex periodontal treatment (Whyman et al, 1995). 
While dietary analysis was not conducted during the present study, the 
cumulative incidence of fractures found for the various self-feeding groups may 
be somewhat related to the findings of Whyman et at (1995). If individuals are 
not capable of self-feeding and perhaps performing minimal oral hygiene skills, it 
may be that these individuals are uncomfortable eating with assistance due to 
discomfort associated with dental disease. This may further translate to less 
consumption of foodstuff and perhaps influence bone health. Encouraging 
findings from McCubbin and Jansma (1987) suggest that individuals with SMR 
are capable of increasing their personal hygiene skills with training. Collectively, 
the findings of this study, and those of McCubbin and Jansma (1987), suggest 
investigating the role of personal hygiene skills and the implications toward the 
development of ideal body weight. 
Reproductive Factors 
Throughout history individuals with MR have been denied rights to 
education, employment, and recreational pursuits (Dunn, 1997). Perhaps one of 
the most controversial of these rights which individuals with MR have been 
denied, and continue to be so in many states, is the right to reproduce or bear 
children (Brant linger, 1995). Traditionally, in order to insure individuals with MR 
were not capable of bearing children, their parents and/or legal guardians 
authorize surgical procedures performed (hysterectomies and bilateral 118 
oophorectomies) on their female children. Today, while not as commonly 
practiced, these procedures are still performed (Brant linger, 1995). 
Unfortunately, one of the consequences of performing these procedures is the 
increased risk of bone fractures due to osteoporosis later in life (Tuppurainen et 
al, 1995a). 
Within the present study, seventeen females had bilateral oophorectomies 
(OPX) and thirty-nine had hysterectomies. Unlike the recent findings of 
Torgerson, Campbell, Thomas, and Reid (1996), individuals in our study did not 
have an increased risk of fracture following hysterectomy. Of the seventeen 
females who experienced OPX, ten experienced at least one fracture. The 
relative risk associated with this surgery was 1.10 but not found to be a 
significant risk. Seventeen of the thirty-nine females with hysterectomy 
experienced a fracture, but unlike women with OPX, these women actually were 
found to have a protective, but non-significant, relative risk against fracture. 
One explanation would be that these women were on some form of ERT or 
HRT. The protective benefits to women who begin ERT/HRT after such 
procedures is well documented (Ettinger et al, 1988; Naessen et al, 1990; 
Tuppurainen et al, 1995a), however, no females residing at the state 
developmental center were on ERT or HRT. While HRT has documented 
benefits in regards to the overall reduction of bone fractures, it is not without 
deleterious side effects, mainly cancers (Ettinger et al, 1988; Rubin et al, 1990). 119 
As a result of the consideration of risks versus benefits, developmental center 
personnel do not prescribe HRT following hysterectomy or OPX. 
Ohta and colleagues (1992) explored which was more osteoporosis-
inducing, the natural menopause or OPX. Their findings suggested that the 
natural menopause influences vertebral BMD in much the same way as OPX 
and recommended both be clinically treated in the same way. Tuppurainen, 
Kroger, Saarikoski, Honkanen, and Alhaua (1995b) investigated the 
gynecological history and BMD among 1605 perimenopausal females and 
reported that gynecological variables accounted for 18.4 to 26.8% of the 
variance in BMD. They further suggested that age, body weight and history of 
hysterectomy were found to be the most significant factors of BMD, and that it is 
unlikely that BMD status can be predicted from gynecological characteristics. 
However, Ulrich, Georgiou, Snow-Harter, and Gillis (1996) suggest that women 
can enhance bone mass through behavior and hormonal control, including 
postmenopausal ERT. 
Medications 
Clearly, with close to 85% of subjects within this study taking one or more 
anticonvulsant medications, examination of the prolonged usage of these 
medications on the relative risk of fractures was justified. Lee et al (1989, 1990), 
and Fischer et al (1988) all have reported that anticonvulsant usage to be 
partially responsible for osteopenia found in children and young adults with 
disabilities. Contrary to the findings of these studies, results from this 120 
investigation revealed no significant risk of fracture associated with 
anticonvulsant usage in this adult population. 
Six commonly prescribed anticonvulsant medications were each individually 
and collectively analyzed for the corresponding relative risk of fracture,  none 
were found to separately result in a significant fracture risk. As two or more 
anticonvulsant medications are frequently taken concurrently, further analysis 
revealed only one combination of these medications to achieve significance, 
Phenytoin with Valporic Acid. This combination was actually found to decrease 
rather than increase the risk of fracture with usage. Nonsignificant relative risk 
were also found for usage of three or four anticonvulsant medication. 
Furthermore, when the cumulative incidence of fractures was compared between 
anticonvulsant users and non-users, hypothesis testing revealed no significant 
difference between groups. 
One possible explanation is the supplementary vitamin D and calcium 
provided to all clients on anticonvulsant therapy. This supplementation is 
indicated as anticonvulsant medications have been documented to interfere with 
normal vitamin D metabolism at the liver (Hahn, 1976), to improve bone quality 
biochemically (Mac Laren & Lifshitz, 1973), and concurrently it has been 
suggested that there is a high prevalence of vitamin D deficiency among children 
with severe disabilities (Lee et al, 1989, 1990). 
The findings of anticonvulsant medication usage and BMD, while not 
determined in the present study, might parallel those of Henderson and 121 
colleagues (1995). That is, they reported that anticonvulsant usage did not 
correlate with LBMD and FNBMD in children and adolescents with spastic 
cerebral palsy, but that ambulatory status was the best predictor of BMD at these 
sites. 
While anticonvulsant medication usage was extensive among clients in this 
study, hypogondial, oral contraceptive, glucocorticoid, and thyroxin usage were 
minimal. With the exception of oral contraceptive usage, none of these agents 
were approaching significance as either a protective or causative risk for 
fracture. Oral contraceptives, while not found to be, were approaching 
significance as a protective agent. These results are not surprising as this 
medication was used exclusively among ambulatory premenopausal females 
who were found to have a significant protective effect against fracture. 
Fractures and Ambulatory Status 
Injuries related to seizures are not uncommon among individuals with 
multihandicaps. Nakken and Lossius (1993) reported during a 13-month 
retrospective study that 62 adults residing in two developmental centers 
experienced nearly 7,000 seizures which resulted in 2,696 falls. As a result of 
these falls, mandibular, femoral, cervical and skull fractures were reported. 
Nakken and Lossius reported the overall risk of serious injury related to the 
occurrence of a seizure to be approximately 1.2%. Unlike Nakken and Lossius, 
this project did not record the number of known seizures during the five-year 
study period. Data from medical records indicated that 90 fractures were directly 122 
attributable to the occurrence of a seizure, including fractures to the ribs, femur, 
and humerus. 
As the occurrence of fractures is reported to be greater in children with 
severe disabilities compared with their same-age healthy peers (Inamo, 
Ayusawa, Yamashita, Sasaki, Takeuchi, & Okuni, 1989), findings of this study 
suggest more fractures as these same individuals grow older, particularly if these 
individuals have difficulty with independent ambulation. Like the findings of 
Nakken and Lossius (1993), falls to the ground were associated with fractures in 
the present study. 
Numerous investigators have examined predictors of falling among adults, 
the consequences of these falls, and explored preventative strategies to reduce 
the occurrence of these falls. Bone mineral density (Nevitt & Cummings, 1993; 
Nguyen et al, 1991), quadricep strength (Nguyen et al, 1991), hypotension 
(Graafmans et al, 1996), selected medications (Torgerson, Garton, & Reid, 
1993), and visual impairment (Nevitt, Cummings, Kidd, & Black, 1989; Tinetti, 
Williams, & Mayewski, 1986) frequently have been cited as factors related to falls 
to the ground among the elderly. Nevitt and Cummings (1993) suggest that the 
factors which attenuate the force of impact upon falling will determine the 
occurrence of a fracture whereas the type of fracture is reported to be dependent 
upon how the individual falls (e.g., backward onto hands). 
Perhaps the fracture site which receives the greatest attention worldwide 
are fractures of the hip.  It is estimated that one-third of all older adults who 123 
experience a hip fracture will never return to their own home (Armstrong & 
Wallace, 1993) and that these fractures result in the greatest socioeconomic 
consequence among the elderly (Kanis, 1993). While the incidence of hip 
fractures continues to rise throughout the world (Zohman & Lieberman, 1995), 
Meunier (1993) reports that a 50-year old Caucasian female has a 17% lifetime 
risk of experiencing a hip fracture. Meunier (1993) suggested that current 
prevention strategies which address the prevention of falls, using hip protectors, 
and strategies which minimize bone fragility are necessary for older adults at risk 
of falling. 
Fall prevention programs have become commonly practiced among 
institutions which provide long-term care for the elderly. For example, Wagner et 
al (1994) randomly assigned 1559 ambulatory adults residing in nursing homes 
to one of three groups to examine the effectiveness of a one-time fall prevention 
program. The group receiving the one-time prevention curriculum had 
significantly fewer falls one year after following the class than did the other two 
groups which did not receive the same specialized instruction. While similar 
results of a one-time fall prevention program are unrealistic for adults with SMR, 
the findings of this study suggest a problem may exist as 46 individuals 
experienced a fracture due to falling in the present study. The use of hip 
protectors might minimize the occurrence of such fractures among these same 
ambulatory adults residing in this state developmental center. While fall 
prevention programs take different forms, most require extensive and prolonged 124 
training programs which may not be feasible to implement with limited personnel 
and financial resources in state developmental centers.  However, hip protectors 
might afford an economic alternative which may decrease the occurrence or 
provide the necessary prevention of hip fracture. Even so, among this group of 
individuals, the occurrence of hip fractures accounted for only 5.2% of the 
fractures and were the eighth most frequent site of fracture. More common were 
fractures of the ribs, vertebrae, and proximal and mid-shaft femur which 
collectively accounted for 60% of all fractures. Perhaps most perplexing  about 
these fractures is the majority were idiopathic in nature. 
Understandably, it is difficult to continuously monitor each client within the 
developmental center. Many individuals are independent ambulators  capable of 
moving freely among selected cottages. Issues such as adequate lighting, floor 
surface, slipping on wet floors, or not using handrails may have contributed to 
accidents and perhaps falls among this group. Most frequently the nature 
surrounding the fracture was unknown and this study did not attempt to identify 
specific cottages, time of day, or even personnel which might have been related 
to the occurrence of fractures. 
While ambulators had the lowest cumulative incidence (.225), they were 
also found to have a significantly reduced risk against any fracture. More 
challenging is identifying those idiopathic fractures among the assisted standing 
group which experienced the greatest cumulative incidence of fractures. 125 
A number of investigations have been conducted on ambulatory and 
nonambulatory children and adults residing in long-term residential settings with 
regards to bone health and fracture outcome. Sturm, Alman, and Christie (1992) 
retrospectively examined the occurrence of femoral fractures following hip spica 
immobilization among 77 children residing in a state developmental center. They 
reported that 29% of nonambulatory children and youth experienced a femoral 
fracture within three months after the discontinuation of the spica casts. 
Conversely, they reported no fractures occurring in ambulatory subjects. Nagraj, 
Gergans, Mattson, Rudman, and Rudman (1990) reported that 50% of males 
between 57 and 85 years old who resided in a nursing home had BMD values 
less than 70% of their age-matched healthy peers at one or more measurement 
sites. Nagraj et al (1990) and Salamone et al (1996) have both reported that 
body weight is significantly correlated with and a determinant of BMD, 
respectively. Orwoll, Bauer, Vogt, and Fox (1996) concluded that body weight is 
strongly associated with BMD in 7963 ambulatory Caucasian women 65 years or 
older, more so than estrogen exposure and calcium intake. Similarly, Rudman et 
al (1994) have reported that the strongest predictors of osteopenia among males 
58 to 95 years old residing in a nursing home was immobility and being under­
weight. 
These findings appear to support the data found in this study. Interestingly, 
in older subjects residing in nursing homes, Visentin et al (1995) suggested that 
reduced BMD values are not as important as a risk factor for fracture as is age 126 
and the occurrence of falls among this group. While subjects in the Visentin et al 
investigation averaged 81.5 years of age, none of the subjects in the present 
study were older than 72 years. 
Recent data from Gambian women suggest that significantly lower BMD 
and BMC values do not necessarily translate to osteoporotic fractures (Aspray, 
Prentice, Cole, Sawo, Reeve, & Francis, 1996). Similar findings have been 
reported with Asian males and females (Russell-Aulet, Wang, Thorton, Colt, & 
Pierson, 1991, 1993). As individuals with SMR may not achieve BMD values 
similar to age-matched healthy subjects (Downs et al, 1996), developmental 
center practices play a significant role in the outcome of fracture. Administration 
of supplemental vitamin D and calcium, achievement of weight-bearing positions, 
preventative strategies to reduce the impact of falls, and staff familiarization with 
the risk of fracture and prevention strategies may positively influence the bone 
health of adults residing in state developmental centers. 
Strengths and Limitations 
As any retrospective investigation has inherent strengths and limitations, 
this was especially obvious during data collection. First, locating subject files for 
the time period in question was often troublesome. As the starting date of the 
study began on April 1, 1991 and concluded on March 31, 1996, there were a 
number of complications including: (a) locating files with the April 1st starting 
date, (b) finding subsequent files for the time between the starting and ending 
date, or as was often the case, (c) finding files for individuals who had left the 127 
state developmental center or had died, and (d) frequently after the files were 
located, there often were pages poorly xeroxed, missing,  or difficult to read 
Alternatively, as data collection was conducted so close to the study end point, 
for the majority of subjects, most of the personal data was unavailable in current 
files. 
Secondly, while the principal investigator had complete access to individual 
data, the amount of paperwork within files made it difficult to access subject 
information. Thankfully, the nursing staff was invaluable in locating information 
which often appeared to be missing or excluded. 
Thirdly, the database while large was manageable but presented logistical 
concerns for the principal investigator. Namely, the accuracy of the data 
collected by the nursing staff over the years and their ability to reliably re-record 
the information onto data sheets. While the nursing staff was entirely 
cooperative and understanding to the challenge of obtaining subject data, it is 
difficult to know the reliability of the data recorded. Time constraints do not allow 
one person to obtain, collect, and record all data requiring the assistance of 
trained nursing personnel. The nurses were familiar with subject file formats, 
location of subject cottage (ward), location and access to information  once within 
cottages, and obtaining data in a timely and accurate manner from subject files. 
In order to minimize inaccuracies during data collection, the principal investigator 
was extensively involved in data recording and conducted weekly random 
checks of data information accuracy as they were completed by the nursing staff. 128 
During data entry of subject information from the completed data sheet into the 
computer database, an Alpha IV program was used which required each data 
point to be entered twice consecutively.  If the two data points did not match, the 
computer program would not record subject data and the information had to be 
re-entered. 
Fourth, compared with interview or recall investigations, one strength of this 
retrospective study is the validation of bone fractures. This was accomplished by 
obtaining fracture data and other important subject information directly from 
individual medical records. However, one of the shortcomings of this research is 
based on identification of fractures. There is no way to know the extent of 
individuals who were asymptomatic or were not identified as having experienced 
a bone fracture within one of the skeletal sites of interest for this study. 
Fifth, while there is documentation and validation of bone fracture(s) within 
individual medical files, there are assumptions associated with retrospective 
studies. It is assumed that over the course of the study period there was a close 
relationship between past and current exposures. Furthermore, it is assumed 
that there are no changes in the exposures of interest throughout the study 
period. For example, individual ambulatory data were recorded at the time of 
fracture. Therefore, it is assumed that individuals who were non-ambulatory at 
the time of fracture were also non-ambulatory from day one of the study. As a 
result, inference drawn from the results of this investigation are limited. 129 
Lastly, specific risk estimates are somewhat lower than reported since 
certain individuals sustained multiple fractures and only the number of fractured, 
not fractures, were widely used throughout data analysis. This study does, 
however, provide guidance for future investigations. 
Recommendations for Future Study 
It may be feasible to improve this research by: 
(1) Conducting a prospective study on this group of individuals with SMR. 
While retrospective studies have obvious advantages (e.g., not having to wait for 
long periods of time before analysis), a prospective study would be able to  : 
(a) ask specific contrast hypothesis a priori thus minimizing any chance of 
observer bias and potential inaccuracies in data recording, and (b) account for 
changes in personal welfare (e.g., ambulatory ability, medication usage,  or other 
significant changes in individual status) over time. 
(2) Examining the consequences of fracture morbidity for this group of 
individuals. Determination of how long individuals were excluded from other 
activities (e.g., specialized training) following a bone fracture would be beneficial. 
(3) Comparing age and gender specific fracture rates within the state 
developmental center to the healthy-normal population within the same 
community. Specifically, asking if fracture rates were excessive or consistent 
with the local community. 130 
(4) Comparing nationwide fracture rates between state developmental 
centers who serve adults with SMR. Specifically, how do these fracture rates 
and risk compare to other developmental centers of similar size. 
(5) Investigating the effectiveness (e.g., reducing fracture incidence rate) of 
different intervention strategies which might help minimize and/or reverse the risk 
of fractures among adults with SMR. For example, incorporating hip protectors 
among ambulatory adults who may be at risk of falling. 
(6) Examining the related cost-benefits ratio to developing training 
programs for medical personnel who work with adults with SMR. That is, can 
effective training protocols be established which (a) yield significant benefits to 
the client with SMR, (b) reduce the cost of treating fractures for the state 
developmental center. 
Summary & Conclusions 
The results of this study provide estimates for risk of fracture among adults 
with severe mental retardation residing in a state developmental center. The 
five-year cumulative incidence of fractures was 44% based on the number of 
individuals fractured and 56% based upon the number of fractures. 
The most frequently fractured sites were ribs, femur, thoracic vertebrae, and 
radius. The mechanism of injury for the majority of fractures was idiopathic in 
nature followed by accidents (e.g., during seizure), falls, and as a result of 
transfers by developmental training center personnel. 131 
Males were found to have a significant protective effect against the risk of 
fractures while females were at a significant risk. Combined gender groups 
found individuals over the age of 40 years to be at greater risk. Contrary to all 
available research data, gender specific results suggest that females over 50 
years old and males over 60 had protective risk of fracture, although this was not 
found to be significant for either group. 
Perhaps the most significant finding of this investigation was that individuals 
with body mass index values less than 20 were at significant risk of fracture. 
Conversely, fracture risk among males with body mass index values greater than 
20 and females with values greater than 25 had a significant protective effect. 
The magnitude of this effect warrants further investigation. 
Relative risk estimates by ethnicity for fracture risk were not found to be 
significant for either Caucasian or non-Caucasian individuals. As the cohort was 
predominately Caucasian, detailed analysis for other specific groups was not 
possible. 
The analysis of ambulatory ability yielded several significant findings. 
Specifically, the group with the greatest risk of fracture was the assisted standing 
group. Relative risk data for individuals who were capable of ambulating 
independently yielded a significant protective effect against fracture. By gender, 
ambulatory males and females had the lowest risk of fracture. Alternatively, 
assisted standing males and assistive device females were at greatest risk. 132 
The progressive decrease in the ability to feed oneself was an increase 
relative risk of fracture. Individuals being tube fed were at the greatest risk 
followed by those who required total assistance. Independent self-eaters were 
found to have a significant protective effect. 
Postmenopausal women, while at slightly greater risk of fracture, were not 
significantly different than premenopausal females. Women who were 
postmenopausal 10 or less years had a slightly reduced risk compared with 
females greater than 10 years postmenopausal. Women experiencing bilateral 
oophorectomies were found to have a moderate risk of fracture while women 
who had hysterectomies and were not postmenopausal had a slight protective 
effect, 
Medications, including hypothyrodial, gulcocorticoids, and the majority of 
anticonvulsants were each found to yield a non-significant increase in fracture 
risk. Oral contraceptive usage among females was found to have a non­
significant protective effect perhaps since ambulatory females were the primary 
recipients of these medications. The anticonvulsant primidone and individuals 
concurrently taking four or more anticonvulsant medications had an increased 
risk of fracture. 
Logistic regression analysis revealed that the combination of ambulatory 
ability, use of calcium supplementation, body weight, BMI, and self-feeding ability 
to best predict fracture outcome. Having established the risk of fracture in this 
population due to ambulatory ability, pharmacological considerations, gender, 133 
age, BMI and other factors, future researchers should address how to alleviate 
and/or minimize the risk of fracture for individuals with SMR either residing within 
state developmental centers or smaller group homes. For example, adults with 
SMR should be encouraged and guided in safe and appropriate weightbearing 
activities which may help prevent premature osteoporotic fractures. Additionally, 
large developmental centers should insure that personnel are trained to identify 
individuals at risk and minimize any situations which may increase individual 
fracture risk unnecessarily. 
Due to the fact that the study population was limited to adults with SMR, 
generalizability of the results is uncertain. However, there is  no reason to 
suspect that this institution's practices or the individuals residing within state 
developmental centers elsewhere are vastly different than the population 
examined in this study. Further investigations would need to determine whether: 
(1) other adults with SMR differ from the population investigated within this study 
with respect to fracture outcome, and (2) the training developmental center 
personnel receive with respect to handling of clients differ from other state 
developmental centers. 
Lastly, further investigation on the role of BMI with relationship to this 
population is justified, particularly as the risk of fractures for both males and 
females was significantly greater among those individuals with BMI values less 
than 20. 134 
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NOTICE OF DECISION
 
INSTITUTIONAL RESEARCH BOARD
 
TO:	  )0000000000000000000C
 
Steven Downs, Doctoral Candidate, Researcher, OSU
 
RE:	  Application For Approval Research on "The Epidemiology of Fractures Among 
Adults with Severe Mental Retardation Residing in a State Developmental Center" 
The Committee met on Wednesday, March 6 (1996), to review a request by Steven 
Downs to conduct research on the epidemiology of bone fractures among adults residing 
at XXXXXXXXXXXXXXX and were residing here on January 1, 1991 to be followed 
throughDecember 31, 1995. Additional requirements are as follows: 
Client identification number 
Client age, gender, height, weight, ethnicity, & cottage 
Client ability to ambulate and eat independently 
Client history of fracture, including date, site, mechanism 
Client history of medications 
Client smoking behavior 
The study will involve examing client medical files for all clients who were residing at 
)000000C3000CX on January 1, 1991. Clients eligible for inclusion into the studywill 
be identified by XXXXXXXXXXXX. The researcher will work with a representative 
from the Department of Rehabilitation Medicine to secure client data. A copy of the 
research proposal, which outlines the study in more detail, is attached. 
The purpose of the research is said to be: 
1)	  To investigate the magnitude, characteristics, and potential risk factors of 
bone fractures among adults with severe mental retardation residing in a 
state developmental center. 
RECOMMENDATION:  APPROVAL 
There were seven members present. The vote was 5 to 1 in favor of approving the 
experiment, with one member abstaining due to a potential conflict of interest. The 
member voting not to approve the study felt that there was insufficient benefit to clients to 
justify moving forward. Also, this member felt that the impact of the study would 
generate negative attention to this and other state training centers. 
There was also discussion by other members (voting favorably) about the possible 
consequences such a study could have for )000CXXX)OCXX. These items were 164 
addressed by XXXXXX3OCX and the researcher. They discussed that the name of the 
training center nor individuals associated with the training center would be identified 
within any documents published, including, presentations ;lade and the doctoral thesis. 
Mr. Downs agreed to this and asked that a second copy of the approval form be 
forwarded to him for use within his study which does not identify the trainingcenter or 
personnel by name (attached). 
There was discussion about the title of the experiment (why the word "profound" was not 
included). The educational community has only two categories; mild and severe 
retardation, whereas the medical community/training center recognizes four (mild, 
moderate, sever, profound). Approval to conduct this experiment is still to be obtained at 
Oregon State University. Collection of all information can begin as soon as the researcher 
and )0000C XXXXXX have all the necessary approvals, forms, and accessibilityto 
medical data. Mr. Downs will work out of an office located in the Department of 
Rehabilitation Medicine and does not have permission to travel to cottages without 
supervision. All necessary documents will be transported to this office. Procedures for 
obtaining documents is to be arranged by )0(X. 
This test is expected to cost approximately $8,000. Mr. Downs will not be paid for the 
research, nor is he expected to reimburse the training center for associated costs. 
cc:	  XXXXXXXXXXX 
Committee Members 165 
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INSTITUTIONAL REVIEW BOARD FOR THE PROTECTION OF HUMAN SCI3JECTS 
OREGON STATE UNIVERSITY 
Report of Review 
TITLE:  Epidemiology of fracture in adults with severe mental retardation residing 
in a state developmental center. 
PRINCIPAL INVESTIGATOR:  Jeffrey McCubbin 
DEPARTMENT:  ExSS 
STUDENT:  Steve Downs 
COMMITTEE DECISION: Approved 
COMMENTS: 
1.	  The informed consent form obtained from each subject should be retained in 
program/project's files for three years beyond the end date of the project. 
Any proposed change to the protocol or informed consent form that is not 
included in the approved application must be submitted to the IRB for review and 
must be approved by the committee before it can be implemented. 
Date	  April 19, 1996 
Warren N. Suzuki, Chair 
Committee for the Protection of Human Subjects 
(Education, 7-6393, suzukiw@ccmail.orst.edu) 167
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Description of the Study 
Title:	  The Epidemiology of Fractures Among Adults with Severe
 
Mental Retardation Residing in a State Developmental
 
Center
 
Investigators:
 
Steve Downs  (Student investigator)
 
Dr. Jeff McCubbin  (Prinicipal investigator)
 
Purpose: 
To investigate the magnitude, characteristics, and potential risk factors of 
bone fractures among adults with severe mental retardation residing in  a state 
developmental center. 
Why is this Study Important? 
Many adults with severe mental retardation cannot stand or participate in 
weightbearing activities and therefore, are at higher risk of developing 
osteoporosis, a degenerative bone disease. This may be particularly evident in 
individuals who reside in continuous care settings, such as board and  care 
homes or state developmental centers, where the severity of mental and/or 
physical impairment diminish the opportunities to participate in weightbearing 
activities. 
What the Subject Needs to do: 
There is no need for the investigators or any other individual associated 
with this study to make contact with the subjects residing in the state 
developmental center. The student investigator will examine the medical records 
of the client and record data from these records into a database. Data to be 
obtained (Appendix B) include: identification number (assigned by the 
developmental center), age, gender, race, cottage of residence (within the 
developmental center), anticonvulsant medication(s) and dosage(s), body height 
and weight, ambulatory ability (e.g., independent ambulator), smoker / 
nonsmoker status, calcium supplementation, years residing in medical center, 
level of assistance needed to eat meals (e.g., total assistance, independent), 
and lastly, the site, type, and etiology of bone fracture. The subject's name will 
not be included within this database and will be identified by a state 
developmental center assigned number. 
Possible Risks to Subject: 
There is no risk due to this investigation. 169 
Benefits to the Subject: 
Data obtained in this study will provide information and direction useful in: 
(1) identifying potential risk factors for bone fracture within this population of
 
adults with severe mental retardation, and (2) identifying individuals at risk.
 
As a result, it is hoped that this information may be useful in stimulating the
 
development of effective preventive programs at this and other similar
 
developmental centers.
 
Subject Characteristics 
This cohort of subjects will include all males and females with severe 
mental retardation who have resided in a state developmental center since 
January 1, 1989. All subjects with severe mental retardation who were residing 
within the developmental center on this date will be included in this study 
regardless of gender, age, or any other criteria. It is estimated that over 450 
individuals will be eligible for study participation. All subjects are over the age of 
21 and are dependent upon continuous care to meet their long term needs. 
Informed Consent 
Permission to conduct this study has been obtained from the 
XXXXXXXXXXX Center (Appendix A).  It was determined by the Institutional 
Review Board of XXXXXXXXXXXXXX that it was not necessary to receive 
subject's informed consent. Futhermore, the student investigator does not have 
permission to travel freely within the training center without supervision, 
therefore, minimizing any contact with subjects in this study. 
Confidentiality: 
The information obtained during this study will be treated as privileged and 
confidential. As the student investigator will be working from an office within the 
Department of Rehabilitation Medicine, all subject files will be brought to this 
office by medical personnel and are not to be removed from this area or copied. 
The data obtained from the medical records will be used for statistical analysis 
and scientific purposes with the clients right to privacy retained. The subject will 
be assigned an identification number by the developmental center on all data 
collection sheets (Appendix B), reports and publication of this data. Access to 
this data will only be available to the student researcher in this study. Upon the 
completion of this study, the code list to numerical references will be destroyed. 
Questions/Concerns? 
Contact Steve Downs (541/737-3402) or Dr. Jeff McCubbin (541/737-5921) 
at Oregon State University. 170
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Statement of Informed Consent 
Title:	  The Epidemiology of Fractures Among Adults with Severe
 
Mental Retardation Residing in a State Developmental Center
 
Purpose: 
The purpose of this study is threefold. First, to examine the number of 
bone fractures which occur to clients at the XXXXXXXXXXXXXXXXXX. 
Secondly, what common characteristics do clients have who fracture a 
bone. That is, age, gender, medications, etc. Lastly, to identify the 
potential risk factors which the client may have which put them at higher 
risk of experiencing more fractures than those who can walk without 
assistance. 
Significance/Benefits: 
At this time the fracture risk factors for adults with severe mental 
retardation have not been identified. While similar information is known 
about men, women, and children without a disability, no information is 
currently available to help understand why fractures may occur and who 
may be at the greatest risk in a group of adults with severe mental 
retardation. To date, no investigations have examined this question. The 
results of this study, are far reaching to a large group of adults with mental 
retardation (perhaps adults without mental retardation). Not only will this 
information help XXXXXXXXXXXXXXXXXXXXXX staff in the therapeutic 
programming of clients, but will help determine those clients at greatest 
risk and help develop approaches for future training.  In addition, all 
subjects, guardians, and hospital personnel can receive a free copy of the 
results of this study. Participation in this study will not require any contact 
with the client. Conversely, only the client's medical records need to be 
made available to the researcher to determine who has experienced  a 
bone fracture and investigate why the client might have had the bone 
fracture. 
Location of the Study:
 
All data will be collected at the Training Center. The student investigator
 
will travel to the Training Center to collect information from each client
 
medical file. The student investigator will not remove the clients record,
 
xerox any part of the file, nor even to know the client name, only their
 
identification number.
 
Risks to the Subject:
 
There is no risk to the client due to this investigation.
 172 
Confidentiality 
The information obtained during this study will be treated as privileged 
and confidential. As the student investigator will be working from an office 
within the Department of Rehabilitation Medicine, all subject files will be 
brought to this office by medical personnel and are not to be removed 
from this area or copied. The data obtained from the medical records will 
be used for statistical analysis and scientific purposes with the clients right 
to privacy retained. Subjects identity will not be known by the 
researchers. Upon completion of this study, the code list of numerical 
references will be destroyed. 
Freedom of Consent 
I have been thoroughly informed and understand the nature and purpose 
of this investigation. The researchers have made it clear that they will 
answer all questions or concerns that I may have. Participation in this 
study is completely voluntary.  I am free to deny consent at any time 
without prejudice or loss of benefits guaranteed by participation. 
Questions concerning rights as a subject can be directed to the 
Institutional Review Board for the Protection of Human Subjects at the 
Research Office of Oregon State University and the XXXXXXXXXXX 
XXXXXX. I understand that Oregon State University does not provide a 
research subject with compensation or medical treatment in the event the 
subject is injured as a result of participation in a research project. 
Questions concerning the study may be directed to Steve Downs at 
541/737-3402, Dr. Jeff McCubbin (737-5921). 
Informed Consent 
Title: The epidemiology of fractures among adults with severe mental 
retardation residing in a state developmental center. 
Acting Parent/Guardian:  I have thoroughly read this statement of 
informed consent and agree to 
allow 
to participate in this study. 
Guardians Signature  Date 
Guardians Name (Please Print) 173
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Medical Questionnaire
 
Sheet A
 
Questions? Call Steve Downs (541) 737-3402
 
Client ID# 
Gender  1  MALE  2  FEMALE 
Cottage 
Date of Birth  Age 
Date of Admission to Instit. 
Yrs Institutionalized 
Weight (kg) 
Height (cm)  BMI 
Medications 
Anticonvulsant(s)  1  YES  9  NO
 
Corticosteroids  1  YES  9  NO
 
Oral Contraceptives  1  YES  9  NO
 
Thyroid Medication  1  YES  9  NO
 
(Use sheet C to report type, dosage, and date started medications) 
Behaviors 
Does the client smoke  1 YES  9 NO  How long? 
Calcium supplements  1 YES  9 NO  Dose 
Vitamin D supplements  1 YES  9 NO  Dose 
Menopausal Status 
Pre-menopausal  1 
Post-menopausal  5  How long?  Date 175 
Ambulatory Ability 
4  Walk independently without assistance 
3  Walk with the aid of a supportive device (cane, walker, etc.) 
2  Restricted to use of wheelchair only for transportation 
1  Restricted to prone/supine lier 
Self-Feeding 
5  Feed independently without assistance 
4  Feed with minimal assistance 
3  Feed mostly with assistance 
2  Feed with total assistance 
1  Tube fed 
Ethnic Background 
Which best describes the clients ethnic identity? 
5  African American 
4  American Indian/Alaskan Native 
3  Asian American 
2  Caucasian 
1  Hispanic American 
0  Other (please specify) 1 
176 
Client ID# 
PREVIOUS FRACTURE(S) (Use sheet B to list type of fracture, if any) 
YES 
9 NO 
Site 
1  Skull 
2  Cervical vertebrae 
3  Thoracic vertebrae 
4  Lumbar vertebrae 
5  Sacrum 
6  Ribs 
7  Clavicle 
8  Pelvis 
9  Hip 
10 Femur 
11 Tibia 
12 Fibula 
13 Ulna 
14 Radius 
15 Humerus 
Date(s)  Reported Cause 
1  = Falls 
2 = Transfer 
3  = Unknown 
4 = Other 
a. seizure 
b. accident 
c. struck 177 
Sheet B 
Client # 
Fracture Summary 
Location  Cause  Date 
1. 
2. 
3. 
4. 
5. 
6. 178 
Sheet C 
Client # 
Medication Summary 
Medication  Dosage  Start Date 179
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Table 38. 
Two-by-Two Table of Fractures and Age (All Subjects 20 - 29 Years) 
Fractures 
YES  NO  TOTAL 
Age  YES  31  47  78 
(All Subjects) 
(20 29 years)  NO  198  242  440 
TOTAL  229  289  518 
Relative Risk=  0.883 
95% RR Cl=  .559 - 1.317 
p-value=  0.390 
Table 39.
 
Two-by-Two Table of Fractures and Age (All Subjects 30 39 Years)
 
Fractures 
YES  NO  TOTAL 
Age  YES  72  103  175 
(All Subjects) 
(30 - 39 years)  NO  157  186  343 
TOTAL  229  289  518 
Relative Risk= 0.899 
95% RR Cl=  .604 - 1.197 
p-value=  0.317 181 
Table 40. 
Two-by-Two Table of Fractures and Age (All Subjects 40 49 Years) 
Fractures 
YES  NO  TOTAL 
Age  YES  60  66  126 
(All Subjects) 
(40 49 years)  NO  169  223  392 
TOTAL  229  1  289  518 
Relative Risk=  1.105 
95% RR Cl=  .854 - 1.795 
p-value=  0.379 
Table 41.
 
Two-by-Two Table of Fractures and Age (All Subjects 50 - 59 Years)
 
Fractures 
YES  NO  TOTAL 
Age  YES  39  41  80 
(All Subjects)
 
(50 - 59 years)  NO  190  248
  438 
TOTAL  229  289  518 
Relative Risk= 1.124 
95% RR Cl=  .847 - 2.002 
p-value=  0.373 182 
Table 42.
 
Two-by-Two Table of Fractures and Age (All Subjects  60 Years)
 
Fractures 
YES  NO  TOTAL 
Age 
(AU Subjects) 
(  60 years) 
YES 
NO 
27 
202 
32 
257 
59 
459 
TOTAL  229  289  518 
Relative Risk= 1.040 
95% RR Cl=  .710 - 1.851 
p-value=  0.803 183 
Table 43. 
Two-by-Two Table of Age (AU Males) 
Fractures 
YES  NO  TOTAL 
Males  YES  96  175  271 
(All Ages)
 
NO  133
  114  247 
TOTAL  229  289  518 
Relative Risk= 0.658 
95% RR Cl=  .342 - .669 
p-value=  >.001 
Table 44.
 
Two-by-Two Table of Age (All Females)
 
Fractures 
YES  NO  TOTAL 
Females  YES  133  114  247 
(All Ages)
 
NO  96
  175  271 
TOTAL  229  289  518 
Relative Risk= 1.54 
95% RR Cl=  1.521 - 3.027 
p-value=  >.001 184 
Table 45.
 
Two-by-Two Table of Males (20 29 Years)
 
Fractures 
YES  NO  TOTAL 
Males  YES  10  31  41 
(20 29 yrs) 
NO  86  144  230 
TOTAL  96  175  271 
Relative Risk=  0.652 
95% RR Cl=  .332 - 1.157 
p-value=  0.107 
Table 46.
 
Two-by-Two Table of Females (20 - 29 Years)
 
Fractures 
YES  NO  TOTAL 
Females  YES  16 21  37 
(20 - 29 Years)
 
NO  112  98  210
 
TOTAL  133  114  247 
Relative Risk= 1.064 
95% RR CI=  .639 - 2.324 
p-value=  0.704 185 
Table 47. 
Two-by-Two Table of Males (30 - 39 Years) 
Fractures 
YES  NO  TOTAL 
Males 
(30  39 years) 
YES 
NO 
29 
67 
65 
110 
94 
177 
TOTAL  96  175  271 
Relative Risk= 0.815 
95% RR Cl=  .473 - 1.248 
p-value=  0.25 
Table 48. 
Two-by-Two Table of Females (30 - 39 Years) 
Fractures 
YES  NO  TOTAL 
Females 
(30  39 Years) 
YES 
NO 
43 
90 
38 
76 
81 
166 
TOTAL  133  114  247 
Relative Risk= 0.979 
95% RR Cl=  .596 - 1.628 
p-value=  0.865 186 
Table 49. 
Two-by-Two Table of Males (40 - 49 Years) 
Fractures 
YES  NO  TOTAL 
Males  YES  41 28  69 
(40 - 49 Years) 
NO  68  134  202 
TOTAL  96  175  271 
Relative Risk=  1.205 
95% RR Cl=  .843 - 2.362 
p-value=  0.298 
Table 50.
 
Two-by-Two Table of Females (40 49 Years)
 
Fractures 
YES  NO  TOTAL 
Females  YES  32  25  57
 
(40 - 49 Years)
 
NO  101  89  190
 
TOTAL  133  114  247 
Relative Risk= 1.056 
95% RR Cl=  .675 - 2.047 
p-value=  0.689 187 
Table 51. 
Two-by-Two Table of Males (50 - 59 Years) 
Fractures 
YES  NO  TOTAL 
Males 
(50  59 Years) 
YES 
NO 
22 
74 
25 
150 
47 
224 
TOTAL  96  175  271 
Relative Risk= 1.417 
95% RR Cl=  1.059 - 3.374 
p-value=  0.073 
Table 52. 
Two-by-Two Table of Females (50 - 59 Years) 
Fractures 
YES  NO  TOTAL 
Females 
(50  59 Years) 
YES 
NO 
17 
116 
16 
98 
33 
214 
TOTAL  133  114  247 
Relative Risk= 0.95 
95% RR Cl=  .500 - 1.871 
p-value=  0.772 188 
Table 53.
 
Two-by-Two Table of Males (60 Years & Above)
 
Fractures 
YES  NO  TOTAL 
Males  YES  7  13  20 
(60 & Above) 
NO  89  162  251 
TOTAL  96  175  271 
Relative Risk=  0.987 
95% RR Cl=  .520 - 2.547 
p-value=  0.682 
Table 54.
 
Two-by-Two Table of Females (60 Years & Above)
 
Fractures 
YES  NO  TOTAL 
Females  YES  19 20  39 
(60 & Above) 
NO  113  95  208 
TOTAL  133  114  247 
Relative Risk= 0.944 
95% RR Cl=  .509 - 1.756 
p-value=  0.726 189 
Table 55. 
Two-by-Two Table of Males (< 40 Years Old) 
Fractures 
YES  NO  TOTAL 
Males 
(< 40 Years Old) 
YES 
NO 
39 
57 
96 
79 
135 
136 
TOTAL  96  175  271 
Relative Risk= 
95% RR Cl= 
p-value= 
0.689 
.362 - .933 
0.029 
Table 56. 
Two-by-Two Table of Females (< 40 Years Old) 
Fractures 
YES  NO  TOTAL 
Females 
(< 40 Years Old) 
YES 
NO 
64 
69 
54 
60 
118 
129 
TOTAL  133  114  247 
Relative Risk= 1.014 
95% RR Cl=  .645 - 1.701 
p-value=  0.849 190 
Table 57. 
Two-by-Two Table of Males (  50 Years Old) 
Fractures 
YES  NO  TOTAL 
Males 
( ?_ 50) 
YES 
NO 
29 
67 
38 
137 
67 
204 
TOTAL  96  175  271 
Relative Risk= 
95% RR Cl= 
p-value= 
1.318 
.969 - 2.746 
0.121 
Table 58. 
Two-by-Two Table of Females ( >_ 50 Years Old) 
Fractures 
YES  NO  TOTAL 
Females 
(_50) 
YES 
NO 
37 
96 
35 
79 
72 
175 
TOTAL  133  114  247 
Relative Risk= 0.937 
95% RR CI=  .540 - 1.508 
p-value=  0.617 191 
Table 59.
 
Two-by-Two Table of Race (Caucasian)
 
Fractures 
YES  NO  TOTAL 
Race  YES  197  252  449 
(Caucasian) 
NO 32  37  69 
TOTAL  229  289  518 
Relative Risk=  0.919 
95% RR Cl=  .512 - 1.431 
p-value=  0.549 
Table 60.
 
Two-by-Two Table of Race (Non-Caucasian)
 
Fractures 
YES  NO  TOTAL 
Race  YES  32  37  69 
(Non-Caucasian) 
NO  197  252  449 
TOTAL  229  289  518 
Relative Risk= 1.057 
95% RR Cl=  .746 - 1.840 
p-value=  0.697 192 
Table 61.
 
Two-by-Two Table of Body Mass Index (< 20)
 
Fractures 
YES  NO  TOTAL 
Body Mass  YES  123  73  196 
Index 
(< 20)  NO  106  216  322 
TOTAL  229  289  518 
Relative Risk= 2416 
95% RR Cl=  1.906 - 4.978 
p-value=  >.001 
Table 62.
 
Two-by-Two Table of Body Mass Index (20  25)
 
Fractures 
YES  NO  TOTAL 
Body Mass  YES  76  127  203 
Index 
(20 - 25)  NO  153  162  315 
TOTAL  229  289  518 
Relative Risk= 0.771 
95% RR Cl=  .465 - .908 
p-value=  0.013 193 
Table 63. 
Two-by-Two Table of Body Mass Index (> 25) 
Fractures 
YES  NO  TOTAL 
Body Mass 
Index 
(> 25) 
YES 
NO 
30 
199 
89 
200 
119 
399 
TOTAL  229  289  518 
Relative Risk= 0.505 
95% RR Cl=  .247 - .536 
p-value=  >.001 194 
Table 64. 
Two-by-Two Table of Males (BMI < 20) 
Fractures 
YES  NO  TOTAL 
Males 
(BMI < 20) 
YES 
NO 
62 
34 
40 
135 
102 
169 
TOTAL  96  175  271 
Relative Risk= 3.633 
95% RR CI=  3.021 - 10.641 
p-value=  > .001 
Table 65. 
Two-by-Two Table of Females (BMI < 20) 
Fractures 
YES  NO  TOTAL 
Females 
(BMI < 20) 
YES 
NO 
61 
72 
33 
81 
94 
153 
TOTAL  133  114  247 
Relative Risk= 1.379 
95% RR Cl=  1.266 - 3.532 
p-value=  0.007 195 
Table 66. 
Two-by-Two Table of Males (BMI 20 - 25) 
Fractures 
YES  NO  TOTAL 
Males 
(BMI 20 25) 
YES 
NO 
22 
74 
72 
103 
94 
177 
TOTAL  96  175  271 
Relative Risk= 
95% RR Cl= 
p-value= 
0.56 
.277 - .747 
0.003 
Table 67. 
Two-by-Two Table of Females (BMI 20 - 25) 
Fractures 
YES  NO  TOTAL 
Females 
(BMI 20 25) 
YES 
NO 
54 
79 
55 
59 
109 
138 
TOTAL  133  114  247 
Relative Risk= 0.865 
95% RR Cl=  .462 - 1.215 
p-value=  0.215 196 
Table 68. 
Two-by-Two Table of Males (BMI > 25) 
Fractures 
YES  NO  TOTAL 
Males 
(BMI > 25) 
YES 
NO 
12 
84 
63 
112 
75 
196 
TOTAL  96  175  271 
Relative Risk= 0.373 
95% RR CI=  .166 - .501 
p-value=  .001 
Table 69. 
Two-by-Two Table of Females (BMI > 25) 
Fractures 
YES  NO  TOTAL 
Females 
(BMI > 25) 
YES 
NO 
18 
115 
26 
88 
44 
203 
TOTAL  133  114  247 
Relative Risk= 0.722 
95% RR CI=  .320 - 1.027 
p-value=  0.057 197 
Table 70.
 
Two-by-Two Table of Immobile Ambulation (All Subjects)
 
Immobile 
Ambulation 
(All Subjects) 
YES 
YES  33 
NO  196 
TOTAL  229 
Fractures 
NO 
45 
244 
289 
Relative Risk= .950 
95% RR Cl=  .630 - 1.486 
p-value=  .711 
TOTAL
 
78
 
440
 
518
 198 
Table 71. 
Two-by-Two Table of Immobile Ambulation (Males) 
Fractures 
YES  NO  TOTAL 
Immobile 
Ambulation 
(Male) 
YES 
NO 
16 
80 
23 
152 
39 
232 
TOTAL  96  175  271 
Relative Risk= 1.19 
95% RR Cl=  .778 - 2.645 
p-value=  0.43 
Table 72. 
Two-by-Two Table of Immobile Ambulation (Females) 
Fractures 
YES  NO  TOTAL 
Immobile 
Ambulation 
(Females) 
YES 
NO 
17 
116 
22 
92 
39 
208 
TOTAL  133  114  247 
Relative Risk= 0.782 
95% RR CI=  .361 - 1.222 
p-value=  0.162 199 
Table 73. 
Two-by-Two Table of Assisted Standing Ambulation (All Subjects) 
Fractures 
YES  NO  TOTAL 
Assisted  YES  102  88  190 
Standing 
Ambulation  NO  127  201  328 
(All Subjects) 
TOTAL  229  289  518 
Relative Risk= 1.386 
95% RR Cl=  1.317 - 2.634 
p-value=  >.001 200 
Table  74.
 
Two-by-Two Table of Assisted Standing Ambulation (Males)
 
Fractures 
YES  NO  TOTAL 
Assisted  YES  43  45  88
 
Standing 
Ambulation  NO  53  130  183 
(Male) 
TOTAL  96  175  271 
Relative Risk= 1.687 
95% RR Cl=  1.454 - 3.968 
p-value=  > .001 
Table 75.
 
Two-by-Two Table of Assisted Standing Ambulation (Females)
 
Fractures 
YES  NO  TOTAL 
Assited  YES  59  43  102 
Standing 
Ambulation  NO  75  71  146 
(Females) 
TOTAL  134  114  248 
Relative Risk= 1.126 
95%  RR Cl=  .809 - 2.163 
p-value=  0.298 201 
Table 76. 
Two-by-Two Table of Assistive Device Ambulation (All Subjects) 
Fractures 
YES  NO  TOTAL 
Assistive Device 
Ambulation 
(All Subjects) 
YES 
NO 
74 
155 
87 
202 
161 
357 
TOTAL  229  289  518 
Relative Risk= 1.059 
95% RR Cl=  .802 - 1.612 
p-value=  0.589 202 
Table 77.
 
Two-by-Two Table of Assistive Device Ambulation (Males)
 
Fractures 
YES  NO  TOTAL 
Assistive  YES  30  65  95 
Device 
Ambulation  NO  66  110  176 
(Male) 
TOTAL  96  175  271 
Relative Risk= 0.842 
95% RR Cl=  .496 - 1.307 
p-value=  0.33 
Table 78.
 
Two-by-Two Table of Assistive Device Ambulation (Females)
 
Fractures 
YES  NO  TOTAL 
Assistive  YES  44  22  66 
Device 
Ambulation  NO  90  92  182 
(Female) 
TOTAL  134  114  248 
Relative Risk= 1.348 
95% RR Cl=  1.195 - 3.684 
p-value=  0.016 203 
Table 79. 
Two-by-Two Table of Independent Ambulation (All Subjects) 
Fractures 
YES  NO  TOTAL 
Independent  YES  20  69  89 
Ambulation 
(All Subjects)  NO  209  220  429 
TOTAL  229  289  518 
Relative Risk= 0.461 
95% RR Cl=  .220 - .520 
p-value=  >.001 204 
Table 80.
 
Two-by-Two Table of Independent Ambulation (Males)
 
Fractures 
YES  NO  TOTAL 
Independent  YES  7  42  49 
Ambulation 
(Males)  NO  89  133  222 
TOTAL  96  175  271 
Relative Risk=  0.356 
95% RR Cl=  .159 - .580 
p-value=  > .001 
Table 81.
 
Two-by-Two Table of Independent Ambulation (Females)
 
Fractures 
YES  NO  TOTAL 
Independent  YES  13  27  40 
Ambulation 
(Females)  NO  121  87  208 
TOTAL  134  114  248 
Relative Risk= 0.559 
95% RR Cl=  .211 -.709 
p-value=  0.003 205 
Table 82. 
Two-by-Two Table of Immobile & Assisted Standing (All Subjects) 
Fractures 
YES  NO  TOTAL 
Immobile &  YES  135  133  268 
Assisted 
Standing 
(All Subjects)  NO  94  156  250 
TOTAL  229  289  518 
Relative Risk= 1.34 
95% RR CI=  1.207 - 2.392 
p-value=  0.004 
Table 83.
 
Two-by-Two Table of Assistive & Independent Ambulation (All Subjects)
 
Fractures 
YES  NO  TOTAL 
Assistive &  YES  94  156  250 
Independent 
Ambulation 
(All Subjects)  NO  135  133  268 
TOTAL  229  289  518 
Relative Risk= 0.746 
95% RR CI=  .433 - .843 
p-value=  0.004 206 
Table 84. 
Two-by-Two Table of Smoking (All Subjects) 
Fractures 
YES  NO  TOTAL 
Smoking  YES  2  12  14 
NO  227  277  504 
TOTAL  229  289  518 
Relative Risk= 0.317 
95% RR CI=  .111 - .919 
p-value=  0.023 207 
Table 85.
 
Two-by-Two Table of Self-Feeding (Tube Fed)
 
Fractures 
YES  NO  TOTAL 
Self-Feeding  YES  20  8  28 
(Tube) 
NO  209  281  490 
TOTAL  229  289  518 
Relative Risk= 1.675 
95% RR Cl=  1.623 -7.784 
p-value=  0.003 
Table 86.
 
Two-by-Two Table of Self-Feeding (Assisted)
 
Fractures 
YES  NO  TOTAL 
Self-Feeding  YES  88  76  164 
(Assisted) 
NO  141  213  354 
TOTAL  229  289  518 
Relative Risk= 1.347 
95% RR Cl=  1.250 - 2.542 
p-value=  0.003 208 
Table 87.
 
Two-by-Two Table of Self-Feeding (Mostly Assist)
 
Fractures 
YES  NO
  TOTAL 
Self-Feeding  YES  61  59  120
 
(Mostly Assist) 
NO  168  230  398
 
TOTAL  229  289
  518
 
Relative Risk=  1.204 
95%  RR Cl=  .999 - 2.132 
p-value=  0.095 
Table 88.
 
Two-by-Two Table of Self-Feeding (Some Assist)
 
Fractures 
YES  NO
  TOTAL 
Self-Feeding  YES  45  73  118
 
(Some Assist) 
NO  184  216  400
 
TOTAL  229
  289  518
 
Relative Risk= 0.829 
95% RR Cl=  .521- 1.102 
p-value=  0.131 209 
Table 89. 
Two-by-Two Table of Self-Feeding (Independent) 
Fractures 
YES  NO  TOTAL 
Self-Feeding 
(Independent) 
YES 
NO 
15 
214 
73 
216 
88 
430 
TOTAL  229  289  518 
Relative Risk= 0.343 
95% RR CI=  .150 -.373 
p-value=  >.001 210 
Table 90. 
Two-by-Two Table of Self-Feeding (Tube. Total & Mostly Assisted) 
Fractures 
YES  NO  TOTAL 
Self-Feeding  YES  169  143  312 
(Tube  Mostly 
Assisted)  NO  60  146  206 
TOTAL  229  289  518 
Relative Risk= 1.994 
95% RR Cl=  1.860 - 4.181 
p-value=  >.001 
Table 91.
 
Two-by-Two Table of Self-Feeding (Some Assist & Independent)
 
Fractures 
YES  NO  TOTAL 
Self-Feeding  YES  60  146  206
 
(Some Assist &
 
Independent)  NO  169  143  312
 
TOTAL  229  289  518 
Relative Risk= 0.506 
95% RR Cl=  .256 - .538 
p-value=  >.001 211 
Table 92.
 
Two-by-Two Table of Anticonvulsant Medication Usage
 
Fractures 
YES  NO  TOTAL 
Anticonvulsant  YES  198  240  438 
Medications 
(All Subjects)  NO  31  49  80 
TOTAL  229  289  518 
Relative Risk=  1.167 
95% RR Cl=  .803 - 2.124 
p-value=  0.285 
Table 93.
 
Two-by-Two Table of No Anticonvulsant Medication Usage
 
Fractures 
YES  NO  TOTAL 
No YES  31  49  80 
Anticonvulsant 
Medications  NO  198  240  438 
(All Subjects) 
TOTAL  229  289  518 
Relative Risk= 0.857 
95% RR Cl=  .534 - 1.249 
p-value=  0.285 212 
Table 94.
 
Two-by-Two Table of Usage of One Anticonvulsant Medication
 
Fractures 
YES  NO  TOTAL 
One (1)  YES  25  33  58 
Anticonvulsant 
Medication  NO  173  207  380 
TOTAL  198  240  438 
Relative Risk=  0.947 
95% RR Cl=  .595 - 1.584 
p-value=  0.726 
Table 95.
 
Two-by-Two Table of Usage of Two Anticonvulsant Medications
 
Fractures 
YES  NO  TOTAL 
Two (2)  YES  118  141  259 
Anticonvulsant 
Medications  NO  80  99  179 
TOTAL  198  240  438 
Relative Risk= 1.019 
95% RR Cl=  .719 - 1.519 
p-value=  0.857 213 
Table 96. 
Two-by-Two Table of Usage of Three Anticonvulsant Medications 
Fractures 
YES  NO  TOTAL 
Three (3)  YES  50  62  112 
Anticonvulsant 
Medications  NO  148  178  326 
TOTAL  198  240  438 
Relative Risk=  0.983 
95% RR Cl=  .677 - 1.494 
p-value=  0.889 
Table 97.
 
Two-by-Two Table of Usage of Four Anticonvulsant Medications
 
Fractures 
YES  NO  TOTAL 
Four (4)  YES  5  4  9 
Anticonvulsant 
Medications  NO  193  236  429 
TOTAL  198  240  438 
Relative Risk= 1.235 
95% RR Cl=  .557 - 5.775 
p-value=  0.529 214 
Table 98.
 
Two-by-Two Table of Usage of Two or less Anticonvulsant Medications
 
Fractures 
YES  NO  TOTAL 
2 or less  YES  143  174  317 
Anticonvulsant 
Medications  NO  55  66  121 
(All Subjects) 
TOTAL  198  240  438 
Relative Risk=  0.992 
95% RR Cl=  .653 - 1.502 
p-value=  0.952 
Table 99.
 
Two-by-Two Table of Usage of Three or more Anticonvulsant Medications
 
Fractures 
YES  NO  TOTAL 
3 or more  YES  55  66  121
 
Anticonvulsant
 
Medications  NO  143  174  317
 
(All Subjects)
 
TOTAL  198  240  438
 
Relative Risk= 1.008 
95% RR Cl=  .710 - 1.545 
p-value=  0.952 215 
Table 100. 
Two-by-Two Table of Usage of Phenytoin & Valproic Acid 
Medications
 
Phenytoin &
 
Valproic Acid
 
Table 101. 
Fractures 
YES  NO  TOTAL 
YES 33  61  94 
NO  196  228  424 
TOTAL  229  289  518 
Relative Risk= 0.759 
95% RR Cl=  .447 - 1.002 
p-value=  0.05 
Two-by-Two Table of Usage of Phenytoin & Carbamazepine 
Medications
 
Phenytoin &
 
Carbamazepine
 
Fractures 
YES  NO  TOTAL 
YES  46  55  101 
NO  183  234  417 
TOTAL  229  289  518 
Relative Risk= 1.038 
95% RR Cl=  .752 - 1.656 
p-value=  0.757 216 
Table 102. 
Two-by-Two Table of Usage of Phenytoin & Phenobarbital 
Fractures 
YES  NO  TOTAL 
Medications  YES  90  94  184 
Phenytoin & 
Phenobarbital  NO  139  195  334 
TOTAL  229  289  518 
Relative Risk=  1.175 
95% RR Cl=  .971 - 1.929 
p-value=  0.110 
Table 103.
 
Two-by-Two Table of Usage of Phenytoin & Primidone
 
Fractures 
YES  NO  TOTAL 
Medications  YES  24  25  49 
Phenytoin & 
Primidone  NO  205  264  469 
TOTAL  229  289  518 
Relative Risk= 1.121 
95% RR Cl=  .787 - 2.229 
p-value=  0.447 217 
Table 104.
 
Two-by-Two Table of Usage of Phenytoin & Ethosuximide
 
Medication
 
Phenytoin &
 
Ethosuximide
 
Table 105. 
YES 
YES  14 
NO  215 
TOTAL  229 
Fractures 
NO 
14 
275 
289 
Relative Risk= 1.14 
95% RR Cl=  .724 - 2.742 
p-value=  0.529 
Two-by-Two Table of Usage of Valproic Acid & Phenobarbital 
Medication
 
Valporic Acid &
 
Phenobarbital
 
Fractures 
YES  NO 
YES  35  51 
NO  194  238 
TOTAL  229  289 
Relative Risk= 0.906 
95% RR Cl=  .589 - 1.348 
p-value=  0.472 
TOTAL 
28 
490 
518 
TOTAL 
86 
432 
518 218 
Table 106.
 
Two-by-Two Table of Usage of Valproic Acid & Primidone
 
Medication
 
Valporic Acid &
 
Primidone
 
Table 107. 
YES
 
YES  12
 
NO  217
 
TOTAL  229
 
Relative Risk=
 
95% RR Cl=
 
p-value=
 
Fractures 
NO 
12
 
277
 
289
 
1.138 
.695 - 2.899 
0.562 
Two-by-Two Table of Usage of Carbamazepine & Primidone 
Medication 
Carbamazepine 
& Primidone 
Fractures
 
YES  NO
 
YES 4  8
 
NO  225  281
 
TOTAL  229  289
 
Relative Risk= 0.75
 
95% RR Cl=  .302 - 2.102
 
p-value=  0.441
 
TOTAL 
24
 
494
 
518
 
TOTAL 
12
 
506
 
518
 219 
Table  108. 
Two-by-Two Table of Usage of Valproic Acid & Ethosuximide 
Fractures 
YES  NO  TOTAL
 
Medication  YES 5  8  13 
Valporic Acid & 
Ethosuximide  NO  224  281  505 
TOTAL  229  289  518
 
Relative Risk=  0.867 
95%  RR Cl=  .379 - 2.431 
p-value=  0.674 
Table  109.
 
Two-by-Two Table of Usage of Carbamazepine & Ethosuximide
 
Fractures 
YES  NO  TOTAL
 
Medication  YES 7  3  10
 
Carbamazepine
 
&  NO  222  286  508
 
Ethosuximide
 
TOTAL  289  518
 
Relative Risk= 1.602 
95%  RR CI=  .949 - 11.767 
p-value=  0.097 220 
Table 110.
 
Two-by-Two Table of Usage of Phenobarbital & Ethosuximide
 
Medication 
Phenobarbital 
& 
Ethosuximide 
YES 
YES  5 
NO  224 
TOTAL  229 
Fractures 
NO 
7 
281 
288 
Relative Risk= 0.939 
95% RR CI=  .414 - 2.863 
p-value=  0.849 
TOTAL 
12 
505 
517 221 
Table 111. 
Two-by-Two Table of Usage of Phenytoin 
Fractures 
YES  NO  TOTAL 
Phenytoin  YES  160  192  352 
NO 69  97  166 
TOTAL  229  289  518 
Relative Risk=  1.094 
95% RR Cl=  .814 - 1.702 
p-value=  0.407 
Table 112. 
Two-by-Two Table of Usage of Valporic Acid 
Fractures 
YES  NO  TOTAL 
Valporic Acid  YES  65  101  166 
NO  164  188  352 
TOTAL  229  289  518 
Relative Risk= 0.84 
95% RR Cl=  .539 - 1.074 
p-value=  0.114 222 
Table 113. 
Two-by-Two Table of Usage of Carbamazepine 
Fractures 
YES  NO  TOTAL 
Carbamazepine  YES  46  55  101 
NO  183  234  417 
TOTAL  229  289  518 
Relative Risk=  1.038 
95% RR Cl=  .752 - 1.656 
p-value=  0.757 
Table 114. 
Two-by-Two Table of Usage of Phenobarbital 
Fractures 
YES  NO  TOTAL 
Phenobarbital  YES  112  122  234 
NO  117  167  284 
TOTAL  229  289  518 
Relative Risk= 1.162 
95% RR Cl=  .949 - 1.858 
p-value=  0.131 223 
Table 115. 
Two-by-Two Table of Usage of Primidone 
Fractures 
YES  NO  TOTAL 
Primidone  YES  31  30  61 
NO  198  259  457 
TOTAL  229  289  518 
Relative Risk=  1.173 
95% RR Cl=  .885 - 2.309 
p-value=  0.246 
Table 116. 
Two-by-Two Table of Usage of Ethosuximide 
Fractures 
YES  NO  TOTAL 
Ethosuximide  YES  17  18  35 
NO  212  271  483 
TOTAL  229  289  518 
Relative Risk= 1.107 
95% RR Cl=  .723 - 2.400 
p-value=  0.596 224 
Table 117. 
Two-by-Two Table of Pre-Menopausal Females 
Fractures 
YES  NO  TOTAL 
Pre-Menopausal 
Females 
YES 
NO 
83 
50 
75 
39 
158 
89 
TOTAL  133  114  247 
Relative Risk= .935 
95% RR Cl=  .521 - 1.456 
p-value=  0.528 
Table 118. 
Two-by-Two Table of Post-Menopausal Females 
Fractures 
YES  NO  TOTAL 
Post-Menopause 
(Females) 
YES 
NO 
50 
83 
39 
75 
89 
158 
TOTAL  133  114  247 
Relative Risk= 1.069 
95% RR Cl=  .712- 1.954 
p-value=  0.582 225 
Table 119. 
Two-by-Two Table of Post-Menopausal Females < 10 years 
Post-Menopause 
< 10 years 
(Females) 
Table 120. 
Fractures 
YES  NO  TOTAL 
YES  19  14  33 
NO  31  25  56 
TOTAL  50  39  89 
Relative Risk=  1.040 
95% RR Cl=  .495 - 2.610 
p-value=  0.818 
Two-by-Two Table of Post-Menopausal Females  10 years 
YES  TOTAL 
Post-Menopause  YES  31  56 
?_ 10 years 
(Females)  NO  19  33 
TOTAL  50  89 
Relative Risk= 
95% RR Cl= 
p-value= 226 
Table 121. 
Two-by-Two Table of Females with Oophorectomy 
Fractures 
YES  NO  TOTAL 
Oophorectomy  YES  10  7  17 
NO  123  107  230 
TOTAL  133  114  247 
Relative Risk=  1.10 
95% RR Cl=  .556 - 3.380 
p-value=  0.667 
Table 122. 
Two-by-Two Table of Females with Hysterectomy 
Fractures 
YES  NO  TOTAL 
Hysterectomy  YES  17  22  39 
NO  116  92  208 
TOTAL  133  114  247 
Relative Risk= 0.782 
95% RR Cl=  .361 - 1.222 
p-value=  0.165 227 
Table 123. 
Two-by-Two Table of Usage of Glucocorticoids 
Fractures 
YES  NO  TOTAL 
Glucocorticoids  YES  11 10  21 
NO  219  278  497 
TOTAL  229  289  518 
Relative Risk= 1.081 
95% RR Cl=  .614 - 2.768 
p-value=  0.749 
Table 124. 
Two-by-Two Table of Usage of Thyroxine 
Fractures 
YES  NO  TOTAL 
Thyroxine  YES  4  5  9 
NO  225  284  509 
TOTAL  229  289  518 
Relative Risk= 1.005 
95% RR Cl=  .409 - 3.807 
p-value=  0.889 228 
Table 125.
 
Two-by-Two Table of Usage of Oral Contraceptives
 
Oral
 
Contraceptives
 
YES 
YES  16 
NO  90 
TOTAL  106 
Fractures 
NO 
18 
67 
85 
Relative Risk= 0.821 
95% RR Cl=  .366 - 1.393 
p-value=  0.059 
TOTAL
 
34
 
157
 
191
 229 
Appendix G
 
Data Collected from State Developmental Center
 230 
KEY TO RAW DATA SHEETS
 
Column 
1.  Subjects Age 
2.  Gender	  (1= Male  2= Female) 
3.	  Ethnicity  (1= Hispanic 2= Caucasian 3= Asian
 
4= American Indian 5= African American
 
6= Other)
 
4.  Years Institutionalized 
5.  Height (cm) 
6.  Weight (kg) 
7.  Body Mass Index	  (Ht squared in meters/weight (kg)) 
8.	  Ambulation Ability  (1= Immobile 2= Immobile/Assisted Standing 
3= Assistive Device 4= Ambulatory) 
9.	  Self Feeding Ability  (1= Tube 2= Total Assistance 3= Mostly
 
Assist 4= Minimal Assistance 5= No
 
Assistance)
 
10.  Menopausal Status	  (1 = Pre  5= Post) 
11.  Years Post Menopause 
12.  Hysterectomy	  (1 = Yes  9 = No) 
13.  Years Post Hysterectomy 
14.  Oophorectomy	  (1 = Yes  9 = No) 
15.  Years Post Oophorectomy 
16.  Oral Contraceptives	  (1 = Yes  9 = No) 
17.  Smoking	  (1 = Yes  9 = No) 
18.  Anticonvulsant Usage	  (1 = Yes  9 = No) 
19.  Phenytoin (mg) 
20.  Valporic Acid (mg) 
21.  Carbamazepine (mg) 
22.  Phenobarbital (mg) 
23.  Primidone (mg) 
24.  Ethosuximide (mg) 
25.  Number of Anticonvulsant Medications Concurrently Taken 
26.  Glucocorticoids	  (1 = Yes  9 = No) 
27.  Thyroxine	  (1 = Yes  9 = No) 
28.  Calcium Supplement	  (1 = Yes  9 = No) 
29.  Vitamin D Supplement	  (1 = Yes  9 = No) 
30.  Term of Study (e.g., date of first fracture, deinstitutionalization) 
31.  Person-Years for Term of Study 
32.  Fracture History	  (1 = Yes  9 = No) 
33.  Fracture 1 Date 
34.  Fracture 1 Site 
35.  Fracture 1 Cause 
36.  Fracture 1 Person-Years 231 
Raw Date Key (continued) 
37.  Fracture 2 Date 
38.  Fracture 2 Site 
39.  Fracture 2 Cause 
40.  Fracture 2 Person-Years 
41.  Fracture 3 Date 
42.  Fracture 3 Site 
43.  Fracture 3 Cause 
44.  Fracture 3 Person-Years 
45.  Fracture 4 Date 
46.  Fracture 4 Site 
47.  Fracture 4 Cause 
48.  Fracture 4 Person-Years 
49.  Total Number of Fractures 
Code 99 = Not Appropriate 232 
1  2  3  4  5  6  7  8  9  10  11  12 
38  1  2  37  163  114  43.00  4  5  99  99  99 
26  1  2  26  163  97  36.59  4  5  99  99  99 
36  1  2  36  157  90  36.51  4  5  99  99  99 
59  1  2  35  142  70  34.72  4  4  99  99  99 
26  1  2  26  183  116  34.66  4  5  99  99  99 
53  2  2  50  135  61  33.58  2  3  5  1  9 
52  1  2  50  160  84  32.81  4  4  99  99  99 
31  1  5  25  163  87  32.74  4  5  99  99  99 
57  2  4  55  127  53  32.66  2  2  5  8  9 
30  1  2  29  150  73  32.44  2  3  99  99  99 
41  1  3  39  150  73  32.44  4  5  99  99  99 
63  2  2  63  119  46  32.18  2  2  5  4  9 
60  1  2  59  140  63  32.14  2  2  99  99  99 
25  1  4  25  145  67  31.87  3  4  99  99  99 
25  2  2  19  137  59  31.22  4  4  1  99  9 
27  1  2  21  150  70  31.11  3  5  99  99  99 
37  1  2  35  142  62  30.75  3  4  99  99  99 
37  1  5  29  152  71  30.73  2  3  99  99  99 
33  1  2  24  147  66  30.54  4  5  99  99  99 
55  1  3  49  160  78  30.47  4  5  99  99  99 
41  1  2  25  152  70  30.30  3  5  99  99  99 
38  1  2  36  140  59  30.10  2  3  99  99  99 
63  2  2  61  132  52  29.93  1  2  5  10  9 
58  1  2  29  152  69  29.86  4  4  99  99  99 
55  1  2  54  165  81  29.75  4  5  99  99  99 
41  1  2  29  163  78  29.55  4  5  99  99  99 
39  1  2  38  152  68  29.43  4  4  99  99  99 
41  2  2  41  140  57  29.32  2  3  5  99  1 
29  1  2  29  157  72  29.21  4  5  99  99  99 
46  1  2  43  157  72  29.21  4  5  99  99  99 
46  1  2  45  142  59  29.05  1  3  99  99  99 
29  2  2  20  145  61  29.01  4  5  1  99  9 
43  1  2  40  145  61  29.01  3  4  99  99  99 
27  1  2  27  152  67  29.00  4  4  99  99  99 
34  1  1  25  152  67  29.00  2  3  99  99  99 
34  1  2  28  152  67  29.00  3  4  99  99  99 
36  1  2  31  152  67  29.00  4  5  99  99  99 
31  2  2  28  152  67  28.72  4  4  1  99  9 
42  1  4  42  165  78  28.65  4  5  99  99  99 
26  2  4  20  145  60  28.54  4  5  1  99  9 233 
13  14  15  16  17  18  19  20  21  22  23 
99  99  99  99  9  1  530  9  1000  9  9 
99  99  99  99  1  1  9  9  9  200  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  9  1500  9  9  9 
99  99  99  99  9  1  9  9  9  240  9 
9  9  99  9  9  1  300  9  600  9  9 
99  99  99  99  9  1  430  9  9  165  9 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  1  260  9  600  9  9 
99  99  99  99  9  1  400  1500  9  140  9 
99  99  99  99  9  1  360  9  800  9  9 
9  9  99  9  9  1  230  9  400  9  9 
99  99  99  99  9  1  330  9  600  9  9 
99  99  99  99  9  1  360  1500  9  132  1000 
9  9  99  1  9  1  300  9  9  116  9 
99  99  99  99  9  1  360  1500  9  140  9 
99  99  99  99  9  1  310  1250  9  132  9 
99  99  99  99  9  1  360  9  9  140  9 
99  99  99  99  9  1  330  9  9  132  9 
99  99  99  99  9  1  390  9  800  9  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  300  9  9  100  9 
9  9  99  9  9  1  260  9  9  100  9 
99  99  99  99  9  1  360  1500  9  132  9 
99  99  99  99  9  1  400  1625  9  165  9 
99  99  99  99  1  1  390  9  9  165  9 
99  99  99  99  9  1  360  9  9  132  9 
16  99  99  99  9  1  300  9  600  9  9 
99  99  99  99  9  1  360  1250  9  148  9 
99  99  99  99  1  1  360  1500  9  9  9 
99  99  99  99  9  1  300  9  9  116  9 
9  9  99  1  9  9  99  99  99  99  99 
99  99  99  99  9  1  300  9  600  9  1000 
99  99  99  99  9  1  9  1500  9  132  9 
99  99  99  99  9  1  360  1500  9  9  9 
99  99  99  99  9  1  360  9  9  132  500 
99  99  99  99  9  1  360  1500  9  132  9 
9  9  99  1  9  1  360  1500  9  9  9 
99  99  99  99  9  1  390  9  800  9  9 
9  9  99  1  9  1  330  1250  9  120  9 234 
24  25  26  27  28  29  30  31  32 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  1  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  9  9  11/27/93  2.66301  9 
9  1  9  9  500  800  3/31/96  5.00548  9 
9  1  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  2/27/96  4.91507  1 
9  2  9  9  500  800  6/17/93  2.21644  9 
99  0  9  9  9  9  6/20/94  3.22466  9 
1250  3  9  9  600  800  3/31/96  5.00548  9 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  700  11/13/91  .62192  1 
9  2  9  9  500  800  1/12/96  4.78904  1 
9  4  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  500  800  10/17/94  3.55068  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  9  9  9/7/92  1.44110  9 
9  2  9  9  500  800  10/11/94  3.53425  1 
9  2  9  9  600  800  7/27/95  4.32603  1 
9  3  9  9  500  800  12/2/95  4.67671  1 
9  3  9  9  500  800  5/27/93  2.15890  1 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  2/1/92  .84110  1 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  4/20/91  .05479  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  600  9  3/31/96  5.00548  9 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  10/13/91  .53699  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  500  800  2/2/95  3.84658  9 
9_  3  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  9/6/91  .43562  9 
9  2  1  9  500  800  3/31/96  5.00548  9 
9  3  9  9  600  800  8/11/92  1.36712  9 235 
33  34  35  36  37  38  39  40 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
2/27/96  6  2  4.91507  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
11/13/91  13  2  .62192  4/17/92  10  2  1.04932 
1/12/96  10  2  4.78904  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
10/11/94  6  3  3.53425  99  99  99  99 
7/27/95  6  2  4.32603  99  99  99  99 
12/2/95  7  4  4.67671  99  99  99  99 
5/27/93  9  1  2.15890  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
2/1/92  6  3  .84110  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 236 
41  42  43  44  45  46  47  48  49 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
8/22/94  10  4  3.39726  99  99  99  99  3 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 237 
1  2  3  4  5  6  7  8  9  10  11  12 
32  1  2  30  163  75  28.53  4  5  99  99  99 
45  2  2  40  142  57  28.27  4  5  5  99  1 
37  1  2  37  178  89  28.15  4  5  99  99  99 
49  1  2  46  152  65  28.13  4  4  99  99  99 
39  1  2  35  173  84  28.07  4  5  99  99  99 
50  2  2  36  142  57  28.05  2  3  3  99  9 
43  1  2  43  170  81  28.03  4  5  99  99  99 
40  2  2  29  157  70  28.02  2  3  1  99  9 
38  1  2  38  150  63  28.00  2  3  99  99  99 
52  1  2  41  157  69  27.99  4  5  99  99  99 
57  2  2  47  122  41  27.80  2  3  5  5  9 
50  2  2  43  147  60  27.77  4  5  3  99  9 
46  2  2  42  145  58  27.73  2  2  3  99  9 
39  1  2  32  152  64  27.70  3  4  99  99  99 
63  1  2  59  152  64  27.70  4  4  99  99  99 
66  2  2  66  142  56  27.60  3  2  5  13  9 
37  1  2  37  157  68  27.59  2  2  99  99  99 
30  2  2  30  145  58  27.59  3  4  1  99  9 
60  2  2  24  122  41  27.50  2  2  5  4  9 
35  1  2  33  163  73  27.48  3  5  99  99  99 
34  1  2  30  163  72  27.32  2  2  99  99  99 
43  2  2  42  147  59  27.30  3  5  1  99  9 
52  1  5  52  147  59  27.30  3  3  99  99  99 
67  2  2  66  137  51  27.27  2  3  5  18  9 
53  2  2  53  155  65  27.24  2  2  5  99  1 
59  1  2  46  137  51  27.17  2  3  99  99  99 
25  1  2  24  152  63  27.17  4  4  99  99  99 
39  2  2  36  114  35  27.11  1  2  5  99  99 
36  2  2  35  150  61  27.11  3  5  1  99  9 
47  1  2  47  170  78  26.99  4  5  99  99  99 
37  1  2  19  168  76  26.97  2  2  99  99  99 
26  1  2  23  142  54  26.83  1  2  99  99  99 
32  1  2  30  145  56  26.78  1  2  99  99  99 
63  2  2  62  142  54  26.78  3  4  5  6  9 
25  1  1  22  163  71  26.72  3  4  99  99  99 
64  2  2  62  150  60  26.69  2  2  5  99  1 
59  1  1  57  155  64  26.64  4  4  99  99  99 
39  2  2  34  147  58  26.54  4  4  1  99  9 
58  1  2  57  167  74  26.53  4  5  99  99  99 
34  1  2  34  150  60  26.49  3  4  99  99  99 238 
13  14  15  16  17  18  19  20  21  22  23 
99  99  99  99  1  1  400  9  800  9  9 
23  99  99  99  9  1  290  1250  9  100  9 
99  99  99  99  9  1  445  9  9  165  9 
99  99  99  99  9  1  330  1500  9  9  9 
99  99  99  99  1  1  430  1625  9  9  9 
9  9  99  9  9  1  290  9  600  9  9 
99  99  99  99  9  1  400  9  9  165  9 
9  9  99  9  9  1  360  1500  9  9  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  360  9  600  9  9 
9  9  99  9  9  1  200  9  9  100  9 
9  9  99  9  9  1  300  9  600  9  9 
9  9  99  9  9  1  300  1250  9  9  9 
99  99  99  99  9  1  330  9  9  108  9 
99  99  99  99  9  1  9  1500  9  132  9 
9  9  99  9  9  1  9  1500  9  120  9 
99  99  99  99  9  1  360  1500  9  9  9 
9  9  99  9  9  1  290  1250  9  116  9 
9  9  99  9  9  1  200  9  9  9  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  9  1500  9  9  9 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  9  1  300  1250  9  9  9 
9  9  99  9  9  1  260  9  600  9  9 
28  99  99  99  9  1  330  9  9  132  9 
99  99  99  99  9  1  260  1125  9  100  9 
99  99  99  99  9  1  330  1500  9  9  9 
99  1  9  99  9  1  190  9  400  9  9 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  1  9  99  99  99  99  99 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  9  1250  9  116  9 
9  9  99  9  9  1  260  9  600  9  9 
99  99  99  99  9  9  99  99  99  99  99 
28  99  99  99  9  1  9  1250  9  120  9 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  1  9  1  290  9  9  100  9 
99  99  99  99  1  9  99  99  99  99  99 
99  99  99  99  9  1  300  9  9  100  9 239 
24  25  26  27  28  29  30  31  32 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  500  800  4/29/94  3.08219  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
99  0  9  9  9  9  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  700  3/16/93  1.96164  1 
9  2  9  9  600  800  3/31/96  5.00548  9 
1000  3  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  1  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  500  800  10/19/91  .55342  9 
9  3  9  9  600  800  3/31/96  5.00548  9 
9  1  1  9  600  600  11/29/91  .66575  1 
99  0  9  9  9  9  9/15/93  2.46301  9 
9  1  9  9  500  800  8/26/92  1.40822  9 
99  0  9  9  600  9  3/31/96  5.00548  9 
9  2  9  9  500  800  5/4/93  2.09589  1 
9  2  9  9  600  800  3/31/96  5.00548  9 
1500  3  9  9  600  800  10/13/93  2.53973  1 
9  3  9  9  500  800  4/20/93  2.05753  1 
9  2  9  9  500  800  3/31/96  5.00548 
9  2  9  9  600  600  9/11/92  1.45205  1 
99  0  9  9  600  9  11/16/92  1.63288  1 
99  0  9  9  9  9  3/31/96  5.00548  9 
99  0  9  9  9  9  10/5/94  3.51781  9 
99  0  9  9  9  9  3/31/96  5.00548  9 
9  2  9  9  500  800  1/26/96  4.82740  9 
9  2  9  9  600  800  7/1/92  1.25479  9 
99  0  9  9  9  9  8/21/93  2.39452  9 
9  2  9  9  600  800  6/19/92  1.22192  1 
99  0  9  9  9  9  8/14/91  .37260  1 
9  2  9  9  600  800  9/8/94  3.44384  9 
99  0  9  9  9  9  6/19/91  .21918  9 
9  2  9  9  500  800  3/31/96  5.00548  9 240 
33  34  35  36  37  38  39  40 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
3/16/93  9  3  1.96164  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
11/29/91  12  3  .66575  3/15/93  11  3  1.95890 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
5/4/93  14  1  2.09589  99  99  99  99 
99  99  99  99  99  99  99  99 
10/13/93  6  4  2.53973  99  99  99  99 
4/20/93  9  1  2.05753  99  99  99  99 
99  99  99  99  99  99  99  99 
9/11/92  14  3  1.45205  6/7/93  14  3  2.18904 
11/16/92  15  1  1.63288  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
6/19/92  6  4  1.22192  99  99  99  99 
8/14/91  6  3  .37260  1/28/96  15  4  4.83288 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 241 
41  42  43  44  45  46  47  48  49 
,  . 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
5/27/95  12  3  4.15890  99  99  99  99  3 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 242 
1  2  3  4  5  6  7  8  9  10  11  12 
39  1  2  37  165  72  26.45  3  4  99  99  99 
25  1  2  25  152  61  26.40  2  3  99  99  99 
32  1  2  31  180  86  26.38  4  5  99  99  99 
34  1  2  30  157  65  26.37  3  3  99  99  99 
55  1  2  54  157  65  26.37  3  4  99  99  99 
29  1  2  23  170  76  26.30  4  5  99  99  99 
51  1  2  49  160  67  26.17  3  4  99  99  99 
54  2  2  53  160  67  26.17  3  5  3  99  9 
43  2  2  40  152  60  26.00  2  3  5  99  99 
45  1  2  41  152  60  25.97  3  5  99  99  99 
42  1  2  40  144  54  25.84  1  2  99  99  99 
61  2  2  60  135  47  25.81  1  2  5  6  9 
63  1  2  61  150  58  25.78  4  4  99  99  99 
24  2  2  20  160  66  25.77  4  4  1  99  9 
25  1  2  21  185  88  25.71  4  5  99  99  99 
32  1  2  32  165  70  25.71  2  3  99  99  99 
60  1  2  59  145  54  25.68  2  2  99  99  99 
44  2  2  41  117  35  25.62  1  2  3  99 
53  2  2  47  163  68  25.60  2  2  5  99  99 
38  2  2  36  142  52  25.59  1  3  1  99  9 
29  2  2  27  140  50  25.57  1  2  1  99  9 
63  2  2  60  157  63  25.56  3  5  5  5  9 
62  2  2  62  162  67  25.53  3  5  5  99  1 
51  1  2  49  168  72  25.51  3  3  99  99  99 
30  2  2  26  112  32  25.48  1  2  1  99  9 
56  2  2  51  147  55  25.45  3  4  5  4  9 
72  2  2  71  112  32  25.45  1  1  5  19  9 
40  1  2  33  160  65  25.39  3  4  99  99  99 
55  2  2  54  155  61  25.39  3  5  3  99  9 
33  2  2  33  142  51  25.36  2  2  1  99  9 
45  1  2  44  165  69  25.34  4  4  99  99  99 
23  1  2  23  150  57  25.25  3  4  99  99  99 
36  2  2  36  157  63  25.24  2  3  5  99  1 
66  2  2  65  149  56  25.22  4  4  5  99  1 
28  1  2  24  163  67  25.22  2  3  99  99  99 
33  1  2  30  175  77  25.21  2  3  99  99  99 
31  1  2  29  157  62  25.15  3  5  99  99  99 
40  2  2  34  157  62  25.08  2  3  1  99  9 
54  1  2  54  173  75  25.06  4  5  99  99  99 
38  2  2  35  160  64  25.00  3  4  5  99  1 243 
13  14  15  16  17  18  19  20  21  22  23 
99  99  99  99  9  1  360  9  800  9  9 
99  99  99  99  9  1  300  1250  9  120  9 
99  99  99  99  9  1  430  1625  9  9  1000 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  330  1500  9  9  9 
99  99  99  99  1  1  400  9  800  9  500 
99  99  99  99  9  1  330  9  9  132  750 
9  9  99  9  9  9  99  99  99  99  99 
99  1  15  99  9  1  9  9  9  100  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  290  9  9  108  9 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  9  1  300  9  9  9  9 
9  9  99  1  9  1  330  1500  9  140  9 
99  99  99  99  9  1  460  1625  9  9  1250 
99  99  99  99  9  1  330  1250  9  140  9 
99  99  99  99  9  1  290  9  9  108  9 
9  9  99  9  9  1  190  750  9  90  9 
99  1  18  99  9  1  9  1500  9  132  500 
9  9  99  9  9  1  260  9  9  100  9 
9  9  99  9  9  1  9  1000  9  100  9 
9  9  99  9  9  1  330  9  9  9  9 
34  99  99  99  9  1  360  1500  9  9  9 
99  99  99  99  9  1  360  9  9  100  9 
9  9  99  9  9  1  160  9  9  65  750 
9  9  99  9  9  1  260  1125  9  9  9 
9  9  99  9  9  1  160  9  400  9  9 
99  99  99  99  9  1  330  1500  9  120  1000 
9  9  99  9  9  1  300  9  9  132  9 
9  9  99  9  9  1  9  1125  9  100  9 
99  99  99  99  9  1  360  9  600  9  9 
99  99  99  99  9  1  290  1250  9  116  9 
15  99  99  99  9  1  330  9  9  132  9 
31  99  99  99  9  1  290  9  600  9  750 
99  99  99  99  9  1  360  1500  9  9  750 
99  99  99  99  9  1  9  1500  9  9  9 
99  99  99  99  9  1  310  9  9  120  9 
9  9  99  9  9  1  300  9  600  9  9 
99  99  99  99  1  9  99  99  99  99  99 
16  99  99  99  9  1  9  1500  9  116  1000 244 
24  25  26  27  28  29  30  31  32 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  9  9  5/21/95  4.14247  9 
9  2  9  9  500  800  3/19/92  .96986  1 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  600  9  3/31/96  5.00548  9 
9  1  9  9  600  800  7/5/91  .26301  1 
99  0  9  9  9  9  3/31/96  5.00548  9 
9  2  9  9  500  800  11/30/93  2.67123  1 
99  0  9  9  600  9  3/31/96  5.00548  9 
9  1  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  600  800  3/31/96  5.00548  9 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  12/22/92  1.73151  1 
9  3  1  9  600  600  3/31/96  5.00548  9 
9  3  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  600  800  12/29/92  1.75068  9 
9  1  9  9  600  800  1/19/94  2.80822  1 
9  2  9  9  600  800  3/10/96  4.94795  1 
9  2  9  9  500  800  8/25/91  .40274  9 
9  3  1  9  600  600  4/27/94  3.07671  1 
9  2  9  9  600  800  11/10/91  .61370  1 
9  2  9  9  600  600  6/12/94  3.20274  1 
9  4  9  9  500  800  6/29/92  1.24932  1 
9  2  9  9  600  800  12/4/93  2.68219  1 
9  2  9  9  600  800  12/26/95  4.74247  1 
9  2  9  9  500  800  1/14/95  3.79452  9 
9  3  9  9  500  800  5/14/95  4.12329  1 
9  2  9  9  600  800  3/31/96  5.00548 
9  3  9  9  600  800  11/4/93  2.60000  9 
9  3  9  9  500  800  3/31/96  5.00548  9 
1500  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  2/11/93  1.87123  9 
99  0  9  9  9  9  10/27/95  4.57808  9 
9  2  9  9  600  800  6/23/91  .23014  9 245 
33  34  35  36  37  38  39  40 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
3/19/92  9  1  .96986  9/17/93  14  1  2.46849 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
7/5/91  6  2  .26301  99  99  99  99 
99  99  99  99  99  99  99  99 
11/30/93  10  2  2.67123  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
12/22/92  9  3  1.73151  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
1/19/94  9  1  2.80822  99  99  99  99 
3/10/96  3  3  4.94795  99  99  99  99 
99  99  99  99  99  99  99  99 
4/27/94  10  2  3.07671  99  99  99  99 
11/10/91  10  3  .61370  5/4/93  3  3  2.09589 
6/12/94  15  4  3.20274  99  99  99  99 
6/29/92  15  3  1.24932  6/2/94  6  4  3.17534 
12/4/93  7  1  2.68219  99  99  99  99 
12/26/95  13  2  4.74247  99  99  99  99 
99  99  99  99  99  99  99  99 
5/14/95  6  1  4.12329  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 246 
41  42  43  44  45  46  47  48  49 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 247 
1  2  3  4  5  6  7  8  9  10  11  12 
24  1  2  19  165  68  24.98  2  3  99  99  99 
33  2  2  31  165  68  24.98  3  5  5  99  1 
28  1  2  27  155  60  24.97  3  5  99  99  99 
33  1  2  32  152  58  24.96  1  2  99  99  99 
30  1  2  26  142  50  24.80  2  2  99  99  99 
44  2  2  43  163  65  24.74  2  2  3  99  9 
41  2  2  36  157  61  24.67  4  5  5  99  1 
42  2  2  42  137  46  24.62  1  3  3  99 
47  1  2  43  165  67  24.61  3  5  99  99  99 
43  1  2  42  170  71  24.57  3  5  99  99  99 
39  1  2  37  155  59  24.56  3  5  99  99  99 
38  1  2  36  163  65  24.46  2  2  99  99  99 
38  1  3  33  168  69  24.45  3  4  99  99  99 
36  2  2  30  157  60  24.34  3  5  1  99  9 
43  2  2  36  157  60  24.34  3  5  5  99 
60  1  2  58  157  60  24.34  3  4  99  99  99 
65  1  2  63  157  60  24.34  3  4  99  99  99 
35  2  2  28  124  38  24.33  1  2  1  99  9 
35  1  2  30  152  56  24.24  2  2  99  99  99 
39  2  2  39  152  56  24.24  3  4  1  99  9 
33  2  2  32  163  64  24.09  4  5  1  99  9 
47  2  2  40  152  56  24.05  2  2  3  99  9 
50  2  2  47  124  37  24.04  2  1  3  99  9 
37  1  2  26  180  78  23.98  3  5  99  99  99 
67  2  1  65  140  47  23.98  3  4  5  99  1 
55  1  2  55  170  69  23.88  3  4  99  99  99 
24  1  2  24  147  52  23.82  3  4  99  99  99 
43  2  2  42  152  55  23.81  3  5  3  99  9 
50  1  2  42  152  55  23.81  2  2  99  99  99 
27  2  1  25  157  59  23.79  1  2  1  99  9 
43  2  2  43  142  48  23.79  1  2  3  99  9 
29  1  5  25  168  67  23.74  3  5  99  99  99 
27  2  2  26  135  43  23.71  4  4  1  99  9 
38  1  2  33  178  75  23.67  3  5  99  99  99 
35  1  4  30  140  46  23.63  1  2  99  99  99 
49  2  4  48  168  66  23.59  2  3  3  99  9 
67  2  5  64  142  48  23.57  2  2  5  99  99 
37  2  4  36  150  53  23.56  4  5  1  99  9 
48  1  2  45  150  53  23.56  3  4  99  99  99 
47  1  2  38  175  72  23.51  4  5  99  99  99 248 
13  14  15  16  17  18  19  20  21  22  23 
99  99  99  99  9  1  360  1500  9  132  9 
10  99  99  99  9  1  360  1500  9  132  9 
99  99  99  99  9  1  9  1250  9  120  9 
99  99  99  99  9  1  9  1250  9  9  9 
99  99  99  99  9  1  260  9  400  9  1250 
9  9  99  9  9  1  9  1500  9  132  9 
18  99  99  99  1  1  300  9  9  132  9 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  9  1  9  1500  9  9  9 
99  99  99  99  9  1  360  9  9  132  9 
99  99  99  99  9  1  300  1250  9  100  9 
99  99  99  99  9  1  330  1500  9  9  9 
99  99  99  99  9  1  360  9  9  132  9 
9  9  99  9  9  1  300  9  9  120  9 
17  99  99  99  9  1  300  1250  9  9  9 
99  99  99  99  9  1  300  1250  9  9  9 
99  99  99  99  9  1  300  1250  9  9  9 
9  9  99  9  9  1  200  9  400  9  750 
99  99  99  99  9  1  290  1250  9  116  9 
9  9  99  9  9  1  9  1125  9  108  9 
9  9  99  1  9  9  99  99  99  99  99 
9  9  99  9  9  1  300  9  600  9  9 
9  9  99  9  9  1  190  9  9  80  9 
99  99  99  99  9  1  390  9  9  165  9 
29  99  99  99  9  1  230  9  9  100  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  1  9  1  9  1125  9  100  9 
99  99  99  99  9  1  290  1125  9  100  9 
9  9  99  9  9  1  300  1000  9  116  9 
9  9  99  1  9  1  260  9  9  100  9 
99  99  99  99  9  1  360  9  600  9  9 
9  9  99  1  9  9  99  99  99  99  99 
99  99  99  99  9  1  9  1500  9  9  9 
99  99  99  99  9  1  9  1000  9  100  9 
9  9  99  9  9  1  330  1500  9  9  9 
99  1  30  99  9  1  260  9  9  9  9 
9  9  99  1  9  9  99  99  99  99  99 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  360  9  9  132  9 249 
24  25  26  27  28  29  30  31  32 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  600  800  1/25/93  1.82466  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  1  9  9  500  800  6/11/91  .19726  1 
9  3  9  9  500  800  7/1/91  .25205  1 
9  2  9  9  600  800  12/1/93  2.67397  1 
9  2  9  9  600  800  3/31/96  5.00548  9 
99  0  9  9  600  9  1/28/93  1.83288  9 
9  1  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  500  800  3/31/96  5.00548  9 
1250  3  9  9  500  800  1/13/92  .78904  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  9/9/92  1.44658  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  500  800  2/18/94  2.89041  9 
9  2  9  9  500  800  5/11/93  2.11507 
9  3  9  9  600  600  11/27/91  .66027  1 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  10/19/94  3.55619  9 
99  0  9  9  600  9  3/31/96  5.00548  9 
1250  3  9  9  600  800  8/19/94  3.38904  1 
9  2  9  9  600  600  9/17/91  .46575  1 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  1  9  600  800  9/25/92  1.49041  1 
99  0  9  9  9  9  7/14/93  2.29041  1 
99  0  9  9  9  9  3/31/96  5.00548  9 
9  2  9  9  600  800  6/26/92  1.24110  1 
9  3  9  9  500  800  12/16/91  .71233  1 
9  3  9  9  600  800  3/31/96  5.00548  9 
9  2  9  1  600  800  8/31/93  2.42192  1 
1250  3  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  600  9  10/10/94  3.53151  1 
9  1  1  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  700  1/27/96  4.83014  9 
1500  3  9  9  600  800  3/31/96  5.00548  9 
1000  2  9  9  600  800  1/22/93  1.81644  1 
99  0  9  9  600  9  3/31/96  5.00548  9 
99  0  9  9  9  9  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 250 
33  34  35  36  37  38  39  40 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
6/11/91  14  4  .19726  99  99  99  99 
7/1/91  14  4  .25205  99  99  99  99 
12/1/93  13  3  2.67397  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
5/11/93  14  1  2.11507  99  99  99  99 
11/27/91  15  3  .66027  2/25/92  10  4  .90685 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
8/19/94  6  4  3.38904  99  99  99  99 
9/17/91  10  2  .46575  8/14/95  15  4  4.37534 
99  99  99  99  99  99  99  99 
9/25/92  6  1  1.49041  12/6/93  15  3  2.68767 
7/14/93  6  1  2.29041  99  99  99  99 
99  99  99  99  99  99  99  99 
6/26/92  6  1  1.24110  99  99  99  99 
12/16/91  3  2  .71233  99  99  99  99 
99  99  99  99  99  99  99  99 
8/31/93  6  3  2.42192  99  99  99  99 
99  99  99  99  99  99  99  99 
10/10/94  15  4  3.53151  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
1/22/93  2  3  1.81644  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 251 
41  42  43  44  45  46  47  48  49 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
7/17/95  10  3  4.29863  99  99  99  99  3 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 252 
1  2  3  4  5  6  7  8  9  10  11  12 
44  1  2  40  165  64  23.51  3  3  99  99  99 
34  2  2  32  150  53  23.47  3  4  1  99  9 
51  1  2  51  173  70  23.39  3  5  99  99  99 
36  1  4  30  152  54  23.37  3  4  99  99  99 
33  2  2  33  163  62  23.34  3  5  1  99  9 
27  1  2  25  145  49  23.32  2  3  99  99  99 
33  2  2  32  155  56  23.31  3  5  1  99  9 
46  2  2  44  167  65  23.31  3  5  3  99  9 
32  1  2  29  145  49  23.31  3  3  99  99  99 
46  2  4  41  162  61  23.24  4  5  3  99  9 
30  1  2  24  170  67  23.18  2  3  99  99  99 
36  1  2  30  170  67  23.18  3  4  99  99  99 
38  2  2  37  145  49  23.18  2  2  1  99  9 
42  2  2  39  145  49  23.18  2  3  3  99  9 
64  2  2  62  137  44  23.17  2  2  5  99  1 
62  2  2  62  165  63  23.16  2  3  5  8  9 
31  2  2  29  157  57  23.12  4  5  1  99  9 
34  1  2  33  145  49  23.11  2  3  99  99  99 
38  1  1  30  173  69  23.05  3  4  99  99  99 
48  1  2  46  178  73  23.04  4  5  99  99  99 
39  2  2  38  140  45  23.04  2  2  5  99  1 
62  2  4  59  173  69  22.98  2  2  5  99  1 
33  1  2  29  152  53  22.94  2  2  99  99  99 
52  1  2  46  137  43  22.91  2  2  99  99  99 
60  2  2  60  155  55  22.87  2  3  5  99  1 
32  2  2  31  150  51  22.84  4  4  1  99  9 
39  2  2  35  145  48  22.75  2  2  1  99  9 
42  2  2  42  163  60  22.68  1  2  5  99 
42  2  2  41  152  53  22.68  2  2  1  99  9 
29  1  2  26  168  64  22.68  3  5  99  99  99 
37  1  2  30  168  64  22.68  3  4  99  99  99 
64  1  2  64  147  49  22.68  2  2  99  99  99 
28  1  2  28  160  58  22.66  3  3  99  99  99 
47  2  1  46  132  40  22.65  2  3  3  99  9 
44  2  2  41  147  49  22.60  1  2  3  99  9 
23  2  2  19  167  63  22.59  3  5  1  99  9 
65  2  2  65  155  54  22.53  1  3  5  99  1 
35  1  2  32  175  69  22.53  3  4  99  99  99 
58  2  2  57  127  36  22.52  2  1  5  5  9 
41  1  2  41  152  52  22.51  2  2  99  99  99 253 
13  14  15  16  17  18  19  20  21  22  23 
99  99  99  99  9  1  330  9  600  9  9 
9  9  99  9  9  1  9  1125  9  9  1250 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  290  9  9  108  9 
9  9  99  9  9  1  310  9  600  9  9 
99  99  99  99  9  1  260  9  9  9  9 
9  9  99  9  9  9  99  99  99  99  99 
9  9  99  9  9  1  330  1500  9  9  9 
99  99  99  99  9  1  260  9  400  9  9 
9  9  99  9  9  1  9  1250  9  9  9 
99  99  99  99  9  1  360  9  9  132  9 
99  99  99  99  9  1  9  1500  9  9  9 
9  9  99  9  9  1  260  9  9  100  9 
9  9  99  9  9  1  260  9  9  100  9 
32  99  99  99  9  1  230  9  9  9  9 
9  9  99  9  9  1  9  9  9  116  9 
9  9  99  1  9  1  290  1250  9  100  9 
99  99  99  99  9  1  9  9  9  100  9 
99  99  99  99  9  1  360  9  9  132  1000 
99  99  99  99  9  9  99  99  99  99  99 
14  99  99  99  9  1  9  1000  9  90  750 
27  99  99  99  9  1  360  9  9  132  1000 
99  99  99  99  9  1  290  9  9  108  9 
99  99  99  99  9  1  230  9  400  9  9 
29  99  99  99  9  1  290  9  9  9  9 
9  9  99  1  9  1  260  9  9  9  9 
9  9  99  9  9  1  260  9  9  100  9 
19  99  99  99  9  1  300  9  9  120  1000 
9  9  99  9  9  1  260  1125  9  9  9 
99  99  99  99  9  1  330  9  9  132  9 
99  99  99  99  9  1  9  1500  9  132  750 
99  99  99  99  9  1  260  1000  9  100  9 
99  99  99  99  9  1  290  9  600  9  9 
9  9  99  9  9  1  200  9  9  80  500 
9  9  99  9  9  1  260  9  9  100  9 
9  9  99  1  9  1  330  9  600  9  9 
30  99  99  99  9  1  9  1125  9  9  9 
99  99  99  99  9  1  360  9  9  132  9 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  9  1  260  9  9  100  1250 254 
24  25  26  27  28  29  30  31  32 
9  2  9  9  500  800  8/2/95  4.34247  9 
9  2  9  9  600  800  7/15/92  1.29315  1 
99  0  9  9  9  9  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
1250  3  9  9  600  800  12/2/91  .67397  1 
9  1  9  9  500  800  2/15/96  4.88219  9 
99  0  9  9  600  9  3/31/96  5.00548  9 
9  2  9  9  600  800  10/17/95  4.55068  1 
9  2  9  9  500  800  2/7/95  3.86027  1 
9  1  9  9  600  800  12/20/95  4.72603  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  1  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  1/23/94  2.81918  1 
9  2  9  9  600  800  8/2/92  1.34247  1 
1250  2  9  9  600  700  3/31/96  5.00548  9 
9  1  9  9  600  800  3/31/96  5.00548  9 
9  3  9  9  600  800  3/31/96  5.00548  9 
9  1  9  9  500  800  11/2/93  2.59452  1 
9  3  9  9  500  800  5/14/92  1.12329  1 
99  0  9  9  9  9  3/31/96  5.00548  9 
9  3  9  9  600  700  3/31/96  5.00548  9 
9  3  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/95  4.00274  9 
9  2  9  9  500  700  5/20/92  1.13973 
9  1  9  9  600  800  10/12/91  .53425  1 
9  1  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  600  700  3/31/96  5.00548  9 
9  3  9  9  600  800  3/31/96  5.00548 
1500  3  9  9  600  800  12/27/93  2.74521 
9  2  9  9  500  800  3/31/96  5.00548 
9  3  9  9  500  800  3/31/96  5.00548 
9  3  9  9  500  700  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  600  600  3/8/93  1.93973 
9  2  9  9  600  800  7/21/94  3.30959  1 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  1  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  600  9  5/2/94  3.09041  1 
9  3  9  9  500  800  4/24/94  3.06849  9 255 
33  34  35  36  37  38  39  40 
99  99  99  99  99  99  99  99 
7/15/92  10  2  1.29315  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
12/2/91  3  2  .67397  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
10/17/95  10  3  4.55068  99  99  99  99 
2/7/95  14  1  3.86027  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
1/23/94  13  3  2.81918  7/3/95  3  3  4.26027 
8/2/92  7  4  1.34247  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
11/2/93  10  4  2.59452  99  99  99  99 
5/14/92  7  1  1.12329  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
10/12/91  6  4  .53425  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
3/8/93  12  4  1.93973  99  99  99  99 
7/21/94  12  3  3.30959  1/25/96  7  3  4.82466 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
5/2/94  6  2  3.09041  99  99  99  99 
99  99  99  99  99  99  99  99 256 
41  42  43  44  45  46  47  48  49 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99 257 
1  2  3  4  5  6  7  8  9  10  11  12 
56  2  2  54  155  54  22.51  2  2  5  8  9 
30  2  2  26  155  54  22.48  3  5  1  99  9 
36  2  2  31  137  42  22.45  1  2  1  99  9 
59  2  2  55  150  50  22.44  2  2  5  99  1 
45  1  2  40  178  71  22.41  3  5  99  99  99 
59  1  2  58  173  67  22.39  3  3  99  99  99 
39  2  2  37  137  42  22.38  4  3  1  99  9 
64  1  2  63  145  47  22.35  3  3  99  99  99 
43  2  2  28  160  57  22.35  2  2  1  99  9 
40  2  2  39  140  44  22.34  2  2  1  99  9 
55  1  2  55  140  44  22.34  2  3  99  99  99 
40  1  1  40  168  63  22.32  3  5  99  99  99 
27  2  2  24  157  55  22.31  3  5  1  99  9 
28  1  2  26  137  42  22.26  1  1  99  99  99 
48  1  2  47  147  48  22.21  3  4  99  99  99 
32  1  4  32  163  59  22.21  2  2  99  99  99 
40  2  2  40  163  59  22.17  2  2  5  99  1 
38  2  2  37  160  57  22.17  2  2  1  99  9 
25  2  2  24  157  55  22.16  2  3  5  99  1 
28  2  2  26  132  39  22.13  1  2  1  99  9 
51  2  2  49  170  64  22.11  2  2  5  99  99 
55  2  5  49  152  51  22.07  4  4  5  99  99 
35  2  2  33  142  45  21.99  2  2  1  99  9 
63  2  2  63  160  56  21.99  2  2  5  7  9 
44  2  2  42  170  64  21.95  2  2  5  99  1 
24  1  5  23  157  54  21.92  1  3  99  99  99 
38  2  1  36  157  54  21.91  3  4  1  99  9 
35  2  2  29  145  46  21.88  3  4  1  99  9 
42  2  2  39  145  46  21.88  3  4  1  99  9 
49  2  2  40  145  46  21.88  2  2  5  3  9 
42  1  1  41  160  56  21.88  3  4  99  99  99 
42  2  2  38  167  61  21.87  3  4  1  99  9 
24  2  2  19  163  58  21.83  4  5  1  99  9 
62  1  2  62  170  63  21.80  2  2  99  99  99 
35  1  2  32  142  44  21.79  1  2  99  99  99 
27  1  2  22  150  49  21.78  2  2  99  99  99 
29  2  2  20  150  49  21.78  4  4  1  99  9 
61  2  2  61  150  49  21.78  3  3  5  99  99 
46  1  2  41  178  69  21.78  3  4  99  99  99 
59  1  2  58  155  52  21.75  1  3  99  99  99 258 
13  14  15  16  17  18  19  20  21  22  23 
9  9  99  9  9  1  290  9  600  9  9 
9  9  99  1  9  1  290  9  9  9  9 
9  9  99  9  9  1  230  9  9  90  9 
29  99  99  99  9  1  9  1125  9  100  9 
99  99  99  99  9  1  9  9  9  132  9 
99  99  99  99  9  1  330  9  600  9  9 
9  9  99  1  9  1  230  9  9  90  1000 
99  99  99  99  9  1  230  9  400  9  9 
9  9  99  9  9  1  9  1250  9  9  9 
9  9  99  9  9  1  230  9  9  90  500 
99  99  99  99  9  1  230  9  9  90  9 
99  99  99  99  9  1  330  1500  9  132  9 
9  9  99  9  9  1  290  9  9  108  9 
99  99  99  99  9  1  230  9  9  80  9 
99  99  99  99  9  1  9  1000  9  9  9 
99  99  99  99  9  1  300  9  9  140  9 
15  99  99  99  9  1  300  9  600  9  9 
9  9  99  9  9  1  290  1250  9  9  9 
5  99  99  99  9  1  290  1125  9  108  9 
9  9  99  9  9  1  190  1000  9  80  9 
99  1  17  99  9  1  330  1500  9  9  9 
99  1  28  99  9  1  260  9  600  9  9 
9  9  99  9  9  9  99  99  99  99  99 
9  9  99  9  9  1  290  1250  9  9  9 
24  99  99  99  9  1  300  1500  9  9  9 
99  99  99  99  9  1  290  1125  9  108  1250 
9  9  99  1  9  9  99  99  99  99  99 
9  9  99  1  9  1  9  1000  9  9  500 
9  9  99  9  9  1  9  1000  9  9  9 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  1  300  9  9  9  9 
9  9  99  1  1  1  290  9  9  9  1000 
99  99  99  99  9  1  9  1500  9  9  9 
99  99  99  99  9  1  9  1000  9  9  9 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  1  9  1  260  9  400  9  9 
99  1  29  99  9  1  9  1000  9  9  9 
99  99  99  99  9  1  9  1500  9  9  9 
99  99  99  99  9  1  260  9  600  9  9 259 
24  25  26  27  28  29  30  31  32 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  1  9  9  600  800  3/31/96  5.00548  9 
1000  3  9  9  600  700  12/12/92  1.70411  1 
9  2  9  9  600  800  3/31/96  5.00548  9 
1250  2  1  9  500  800  5/5/92  1.09863  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  600  700  6/17/93  2.21644  1 
9  2  9  9  500  800  3/31/96  5.00548 
9  1  9  9  600  800  12/20/93  2.72603 
9  3  9  9  600  700  5/29/93  2.16438  1 
9  2  9  9  500  700  8/12/92  1.36986  1 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  500  700  5/18/92  1.13425  1 
9  1  1  9  500  800  11/2/91  .59178  1 
9  2  9  9  500  800  5/31/95  4.16986  1 
9  2  9  9  600  800  10/11/94  3.53425  9 
9  2  9  9  600  800  5/11/93  2.11507  9 
9  3  9  9  600  800  8/25/94  3.40548  9 
9  3  9  9  600  600  9/6/91  .43562  1 
9  2  9  9  600  800  8/10/91  .36164  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
99  0  9  9  600  9  4/29/95  4.08219  1 
9  2  9  9  600  800  3/9/95  3.94247  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  4  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  600  9  5/4/95  4.09589  1 
9  2  9  9  600  700  9/24/93  2.48767  1 
9  1  9  9  600  700  7/15/92  1.29315  1 
99  0  9  1  600  9  7/16/91  .29315  9 
99  0  9  9  9  9  3/31/96  5.00548  9 
9  1  9  9  600  800  5/27/94  3.15890  1 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  1  9  9  500  800  3/31/96  5.00548  9 
9  1  9  9  500  700  11/2/93  2.59452  1 
99  0  9  9  9  9  3/31/96  5.00548  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  1  9  9  600  700  3/6/93  1.93425  1 
9  1  9  9  500  800  4/14/94  3.04110  9 
9  2  9  9  500  800  2/21/93  1.89863  1 260 
33  34  35  36  37  38  39  40 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
12/12/92  7  3  1.70411  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
6/17/93  6  1  2.21644  99  99  99  99 
99  99  99  99  99  99  99  99 
12/20/93  15  4  2.72603  99  99  99  99 
5/29/93  14  2  2.16438  99  99  99  99 
8/12/92  15  4  1.36986  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
5/18/92  10  3  1.13425  99  99  99  99 
11/2/91  14  1  .59178  99  99  99  99 
5/31/95  15  4  4.16986  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
9/6/91  10  3  .43562  12/14/95  7  4  4.70959 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
4/29/95  7  3  4.08219  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
5/4/95  8  1  4.09589  99  99  99  99 
9/24/93  10  3  2.48767  99  99  99  99 
7/15/92  10  3  1.29315  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
5/27/94  9  1  3.15890  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
11/2/93  10  2  2.59452  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
3/6/93  14  3  1.93425  99  99  99  99 
99  99  99  99  99  99  99  99 
2/21/93  15  2  1.89863  99  99  99  99 261 
41  42  43  44  45  46  47  48  49 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 262 
1  2  3  4  5  6  7  8  9  10  11  12 
37  1  2  27  157  54  21.74  1  2  99  99  99 
30  2  2  23  155  52  21.64  4  5  1  99  9 
32  1  2  30  155  52  21.64  3  4  99  99  99 
31  2  2  30  152  50  21.64  3  5  1  99  9 
36  2  2  30  152  50  21.64  3  4  1  99  9 
36  2  2  33  160  55  21.64  2  2  1  99  9 
36  1  2  36  168  61  21.63  4  4  99  99  99 
68  2  2  66  155  52  21.57  3  3  5  13  9 
34  1  2  34  155  52  21.55  1  2  99  99  99 
33  1  2  27  178  68  21.54  4  4  99  99  99 
49  2  2  38  167  60  21.51  3  4  5  99  1 
37  2  2  25  152  50  21.51  2  2  1  99  9 
59  1  2  58  165  59  21.49  1  2  99  99  99 
35  2  2  25  137  40  21.48  2  2  1  99  9 
42  2  2  40  163  57  21.45  3  5  1  99  9 
45  1  1  45  163  57  21.45  2  2  99  99  99 
28  1  2  22  173  64  21.38  2  3  99  99  99 
38  2  2  37  142  43  21.33  3  3  5  99  1 
31  1  2  25  170  62  21.30  4  4  99  99  99 
46  2  2  35  157  53  21.24  1  2  3  99  9 
36  2  1  29  155  51  21.23  4  5  1  99  9 
36  2  2  35  155  51  21.23  3  5  1  99  9 
54  1  2  53  152  49  21.21  3  4  99  99  99 
31  2  2  29  140  41  21.19  4  3  5  99  1 
39  2  3  34  155  51  21.19  2  3  1  99  9 
36  1  2  33  155  51  21.16  3  3  99  99  99 
29  2  2  27  147  46  21.15  3  4  1  99  9 
32  1  2  26  178  67  21.15  2  3  99  99  99 
37  1  2  34  157  52  21.10  3  4  99  99  99 
57  1  2  46  160  54  21.09  3  3  99  99  99 
33  1  4  26  163  56  21.08  3  4  99  99  99 
30  2  2  27  150  47  21.03  2  2  1  99  9 
56  2  2  54  137  40  21.00  2  2  5  99  1 
26  1  2  24  165  57  20.98  2  3  99  99  99 
48  2  2  35  163  55  20.96  2  2  3  99  9 
33  2  5  30  140  41  20.94  2  2  1  99  9 
60  2  2  59  145  44  20.93  3  3  5  7  9 
33  1  2  33  168  59  20.90  3  4  99  99  99 
55  2  2  55  142  42  20.87  2  2  5  3  9 
58  2  4  56  145  44  20.80  1  2  5  99  1 263 
13  14  15  16  17  18  19  20  21  22  23 
99  99  99  99  9  1  290  9  9  108  9 
9  9  99  1  9  1  260  9  9  100  9 
99  99  99  99  9  1  260  9  9  100  9 
9  9  99  9  9  1  9  9  9  100  1500 
9  9  99  1  9  1  260  9  400  9  9 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  9  1  300  9  9  132  9 
9  9  99  9  9  1  260  1125  9  9  9 
99  99  99  99  9  1  260  9  9  100  9 
99  99  99  99  9  1  360  9  9  132  9 
19  99  99  99  9  1  9  1250  9  120  9 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  9  1  9  1250  9  116  9 
9  9  99  9  9  1  9  1000  9  80  9 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  9  1  290  9  600  9  9 
99  99  99  99  9  1  330  1500  9  9  750 
12  99  99  99  9  1  9  1000  9  90  9 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  1  260  9  9  100  9 
9  9  99  1  1  1  260  9  600  9  9 
9  9  99  9  9  1  260  9  9  100  1250 
99  99  99  99  9  1  260  9  400  9  1000 
9  99  99  99  1  1  230  9  9  90  9 
9  9  99  9  9  1  260  9  600  9  9 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  9  1  360  1500  9  9  9 
99  99  99  99  9  1  260  9  600  9  9 
99  99  99  99  9  1  260  9  9  9  9 
99  99  99  99  9  1  290  9  600  9  1250 
9  9  99  9  9  9  99  99  99  99  99 
30  99  99  99  9  1  9  9  9  80  9 
99  99  99  99  9  1  9  1250  9  9  9 
9  9  99  9  9  1  290  9  9  116  9 
9  9  99  1  9  9  99  99  99  99  99 
9  9  99  9  9  1  230  9  9  90  9 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  1  9  1000  9  9  9 
35  99  99  99  9  1  230  9  400  9  9 264 
24  25 26 27 28 29  30  31  32 
1250  3  9  9  500  800  12/15/92  1.71233  9 
9  2  9  9  600  800  5/1/93  2.08767  9 
9  2  9  9  500  800  8/23/95  4.40000  9 
9  2  9  9  600  800  3/31/96  5.00548 
9  2  9  9  600  800  4/20/92  1.05753  1 
99  0  9  9  600  9  3/31/96  5.00548  9 
9  2  9  9  500  800  9/10/94  3.44932  9 
9  2  9  1  600  800  6/22/91  .22740  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
99  0  9  9  600  9  11/6/94  3.60548  1 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  600  3/27/94  2.99178  1 
99  0  9  9  600  9  9/4/93  2.43288  1 
9  2  9  9  500  800  3/31/96  5.00548 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  700  2/13/96  4.87671  1 
99  0  9  9  9  9  3/31/96  5.00548  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  3  9  9  600  800  1/17/96  4.80274  1 
9  3  9  9  500  800  7/27/95  4.32603  9 
9  2  9  9  600  700  4/20/92  1.05753  1 
1 9  2  1  9  600  800  6/28/95  4.24658 
99  0  9  9  9  9  3/31/96  5.00548  9 
99  0  9  1  600  9  8/24/91  .40000  1 
9  2  9  9  500  800  2/28/92  .91507  9 
9  2  9  9  500  800  7/17/95  4.29863  1 
9  1  9  9  500  800  8/17/92  1.38356  9 
9  3  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  600  9  6/5/95  4.18356 
1 
1 
9  1  9  9  600  600  3/13/92  .95342 
9  1  9  9  500  800  6/21/93  2.22740  9 
9  2  9  9  600  800  5/19/92  1.13699  1 
99  0  9  9  600  9  3/31/96  5.00548  9 
750  3  9  9  600  700  8/31/94  3.42192  1 
99  0  9  9  9  9  3/31/96  5.00548  9 
1000  2  9  9  600  700  4/26/92  1.07397  1 
9  2  9  9  600  700  6/10/93  2.19726  1 265 
33  34  35  36  37  38  39  40 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
4/20/92  6  1  1.05753  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
11/6/94  6  4  3.60548  99  99  99  99 
99  99  99  99  99  99  99  99 
3/27/94  14  3  2.99178  99  99  99  99 
9/4/93  3  4  2.43288  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
2/13/96  9  1  4.87671  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
1/17/96  10  1  4.80274  99  99  99  99 
99  99  99  99  99  99  99  99 
4/20/92  7  1  1.05753  99  99  99  99 
6/28/95  3  4  4.24658  99  99  99  99 
99  99  99  99  99  99  99  99 
8/24/91  3  3  .40000  99  99  99  99 
99  99  99  99  99  99  99  99 
7/17/95  3  1  4.29863  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
6/5/95  12  3  4.18356  99  99  99  99 
3/13/92  14  3  .95342  99  99  99  99 
99  99  99  99  99  99  99  99 
5/19/92  14  4  1.13699  99  99  99  99 
99  99  99  99  99  99  99  99 
8/31/94  14  4  3.42192  6/12/95  10  4  4.20274 
99  99  99  99  99  99  99  99 
4/26/92  10  3  1.07397  7/29/92  4  3  1.33151 
6/10/93  6  3  2.19726  99  99  99  99 266 
41  42  43  44  45  46  47  48  49 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  0 
4/27/94  3  3  3.07671  99  99  99  99  3 
99  99  99  99  99  99  99  99  1 267 
1  2  3  4  5  6  7  8  9  10  11  12 
24  1  2  16  152  48  20.78  3  4  99  99  99 
47  2  2  45  152  48  20.78  3  4  3  99  9 
41  1  2  40  170  60  20.76  2  3  99  99  99 
23  2  2  20  160  53  20.75  1  2  1  99  9 
64  1  2  58  147  45  20.72  2  2  99  99  99 
42  1  2  39  163  55  20.70  4  4  99  99  99 
43  2  2  41  163  55  20.70  4  5  1  99  9 
28  2  4  27  157  51  20.69  2  3  1  99  9 
62  1  2  60  165  56  20.57  2  2  99  99  99 
64  1  2  61  165  56  20.57  3  4  99  99  99 
34  2  2  28  132  36  20.56  2  2  1  99  9 
33  1  1  33  168  58  20.55  2  2  99  99  99 
34  1  2  29  168  58  20.55  2  2  99  99  99 
61  1  2  62  168  58  20.55  4  3  99  99  99 
56  2  2  51  152  48  20.53  1  2  5  7  9 
50  1  2  49  178  65  20.52  4  4  99  99  99 
25  2  2  22  140  40  20.48  2  2  1  99  9 
39  1  2  36  170  59  20.42  3  5  99  99  99 
41  2  2  40  170  59  20.42  4  4  5  99  99 
32  2  2  27  155  49  20.40  3  4  1  99  9 
49  1  2  46  173  61  20.38  3  5  99  99  99 
31  1  2  30  160  52  20.31  3  4  99  99  99 
46  2  2  46  160  52  20.31  3  5  3  99  9 
40  2  2  37  137  38  20.29  2  3  5  99  99 
61  2  2  58  147  44  20.29  1  3  5  3  9 
26  1  2  20  157  50  20.28  2  2  99  99  99 
43  1  4  41  157  50  20.28  3  3  99  99  99 
65  1  2  64  137  38  20.27  1  1  99  99  99 
30  1  2  15  175  62  20.24  2  2  99  99  99 
53  1  2  52  175  62  20.24  3  4  99  99  99 
26  2  2  21  140  40  20.24  2  2  1  99  9 
53  2  2  51  140  40  20.24  1  2  3  99  9 
26  2  2  23  155  49  20.24  2  3  1  99  9 
57  2  2  43  160  52  20.22  2  2  5  99  99 
30  1  4  29  165  55  20.20  3  4  99  99  99 
29  2  2  18  142  41  20.20  2  2  1  99  9 
35  1  2  35  168  57  20.20  2  3  99  99  99 
30  1  2  30  163  54  20.17  2  2  99  99  99 
34  2  2  33  165  55  20.16  2  3  1  99  9 
46  1  2  42  166  55  20.13  1  2  99  99  99 268 
13  14  15  16  17  18  19  20  21  22  23 
99  99  99  99  9  1  260  9  400  9  9 
9  9  99  1  9  1  260  9  9  100  9 
99  99  99  99  9  1  9  1250  9  120  9 
9  9  99  9  9  1  290  1125  9  108  1250 
99  99  99  99  9  1  230  9  9  9  9 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  9  99  99  99  99  99 
9  9  99  9  9  1  260  9  600  9  9 
99  99  99  99  9  1  9  1125  9  9  9 
99  99  99  99  9  1  290  9  600  9  9 
9  9  99  9  9  1  190  9  9  80  9 
99  99  99  99  9  1  290  9  9  108  9 
99  99  99  99  9  1  290  1250  9  9  9 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  1  230  9  9  100  9 
99  99  99  99  9  1  9  9  9  132  9 
9  9  99  9  9  1  200  9  400  9  9 
99  99  99  99  9  1  9  1250  9  9  9 
99  1  10  99  9  1  9  1250  9  100  9 
9  9  99  9  9  1  260  1000  9  100  9 
99  99  99  99  9  1  300  9  9  132  9 
99  99  99  99  9  1  260  9  9  100  9 
9  9  99  9  9  1  260  9  9  100  750 
99  1  20  99  9  1  200  1000  9  80  9 
9  9  99  9  9  1  230  9  400  9  9 
99  99  99  99  9  1  260  1000  9  100  9 
99  99  99  99  9  1  9  1000  9  100  9 
99  99  99  99  9  1  190  1000  9  9  9 
99  99  99  99  9  1  9  1250  9  9  9 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  1  200  9  400  9  9 
9  9  99  9  9  1  200  9  9  80  9 
9  9  99  9  9  9  99  99  99  99  99 
99  1  30  99  9  1  230  9  600  9  750 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  1  230  9  400  9  9 
99  99  99  99  9  1  290  9  9  100  9 
99  99  99  99  9  1  290  9  600  9  9 
9  9  99  9  9  1  290  9  9  100  9 
99  99  99  99  9  9  99  99  99  99  99 269 
24  25 26 27 28 29  30  31  32 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  3/4/93  1.92877  1 
9  2  9  9  500  800  10/26/91  .57260  1 
9  4  9  9  600  800  11/23/93  2.65205  9 
9  1  9  9  500  700  1/31/96  4.84110  1 
99  0  9  9  9  9  7/13/95  4.28767  9 
99  0  9  9  600  9  3/27/92  .99178  1 
9  2  9  9  600  800  4/5/94  3.01644  9 
9  1  9  9  500  800  1/17/95  3.80274  9 
9  2  9  9  500  800  1/21/95  3.81370  9 
9  2  9  9  600  600  3/31/96  5.00548  9 
9  2  9  500  800  3/31/96  5.00548 
9  2  9  9  500  800  11/2/93  2.59452  9 
99 0 9 9 9 9 5/22/91 .14247  1 
9  2  9  9  600  700  3/31/96  5.00548  9 
9  1  9  9  500  800  10/17/91  .54795  9 
9  2  9  9  600  600  4/6/91  .00164 
1 
1 
9  1  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  8/6/94  3.35342  9 
9  3  9  9  600  800  8/6/92  1.35342  1 
9  2  9  9  500  800  6/3/91  .17534  1 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  600  800  4/9/91  .02466  1 
9  3  9  9  600  600  9/27/91  .49315  1 
9  2  9  9  600  700  11/26/94  3.66027  1 
9  3  9  9  500  800  10/16/91  .54521  1 
9  2  9  9  500  800  6/7/91  .18630  1 
9  2  9  9  500  600  3/31/96  5.00548  9 
9  1  1  9  500  800  3/31/96  5.00548  9 
99 0 9 9 9 9  1/2/92  .75890  1 
750  3  9  9  600  600  6/3/94  3.17808  1 
9  2  9  9  600  600  3/31/96  5.00548  9 
99  0  9  9  600  9  3/31/96  5.00548  9 
9  3  9  9  600  800  3/31/96  5.00548  9 
99  0  9  9  9  9  3/31/96  5.00648  9 
9  2  9  9  600  600  8/12/91  .36712  1 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  800  1/6/96  4.77260  9 
99  0  9  9  9  9  3/31/96  5.00548  9 270 
33  34  35  36  37  38  39  40 
99  99  99  99  99  99  99  99 
3/4/93  9  1  1.92877  99  99  99  99 
10/26/91  3  4  .57260  4/18/92  14  3  1.05205 
99  99  99  99  99  99  99  99 
1/31/96  10  3  4.84110  99  99  99  99 
99  99  99  99  99  99  99  99 
3/27/92  3  3  .99178  10/14/94  6  3  3.54247 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
5/22/91  1  1  .14247  6/27/92  7  3  1.24384 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
4/6/91  15  3  .00164  2/15/93  6  4  1.88219 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
8/6/92  10  1  1.35342  9/17/93  14  1  2.46849 
6/3/91  8  1  .17534  99  99  99  99 
99  99  99  99  99  99  99  99 
4/9/91  14  4  .02466  99  99  99  99 
9/27/91  13  3  .49315  99  99  99  99 
11/26/94  15  4  3.66027  99  99  99  99 
10/16/91  6  3  .54521  99  99  99  99 
6/7/91  14  4  .18630  6/7/91  9  4  .18630 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
1/2/92  6  4  .75890  99  99  99  99 
6/3/94  6  3  3.17808  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99 
99 
99 
99 
99 
99 
99 
99 
99 
99 
99 
99 
99 
99 
99 
99 
8/12/91  14  3  .36712  12/6/92  12  4  1.68767 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 271 
41  42  43  44  45  46  47  48  49 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
12/1/95  3  3  4.67397  99  99  99  99  3 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
1/9/93  10  4  1.78082  5/14/95  6  4  4.12603  4 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
3/21/93  14  3  1.97534  11/29/94  14  3  3.66848 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99 272 
1  2  3  4  5  6  7  8  9  10  11  12 
33  1  2  29  180  65  20.11  4  4  99  99  99 
54  2  2  53  147  44  20.08  2  2  3  99 
23  2  5  18  155  48  19.98  4  4  1  99 
33  1  2  26  157  50  19.96  3  3  99  99  99 
28  2  2  28  145  42  19.95  4  4  1  99  9 
56  1  2  53  163  53  19.95  2  2  99  99  99 
33  2  2  30  145  42  19.93  2  3  1  99  9 
54  1  2  53  145  42  19.93  1  2  99  99  99 
51  2  2  48  152  46  19.91  3  4  5  99  1 
37  2  2  35  147  43  19.90  3  4  1  99  9 
42  1  2  39  147  43  19.90  2  3  99  99  99 
40  2  2  30  140  39  19.90  4  4  1  99  9 
50  1  2  43  157  49  19.88  1  2  99  99  99 
26  2  2  26  147  43  19.88  2  2  1  99  9 
25  1  2  24  155  48  19.85  2  2  99  99  99 
24  1  2  21  168  56  19.84  3  3  99  99  99 
40  1  2  39  137  37  19.84  2  1  99  99  99 
27  1  4  19  142  40  19.84  2  2  99  99  99 
46  1  2  44  142  40  19.84  2  2  99  99  99 
38  2  2  35  137  37  19.79  1  2  1  99  9 
45  2  2  44  137  37  19.79  2  1  3  99  9 
38  2  4  32  137  37  19.71  3  3  5  99  99 
59  2  2  58  137  37  19.71  3  3  5  4  9 
41  1  2  37  173  59  19.71  3  4  99  99  99 
53  1  2  39  173  59  19.71  3  5  99  99  99 
34  2  2  31  160  50  19.68  2  3  5  99  1 
35  2  2  35  160  50  19.68  1  2  1  99  9 
57  1  2  50  175  60  19.59  3  3  99  99  99 
51  1  2  47  163  52  19.59  1  2  99  99  99 
45  1  2  42  163  52  19.57  4  5  99  99  99 
37  2  2  37  155  47  19.56  3  4  1  99  9 
38  2  5  38  155  47  19.56  3  4  1  99  9 
43  1  2  41  150  44  19.56  2  2  99  99  99 
48  2  2  28  150  44  19.56  1  4  5  2  9 
28  1  2  22  152  45  19.55  3  4  99  99  99 
44  2  2  38  140  38  19.54  1  3  5  99  1 
57  2  2  51  175  60  19.51  2  3  5  99  1 
47  1  5  44  168  55  19.49  3  5  99  99  99 
66  2  2  60  155  47  19.48  2  2  5  99  99 
61  2  2  60  152  45  19.48  4  5  5  8  9 273 
13  14  15  16  17  18  19  20  21  22  23 
99  99  99  99  9  1  330  1500  9  9  9 
9  9  99  9  9  1  9  9  9  90  9 
9  9  99  1  9  9  99  99  99  99  99 
99  99  99  99  9  1  260  1000  9  100  1500 
9  9  99  1  9  1  230  9  9  90  9 
99  99  99  99  9  1  260  9  9  108  9 
9  9  99  9  9  1  230  9  9  90  9 
99  99  99  99  9  1  200  9  9  90  9 
26  99  99  99  9  1  230  9  9  90  9 
9  9  99  9  9  1  200  9  9  90  9 
99  99  99  99  9  1  230  9  9  90  1000 
9  9  99  1  9  1  200  9  9  80  9 
99  99  99  99  9  1  260  9  9  9  750 
9  9  99  9  9  1  9  1000  9  9  9 
99  99  99  99  9  1  260  9  9  100  9 
99  99  99  99  9  1  290  1125  9  116  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  1  190  9  400  9  9 
9  9  99  9  9  1  190  750  9  80  9 
99  1  7  99  9  1  185  9  400  9  1000 
9  9  99  9  9  1  190  9  9  9  500 
99  99  99  99  9  1  9  1250  9  9  9 
99  99  99  99  9  1  300  1250  9  100  9 
11  99  99  99  9  1  260  9  600  9  9 
9  9  99  9  9  1  260  1125  9  9  9 
99  99  99  99  9  1  260  9  600  9  9 
99  99  99  99  9  1  260  9  600  9  9 
99  99  99  99  9  1  260  9  600  9  9 
9  9  99  9  9  1  260  9  400  9  9 
9  9  99  9  9  1  260  9  9  9  9 
99  99  99  99  9  1  230  9  9  90  9 
9  9  99  9  9  1  230  9  400  9  9 
99  99  99  99  9  1  230  9  9  90  750 
20  99  99  99  9  1  9  1000  9  80  1000 
33  99  99  99  9  1  300  1250  9  120  9 
99  99  99  99  9  9  99  99  99  99  99 
99  1  34  99  9  1  230  9  9  9  9 
9  9  99  9  9  1  230  9  400 274 
24  25  26  27  28  29  30  31  32 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  1  9  9  600  700  12/4/94  3.68219  1 
99  0  9  9  600  9  2/20/94  2.89589  1 
9  4  9  9  500  800  10/12/95  4.53699 
9  2  9  9  600  700  10/13/95  4.53973  1 
9  2  1  9  500  800  12/28/94  3.74795  9 
9  2  9  9  600  700  4/3/93  2.01096  9 
9  2  9  9  500  700  8/26/91  .40548  1 
9  2  9  9  600  700  3/31/96  5.00548  9 
9  2  9  9  600  700  3/31/96  5.00548  9 
9  3  9  9  500  700  6/9/91  .19178  1 
9  2  9  9  600  600  8/16/92  1.38082  1 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  1  9  9  600  700  1/28/94  2.83288  1 
9  2  9  9  500  700  7/30/91  .33151  1 
9  3  9  9  500  800  10/15/94  3.54521  9 
99  0  9  9  9  9  3/31/96  5.00548 
99  0  9  9  9  9  4/1/95  4.00548  1 
99  0  9  9  9  9  7/24/92  1.31781  1 
9  2  9  9  600  600  3/31/96  5.00548  9 
9  3  9  9  600  600  6/13/92  1.20548  1 
9  3  9  9  600  600  11/6/92  1.60548  1 
9  2  9  9  600  600  4/11/93  2.03288  1 
9  1  9  9  500  800  3/31/96  5.00548  9 
9  3  1  9  500  800  11/21/91  .64384  1 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  500  800  11/29/94  3.66849  1 
9.  2  1  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  1  9  600  700  11/5/92  1.60274  1 
9  1  9  9  600  700  3/31/96  5.00548  9 
9  2  9  9  500  700  4/29/92  1.08219  1 
9  2  9  9  600  700  7/9/92  1.27672  9 
9  3  1  9  500  700  8/2/95  4.34247  1 
9  3  9  9  600  600  11/14/95  4.62740  1 
9  3  9  9  600  800  3/31/96  5.00548  9 
99  0  9  9  9  9  10/24/93  2.56986  9 
9  1  9  9  600  800  12/31/92  1.75616  9 
9  2  9  9  600  700  6/6/93  2.18630  9 275 
33  34  35  36  37  38  39  40 
99  99  99  99  99  99  99  99 
12/4/94  2  3  3.68219  99  99  99  99 
2/20/94  8  1  2.89589  99  99  99  99 
10/12/95  12  1  4.53699  99  99  99  99 
10/13/95  12  3  4.53973  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
8/26/91  3  2  .40548  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
6/9/91  9  3  .19178  11/9/92  10  3  1.61370 
8/16/92  14  4  1.38082  3/2/95  15  3  3.92329 
99  99  99  99  99  99  99  99 
1/28/94  7  3  2.83288  1/28/94  14  3  2.83288 
7/30/91  7  4  .33151  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
4/1/95  10  4  4.00548  99  99  99  99 
7/24/92  2  3  1.31781  99  99  99  99 
99  99  99  99  99  99  99  99 
6/13/92  15  4  1.20548  99  99  99  99 
11/6/92  10  3  1.60548  99  99  99  99 
4/11/93  4  3  2.03288  99  99  99  99 
99  99  99  99  99  99  99  99 
11/21/91  13  4  .64384  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
11/29/94  7  1  3.66849  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
11/5/92  7  3  1.60274  6/3/93  6  3  2.17808 
99  99  99  99  99  99  99  99 
4/29/92  6  4  1.08219  7/14/93  6  3  2.29041 
99  99  99  99  99  99  99  99 
8/2/95  3  4  4.34247  99  99  99  99 
11/14/95  14  3  4.62740  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 276 
41  42  43  44  45  46  47  48  49 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  0 
2/17/95  15  3  3.88767  99  99  99  99  3 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
5/3/95  14  3  4.09315  99  99  99  99  3 
99  99  99  99  99  99  99  99  0 
9/17/95  3  4  4.46849  99  99  99  99  3 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 277 
1  2  3  4  5  6  7  8  9  10  11  12 
66  1  2  65  152  45  19.48  3  3  99  99  99 
34  1  2  33  140  38  19.39  2  2  99  99  99 
54  1  2  52  173  58  19.38  2  2  99  99  99 
30  1  2  17  170  56  19.38  3  5  99  99  99 
41  1  2  33  150  44  19.37  1  2  99  99  99 
35  2  5  34  155  46  19.29  2  2  1  99  9 
47  1  2  46  168  54  19.23  3  3  99  99  99 
40  1  2  40  145  40  19.22  1  2  99  99  99 
38  2  2  30  130  32  19.21  1  1  1  99  9 
30  1  2  19  157  47  19.16  1  2  99  99  99 
48  2  2  39  155  46  19.15  4  4  5  99  99 
52  1  2  52  160  49  19.14  2  3  99  99  99 
29  1  2  29  160  49  19.14  3  3  99  99  99 
56  1  2  55  180  62  19.14  2  2  99  99  99 
41  1  2  40  168  54  19.13  2  3  99  99  99 
53  1  2  42  168  54  19.13  3  3  99  99  99 
34  2  2  33  150  43  19.11  3  3  1  99  9 
35  2  2  31  150  43  19.11  4  4  1  99  9 
45  2  5  41  150  43  19.11  3  4  5  1 
46  1  2  45  150  43  19.11  3  4  99  99  99 
64  2  5  63  150  43  19.11  4  4  5  16  9 
35  1  4  34  155  46  19.09  2  2  99  99  99 
60  2  2  58  157  47  19.07  4  5  5  9  9 
58  1  2  56  152  44  19.04  2  2  99  99  99 
37  2  2  34  147  41  19.04  2  2  5  99 
62  2  2  61  145  40  19.02  4  4  5  9  9 
34  1  2  19  150  43  19.02  4  3  99  99  99 
61  2  3  31  167  53  19.00  3  4  5  99  1 
44  1  2  44  147  41  18.97  1  3  99  99  99 
31  2  4  30  155  45  18.92  1  2  1  99  9 
40  2  2  36  155  45  18.92  1  1  1  99 
47  2  2  46  140  37  18.85  1  2  5  99 
35  2  2  32  142  38  18.85  3  4  1  99  9 
36  2  2  26  142  38  18.85  4  3  1  99  9 
42  2  2  34  165  51  18.82  2  2  1  99  9 
31  2  2  31  160  48  18.80  2  2  1  99 
62  1  2  63  160  48  18.80  3  2  99  99  99 
23  2  2  23  152  44  18.77  2  3  1  99  9 
28  1  2  24  165  51  18.73  2  3  99  99  99 
50  2  2  47  165  51  18.73  3  4  3  99  9 278 
13 14 15 16 17 18  19  20  21  22  23 
99 99 99 99  9  9  1000  9  90  9 1 
99 99 99 99 9  1 190  9  9  80  9 
99 99 99 99  9  300  9  9  65  9 1 
1 99 99 99 99  9  290  9  9  116  9 
99 99 99 99  9  1 230 1000  9  9  9 
9 9 99 9 9  1  9 1000 9 90  9 
99 99 99 99  9  1 260  9  600  9  9 
99 99 99 99  9  1 200  9  400  9  9 
9 9 99 9 9  1 190 9  9  65  9 
99 99 99 99  9  1  9 1000  9  9  9 
99  1 20 99 9  1 230  9  9  100  9 
99  99 99  99  9  1  230 1000  9  100  9 
99 99 99 99  9  1  260 1000  9  9  9 
99 99 99 99  9  1  330 1250  9  9  9 
99 99 99 99  9  290  9  9  108 1250 1 
99 99 99 99  9  1  290 1125  9  9  9 
9  9 99  1  9  9 99  99  99 99  99 
9 9 99 9 9  1 230 9 400 9  9 I 
9 9 99 9 9  1 230 9 400 9  9 
99 99 99 99  9  1 330  9  9  90  9 
9 9 99 9 9  1 230 9 400 9  9 
99 99 99 99  9  1 230  9  400  9  9 
9 9 99 9 9  1 260 9  9 100 9 
99 99 99 99  9  1 230  9  400  9  9 
12 99 99 99  9  1 230  9  400  9  9 
9 9 99 9 9 9 99 99  99 99 99 
99 99 99 99  9  1  230 1000  9  90  9 
35 99 99 99  9  1 290  9  9  9  9 
99 99 99 99  9  1 200  9  9  90  9 
9  9 99 9  9  1 230 1000  9  9  9 
9 9 99 9 9  1  9 1000 9  9  9 
20 99 99 99  9  1 190  9  400  9  9 
9 9 99 9  9  1 190  9  9 100 9 
9 9 99  1 9  1 190 9  9 80  9 
9 9 99 9  9  1 260  9  9 100 9 
9  9 99 9  9  1  9 1000  9  100 
99 99 99 99  9  1 230  9  400  9  9 
9  9  99  9  9  1  230 1000  9  90 1000 
99 99 99 99  9  260 1125  9  100  9 1 
9 9  99 9  9  9 99  99  99  99 99 279 
24  25  26  27  28  29  30  31  32 
9  2  9  9  500  700  3/31/96  5.00548  9 
9  2  9  9  500  600  2/14/94  2.87945  1 
9  2  9  9  500  800  11/19/93  2.64110  1 
1250  3  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  700  7/29/94  3.33151  1 
9  2  9  9  600  700  3/31/96  5.00548  9 
9  2  9  9  500  800  10/29/91  .58082  1 
750  3  9  9  500  600  3/31/96  5.00548  9 
9  2  9  9  600  600  3/31/96  5.00548  9 
9  1  9  9  500  700  2/9/93  1.86575  1 
9  2  9  9  600  700  2/27/93  1.91507  1 
9  3  9  9  500  800  10/3/92  1.51233  1 
9  2  9  9  500  800  1/16/92  .79726  1 
1250  3  1  9  500  800  7/25/91  .31781  1 
9  3  9  9  500  800  11/6/93  2.60548  1 
9  2  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  600  9  11/8/91  .60822  1 
9  2  9  9  600  700  3/6/92  .93425  1 
1250  3  9  9  600  700  4/9/93  2.02740  1 
9  2  9  9  500  700  5/15/91  .12329  1 
9  2  9  9  600  700  12/20/91  .72329  9 
9  2  9  9  500  700  2/10/92  .86575  1 
9  2  9  9  600  700  3/31/96  5.00548  9 
9  2  9  1  500  700  3/31/96  5.00548  9 
9  2  9  9  600  700  9/1/92  1.42466  1 
99  0  9  9  600  9  2/27/92  .91233  1 
9  3  9  9  500  700  5/20/92  1.13973  1 
9  1  9  9  600  800  4/14/91  .03836  1 
9  2  9  9  500  700  3/31/96  5.00548  9 
9  2  9  9  600  700  2/9/95  3.86575  1 
9  1  9  9  600  700  3/31/96  5.00548  9 
9  2  9  9  600  600  3/31/96  5.00548  9 
1000  3  9  9  600  600  3/31/96  5.00548  9 
9  2  9  9  600  600  2/20/93  1.89589  1 
9  2  9  9  600  800  5/1/95  4.08767  1 
1000  3  9  9  600  800  3/31/96  5.00548  9 
9  2  9  9  500  700  4/24/91  .06575  1 
9  4  9  9  600  700  4/15/92  1.04384  1 
1000  4  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  600  9  2/9/96  4.86575  1 280 
33  34  35  36  37  38  39  40 
99  99  99  99  99  99  99  99 
2/14/94  6  4  2.87945  99  99  99  99 
11/19/93  10  4  2.64110  99  99  99  99 
99  99  99  99  99  99  99  99 
7/29/94  6  4  3.33151  99  99  99  99 
99  99  99  99  99  99  99  99 
10/29/91  7  3  .58082  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
2/9/93  12  3  1.86575  99  99  99  99 
2/27/93  9  3  1.91507  99  99  99  99 
10/3/92  15  3  1.51233  99  99  99  99 
1/16/92  13  3  .79726  99  99  99  99 
7/25/91  3  3  .31781  99  99  99  99 
11/6/93  15  4  2.60548  99  99  99  99 
99  99  99  99  99  99  99  99 
11/8/91  4  3  .60822  99  99  99  99 
3/6/92  6  3  .93425  4/17/93  3  4  2.04932 
4/9/93  12  4  2.02740  99  99  99  99 
5/15/91  6  3  .12329  99  99  99  99 
99  99  99  99  99  99  99  99 
2/10/92  7  3  .86575  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
9/1/92  3  2  1.42466  99  99  99  99 
2/27/92  8  1  .91233  99  99  99  99 
5/20/92  10  3  1.13973  99  99  99  99 
4/14/91  10  4  .03836  7/12/93  14  4  2.28493 
99  99  99  99  99  99  99  99 
2/9/95  13  4  3.86575  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
2/20/93  3  4  1.89589  99  99  99  99 
5/1/95  14  4  4.08767  99  99  99  99 
99  99  99  99  99  99  99  99 
4/24/91  14  4  .06575  11/12/91  6  3  .61918 
4/15/92  6  2  1.04384  99  99  99  99 
99  99  99  99  99  99  99  99 
2/9/96  14  4  4.86575  99  99  99  99 281 
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99  99  99  99  99  99  99  99  1 
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40  1  5  36  155  45  18.73  2  2  99  99  99 
46  1  2  46  155  45  18.73  1  4  99  99  99 
47  1  2  41  155  45  18.73  3  4  99  99  99 
45  1  2  45  185  64  18.70  2  3  99  99  99 
51  2  2  46  150  42  18.67  3  3  5  5  9 
65  2  2  65  137  35  18.65  4  4  5  10  9 
36  2  2  34  145  39  18.63  2  2  1  99  9 
65  2  2  64  140  36  18.62  2  2  5  16  9 
56  1  2  54  175  57  18.61  2  2  99  99  99 
23  2  2  15  150  42  18.60  2  2  1  99  9 
48  2  3  47  145  39  18.55  3  3  3  99  9 
52  2  2  52  145  39  18.55  3  3  5  6  9 
69  2  2  67  135  34  18.54  2  2  5  15  9 
50  1  2  50  180  60  18.52  2  3  99  99  99 
40  1  2  39  152  43  18.47  1  2  99  99  99 
24  1  4  24  160  47  18.45  1  2  99  99  99 
43  1  2  41  163  49  18.44  3  3  99  99  99 
61  1  2  59  163  49  18.44  3  3  99  99  99 
25  2  2  16  145  39  18.43  2  2  1  99  9 
36  2  2  33  145  39  18.43  2  1  1  99  9 
56  1  1  56  168  52  18.42  4  4  99  99  99 
32  2  4  30  147  40  18.41  2  2  1  99  9 
32  2  4  28  140  36  18.38  2  1  1  99  9 
45  1  2  37  173  55  18.38  2  3  99  99  99 
35  2  2  35  140  36  18.37  3  4  5  99  1 
26  2  2  25  160  47  18.36  3  4  1  99  9 
49  1  2  49  157  45  18.31  2  2  99  99  99 
37  2  2  28  165  50  18.31  2  3  1  99  9 
23  1  2  20  178  58  18.31  3  4  99  99  99 
52  2  2  48  135  33  18.29  2  1  3  99  9 
49  1  2  38  180  59  18.21  1  4  99  99  99 
57  1  2  55  180  59  18.21  3  4  99  99  99 
38  1  2  38  163  48  18.20  3  2  99  99  99 
38  2  2  36  150  41  18.20  2  3  1  99  9 
31  1  3  30  150  41  18.16  1  2  99  99  99 
38  2  2  38  140  35  18.15  2  1  1  99  9 
23  1  2  22  178  57  18.09  2  2  99  99  99 
35  1  2  35  180  59  18.09  3  4  99  99  99 
36  1  2  36  160  46  18.08  1  3  99  99  99 
37  1  2  37  147  39  18.07  2  1  99  99  99 283 
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99  99  99  99  9  1  9  1000  9  9  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  230  9  9  100  500 
99 199  99  99  9  1  330  9  9  132  9 
9  9  99  9  9  1  230  9  9  90  9 
9  9  99  9  9  1  190  9  9  9  9 
9  9  99  9  9  1  200  9  9  9  9 
9  9  99  9  9  1  190  9  9  65  9 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  1  230  9  400  9  9 
9  9  99  9  9  1  200  9  400  9  9 
9  9  99  9  9  1  200  9  9  80  9 
9  9  99  9  9  1  160  9  400  9  9 
99  99  99  99  9  1  300  9  600  9  9 
99  99  99  99  9  1  9  1000  9  90  9 
99  99  99  99  9  1  9  9  9  100  9 
99  99  99  99  9  1  9  1000  9  9  9 
99  99  99  99  9  1  260  9  9  100  9 
9  9  99  9  9  1  9  1000  9  9  1000 
9  9  99  9  9  1  200  9  9  80  9 
99  99  99  99  9  1  9  1125  9  100  750 
9  9  99  9  9  1  200  9  9  80  9 
9  9  99  9  9  1  200  9  9  80  1000 
99  99  99  99  9  1  290  1125  9  65  9 
12  99  99  99  9  1  200  9  9  80  9 
9  9  99  9  9  1  260  1000  9  90  9 
99  99  99  99  9  1  230  9  400  9  9 
9  9  99  9  9  1  260  9  9  100  9 
99  99  99  99  9  1  290  9  9  116  9 
9  9  99  9  9  1  160  9  9  65  9 
99  99  99  99  9  1  9  1250  9  9  9 
99  99  99  99  9  1  300  9  9  132  9 
99  99  99  99  9  1  260  1000  9  100  1250 
9  9  99  9  9  1  9  1000  9  80  9 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  1  190  9  400  9  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  300  9  600  9  1000 
99  99  99  99  9  1  9  1000  9  9 
99  99  99  99  9  1  9  9  9  80 284 
24  25 26 27  28  29  30  31  32 
9  1  9  1  500  700  12/7/95  4.69041  1 
99  0  9  9  9  9  3/31/96  5.00548  9 
9  3  9  9  500  700  5/8/92  1.10685  1 
9  2  9  9  500  800  8/21/93  2.39452  1 
9  2  9  9  600  700  4/12/94  3.03562  1 
1000  2  9  9  600  700  4/11/95  4.03288  9 
9  1  9  9  600  600  4/19/93  2.05479  1 
9  2  9  9  600  600  3/31/96  5.00548  9 
99  0  9  9  9  9  3/31/96  5.00548  9 
750  3  9  9  600  700  8/4/91  .34521  1 
9  2  9  9  600  600  12/19/91  .72055  1 
9  2  9  9  600  600  7/12/91  .28219  1 
9  2  9  9  600  600  3/24/92  .98356  1 
9  2  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  500  700  10/9/91  .52603  1 
9  1  9  9  500  700  8/20/91  .38904  1 
9  1  9  9  500  800  6/19/94  3.22192  9 
9  2  9  9  500  700  3/2/95  3.92329  1 
9  2  1  9  600  600  10/21/94  3.56164  1 I 
9  2  9  9  600  600  3/12/95  3.95068  1 
9  3  9  9  500  800  8/5/93  2.35068  1 
9  2  9  9  600  600  7/19/94  3.30411  1 
9  3  9  9  600  600  10/14/92  1.54247  1 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  600  1/14/93  1.79452  1 
9  3  9  9  600  700  6/24/92  1.23562  1 
9  2  9  9  500  700  10/7/92  1.52329  1 
9  2  9  9  600  800  5/4/91  .09315  1 
9  2  1  9  500  800  3/31/96  5.00548  9 
9  2  9  9  600  600  8/16/93  2.38082  1 
9  1  9  9  500  800  11/21/93  2.64658  9 
9  2  9  9  500  800  2/19/93  1.89315  1 
9  4  9  9  500  800  11/8/92  1.61096  1 
9  2  9  9  600  600  12/7/91  .68767  1 
99  0  9  9  9  9  12/14/94  3.70959  1 
9  2  9  9  600  600  12/17/91  .71507  1 
99 0 9 9 9  9 5/27/91 .15616 9 
9  3  9  9  500  800  3/31/96  5.00548  9 
9  1  9  9  500  700  4/10/95  4.03014  1 
9  1  9  9  500  600  12/1/94  3.67397 285 
33  34  35  36  37  38  39  40 
12/7/95  7  3  4.69041  99  99  99  99 
99  99  99  99  99  99  99  99 
5/8/92  6  3  1.10685  99  99  99  99 
8/21/93  3  3  2.39452  99  99  99  99 
4/12/94  6  1  3.03562  99  99  99  99 
99  99  99  99  99  99  99  99 
4/19/93  15  3  2.05479  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
8/4/91  7  1  .34521  12/16/94  12  3  3.71507 
12/19/91  12  3  .72055  99  99  99  99 
7/12/91  6  4  .28219  5/1/95  10  3  4.08767 
3/24/92  6  3  .98356  99  99  99  99 
99  99  99  99  99  99  99  99 
10/9/91  6  2  .52603  99  99  99  99 
8/20/91  10  3  .38904  99  99  99  99 
99  99  99  99  99  99  99  99 
3/2/95  7  1  3.92329  99  99  99  99 
10/21/94  4  3  3.56164  99  99  99  99 
3/12/95  14  4  3.95068  99  99  99  99 
8/5/93  14  3  2.35068  99  99  99  99 
7/19/94  12  1  3.30411  99  99  99  99 
10/14/92  10  3  1.54247  99  99  99  99 
99  99  99  99  99  99  99  99 
1/14/93  10  4  1.79452  99  99  99  99 
6/24/92  9  1  1.23562  7/11/94  15  4  3.28219 
10/7/92  12  4  1.52329  99  99  99  99 
5/4/91  13  3  .09315  99  99  99  99 
99  99  99  99  99  99  99  99 
8/16/93  11  3  2.38082  99  99  99  99 
99  99  99  99  99  99  99  99 
2/19/93  2  3  1.89315  99  99  99  99 
11/8/92  3  3  1.61096  99  99  99  99 
12/7/91  3  4  .68767  99  99  99  99 
12/14/94  6  4  3.70959  3/18/95  3  3  3.96712 
12/17/91  7  3  .71507  7/9/93  15  4  2.27671 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
4/10/95  15  4  4.03014  99  99  99  99 
12/1/94  15  3  3.67397  99  99  99  99 286 
41  42  43  44  45  46  47  48  49 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
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99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
1/12/96  14  4  4.78904  99  99  99  99  3 
99  99  99  99  99  99  99  99  1 
99  99  199  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  2 
6/14/94  14  4  3.20822  99  99  99  99  3 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99 287 
8  9  10 11 12 1 2 3 4 5  6  7 
27  1  3 27 168 51 18.07 3  4  99 99 99 
41  2  2  38 147 39 18.05  3  3  5  99  1 
34  2  2  34 135 33 18.04  1  1  5  99 99 
28  1  2  21 165 49 18.00 3  3 99 99 99 
44  1  2 40 178 57 17.99  1  4  99 99 99 
28  2  2  28 160 46 17.91  2  2  5  99  1 
41  2  2  38 167 50 17.89  4  5  1  99  9 
29  2  2  19 137 34 17.86  2  2  1  99  9 
29  2  2  29 147 39 17.80  2  2  5  99 99 
36 2  2 35 152 41 17.79 2  2  1  99 9 
26  2  2  17 145 37 17.78  2  2  1  99  9 
32  2  2  29 150 40 17.78  3  4  1  99  9 
62  1  2  28 152 41 17.75  1  1  99 99 99 
27  1  2 26 173 53 17.71  3  4 99 99 99 
51  1  2  50 173 53  17.71  2  2  99  99 99 
30  1  2  23 165 48 17.63  2  2  99 99 99 
31  2  2  30 145 37 17.60  3  4  99  9 1 
26  2  2  23 152 41 17.60  1  3  1  99  9 
68  2  2  67 145 37 17.55  2  1  5  13  9 
53  2  2  51 162 46 17.53 4  4  3  99  9 
39  1  2  39 180 57 17.50  2  2  99 99 99 
31  1  2  31 155 42 17.48 2  1  99 99 99 
23  1  2  22 152 40 17.42  1  2  99  99 99 
36  2  2  36 170 50 17.40  2  3  5  99 99 
32  2  2  29 150 39 17.39  1  3  1  99  9 
39  1  1  37 173 52 17.37  2  3  99 99 99 
44  1  2  43 168 49 17.36  2  2  99 99 99 
42  1  2  40 150 39 17.33  2  2  99  99 99 
24  2  2  23 145 36 17.33  2  2  99  9 1 
41  2  2  39 163 46 17.31  3  5  1  99  9 
61  1  2  60 175 53  17.31  3  3  99 99 99 
41  1  2  39 170 50 17.27  3  3  99 99 99 
68  2  2  68 152 40 17.21  1  3  5  16  9 
39  1  2  36 165 47 17.18  3  2  99 99 99 
31  1  2  31 147 37 17.12 2  2 99 99 99 
40  2  3  35 145 36 17.12  3  4  1  99  9 
50  1  2 39 173 51 17.04 3  3 99 99 99 
39  1  2  37 173  51  17.04  2  3  99 99 99 
43  1  2  40 173  51  17.04  2  2  99 99 99 
39  1  2  39 165 46 16.90  2  2  99 99 99 288 
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99  99  99  99  9  1  260  1125  9  9  1250 
20  99  99  99  9  1  9  1000  9  90  9 
99  1  10  99  9  1  190  9  9  65  9 
99  99  99  99  9  1  260  1000  9  100  1000 
99  99  99  99  9  1  290  1250  9  100  9 
7  99  99  99  9  9  99  99  99  99  99 
9  9  99  1  9  9  99  99  99  99  99 
9  9  99  9  9  1  190  750  9  9  9 
99  1  9  99  9  1  190  9  9  80  9 
9  9  99  9  9  9  99  99  99  99  99 
9  9  99  9  9  9  99  99  99  99  99 
9  9  99  9  9  1  200  9  400  9  1250 
99  99  99  99  9  1  200  9  9  9  9 
99  99  99  99  9  1  290  1125  9  108  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  260  9  9  100  9 
9  9  99  1  9  1  190  9  400  9  9 
9  9  99  9  9  1  230  9  9  80  1000 
9  9  99  9  9  1  190  9  9  65  9 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  9  1  9  1250  9  100  9 
99  99  99  99  9  1  230  9  9  90  9 
99  99  99  99  9  1  230  9  400  9  9 
99  1  9  99  9  1  9  1125  9  100  9 
9  9  99  9  9  1  200  1000  9  9  9 
99  99  99  99  9  1  260  9  600  9  9 
99  99  99  99  9  1  260  9  400  9  9 
99  99  99  99  9  1  190  9  400  9  9 
9  9  99  9  9  9  99  99  99  99  99 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  260  9  9  100  9 
9  9  99  9  9  1  9  9  9  80  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  190  9  400  9  9 
9  9  99  9  9  1  190  9  9  90  9 
99  99  99  99  9  1  260  9  600  9  9 
99  99  99  99  9  1  260  9  600  9  9 
99  99  99  99  9  1  9  1125  9  100  1250 
99  99  99  99  9  1  230  9  9  100  1000 289 
24  25  26  27  28  29  30  31  32 
9  3  9  9  500  800  3/2/92  .92329  9 
9  2  9  9  600  600  3/2/96  4.92603  1 
9  2  9  9  600  600  8/19/95  4.38904  1 
9  4  9  9  500  800  7/25/92  1.32055  1 
9  3  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  600  9  3/31/96  5.00548  9 
99  0  9  9  600  9  3/31/96  5.00548  9 
9  2  9  9  600  600  7/9/94  3.27761  1 
9  2  9  9  600  600  5/12/95  4.11781  1 
99  0  9  9  600  9  12/29/91  .74795  1 
99  0  9  9  600  9  11/23/95  4.65205  1 
9  3  9  9  600  600  5/24/93  2.15068  1 
9  1  9  9  500  700  3/31/96  5.00548  9 
9  3  9  9  500  800  3/31/96  5.00548  9 
99  0  9  9  9  9  3/31/96  5.00548  9 
9  2  9  9  500  800  1/21/95  3.81370  1 
9  2  9  9  600  600  10/6/91  .51781  1 
9  3  9  9  600  600  1/13/96  4.79178  9 
9  2  9  9  600  600  2/1/93  1.84384  1 
99  0  9  9  600  9  3/31/96  5.00548  9 
1500  3  9  9  500  800  8/2/94  3.34247  1 
9  2  9  9  500  700  1/16/92  .79726  1 
9  2  9  9  500  600  12/11/93  2.70137  1 
9  2  9  9  600  800  3/27/95  3.99178  9 
9  2  9  9  600  600  3/26/93  1.98904  1 
9  2  9  9  500  800  11/9/95  4.61370  9 
9  2  9  1  500  800  3/31/96  5.00548  9 
9  2  9  9  500  600  4/12/92  1.03562  1 
99  0  9  1  600  9  1/25/94  2.82466  1 
99  0  9  9  600  9  8/10/92  1.36438  9 
99  0  9  9  9  9  3/31/96  5.00548  9 
1250  3  9  9  500  800  3/31/96  5.00548  9 
9  1  9  9  600  600  3/31/96  5.00548  9 
99  0  9  9  9  9  1/3/95  3.76438  1 
9  2  9  9  500  600  3/11/93  1.94795  1 
9  2  9  9  600  600  1/8/96  4.77808  1 
9  2  9  9  500  800  4/3/94  3.01096  1 
9  2  9  9  500  800  9/16/94  3.46575  1 
9  3  9  9  500  800  11/13/93  2.32466  1 
9  3  9  9  500  700  8/8/94  3.35890 290 
33  34  35  36  37  38  39  40 
99  99  99  99  99  99  99  99 
3/2/96  13  1  4.92603  99  99  99  99 
8/19/95  3  3  4.38904  99  99  99  99 
7/25/92  1  1  1.32055  12/26/95  6  3  4.74247 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
7/9/94  15  3  3.27761  99  99  99  99 
5/12/95  3  3  4.11781  99  99  99  99 
12/29/91  10  4  .74795  6/5/92  12  4  1.18356 
11/23/95  6  4  4.65205  99  99  99  99 
5/24/93  9  3  2.15068  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
1/21/95  11  3  3.81370  99  99  99  99 
10/6/91  10  4  .51781  4/3/95  14  4  4.01096 
99  99  99  99  99  99  99  99 
2/1/93  10  2  1.84384  99  99  99  99 
99  99  99  99  99  99  99  99 
8/2/94  14  4  3.34247  99  99  99  99 
1/16/92  15  2  .79726  99  99  99  99 
12/11/93  14  4  2.70137  99  99  99  99 
99  99  99  99  99  99  99  99 
3/26/93  3  3  1.98904  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
4/12/92  8  3  1.03562  99  99  99  99 
1/25/94  8  3  2.82466  5/30/95  3  4  4.16712 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
1/3/95  12  3  3.76438  99  99  99  99 
3/11/93  3  4  1.94795  99  99  99  99 
1/8/96  14  4  4.77808  99  99  99  99 
4/3/94  14  4  3.01096  99  99  99  99 
9/16/94  10  2  3.46575  99  99  99  99 
11/13/93  14  3  2.32466  99  99  99  99 
8/8/94  6  4  3.35890  12/13/95  10  3  4.70685 291 
41  42  43  44  45  46  47  48  49 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
1/19/94  10  3  2.80822  99  99  99  99  3 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99 292 
1 2 3 4 5 6  7  8 9 10 11 12 
31  1  2  23 160 43 16.85  1  2  99 99 99 
31  1  2  27 155 40 16.85  1  3  99 99 99 
53  1  4  50 155 40 16.83  1  1  99 99 99 
51  2  2  50 160 43 16.80  4  5  5  99  1 
44  2  2 44 163 44 16.67 2  3  5  2  9 
48  1  2  46 145 35 16.65  2  1  99 99 99 
41  2  4  40 155 40 16.65  2  2  1  99  9 
58  1  2  58 170 48 16.61  1  4  99 99 99 
31  2  2  31 165 45 16.49 2  2  1  99  9 
37  2  1  37 165 45 16.49  2  2  1  99  9 
59  2  2 57 155 40 16.46  1  2  5  2  9 
24  2  2  18 152 38 16.45 3  4  1  99  9 
66  2  2  65 154 39 16.44  1  5  5  15  9 
37  1  2  32 142 33 16.44  1  1  99 99 99 
45  2  2  45 144 34 16.40  3  3  3  99  9 
44  1  2  36 180 53 16.36  3  3  99 99 99 
67  2  2  66 163 43 16.32  2  2  5  16  9 
25  2  2  23 165 44 16.16  3  4  1  99  9 
40  2  2 38 140 31 16.07  1  2  1  99  9 
66  2  2  61 145 34 16.03  1  2  5  19  9 
36  1  2  35 175 49 16.00  2  2  99  99  99 
56  1  2  56 170 46 15.83  1  3  99 99 99 
40  1  2  39 157 39 15.82  2  2  99 99 99 
43  1  2 43 155 38 15.82 2  3 99 99 99 
43  1  2  29 165 43 15.79  2  1  99 99 99 
37  1  2 28 185 54 15.78 4  3 99 99 99 
41  1  2  40 160 40 15.43  2  99 99 99 1 
44  1  3  42 157 38  15.42  2  1  99 99  99 
26  2  2  19 145 32 15.40  2  1  1  99  9 
35  2  2  32 152 35 15.25  3  2  1  99  9 
63  1  2  61 152 35 15.15  1  1  99 99 99 
29  2  1  21 150 34 15.11  4  3  5  99 99 
65  2  2  64 160 38 14.72  2  1  5  99  1 
49  1  2  41 163 39 14.68  2  3  99 99 99 
49  1  1  45 165 39 14.33  1  1  99  99 99 
33  1  2 27 180 45 13.89 2  3 99 99 99 
42  1  2  41 178 44 13.89  3  3  99 99 99 
1 
51  1  51 178 42 13.26  2  2  99 99 99 1 293 
13  14  15  16  17  18  19  20  21  22  23 
99  99  99  99  9  1  230  9  400  9  1000 
99  99  99  99  9  1  230  9  9  80  9 
99  99  99  99  9  1  200  9  400  9  9 
30  99  99  99  1  1  230  9  400  9  9 
9  9  99  9  9  1  9  1000  9  9  9 
99  99  99  99  9  1  9  750  9  9  9 
9  9  99  9  9  9  99  99  99  99  99 
99  99  99  99  9  1  260  9  9  9  9 
9  9  99  9  9  1  230  1000  9  90  9 
9  9  99  9  9  1  230  9  9  90  750 
9  9  99  9  9  1  200  9  400  9  9 
9  9  99  1  9  9  99  99  99  99  99 
9  9  99  9  9  1  200  9  400  9  9 
99  99  99  99  9  1  190  9  9  65  9 
9  9  99  1  9  1  9  750  9  65  750 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  1  230  9  9  9  9 
9  9  99  9  9  1  230  9  400  9  9 
9  9  99  9  9  1  160  9  9  65  9 
9  9  99  9  9  1  160  9  9  9 
99  99  99  99  9  1  260  9  9  100  1000 
99  99  99  99  9  1  230  9  400  9  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  200  1000  9  9  9 
99  99  99  99  9  1  230  1000  9  9  9 
99  99  99  99  9  1  290  9  600  9  9 
99  99  99  99  9  1  200  9  9  80  9 
99  99  99  99  9  9  99  99  99  99  99 
9  9  99  9  9  1  190  9  9  65  9 
9  9  99  9  9  1  190  9  9  80  9 
99  99  99  99  9  1  9  9  9  65 
99  1  6  99  9  1  190  9  9  65  9 
36  99  99  99  9  1  9  750  9  9  9 
99  99  99  99  9  1  200  9  9  80  9 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  9  99  99  99  99  99 
99  99  99  99  9  1  230  9  9  90  9 
99  99  99  99  9  1  9  1000 294 
24  25  26  27  28  29  30  31  32 
9  3  9  9  500  700  3/31/96  5.00548  9 
750  3  9  9  500  600  9/14/92  1.46027  1 
9  2  9  9  500  600  10/4/94  3.51507  1 
9  2  9  9  600  700  9/25/95  4.49041  1 
1250  2  9  9  600  700  5/11/94  3.11507  9 
9  1  9  9  500  600  3/31/96  5.00548  9 
99  0  9  9  600  9  7/28/93  2.32877  1 
9  1  9  9  500  800  3/31/96  5.00548  9 
9  3  9  9  600  700  4/10/94  3.03014  9 
9  3  9  9  600  700  3/31/96  5.00548  9 
9  2  1  9  600  600  1/14/95  3.79492  9 
99  0  9  9  600  9  9/8/94  3.44384  1 
9  2  9  9  600  600  3/31/96  5.00548  9 
9  2  9  1  500  600  3/31/96  5.00548  9 
9  3  9  9  600  600  7/1/93  2.25479  1 
99  0  9  9  9  9  10/2/93  2.50959  1 
9  1  9  9  600  700  7/24/91  .31507  1 
750  3  9  9  600  700  8/29/95  4.41644  1 
9  2  9  9  600  600  1/6/94  2.77260  1 
750  3  9  9  600  600  4/22/93  2.06301  1 
9  3  9  9  500  800  11/7/94  3.60822  1 
9  2  9  9  500  700  2/8/96  4.86301  9 
99  0  9  9  9  9  8/30/91  .41644  9 
9  2  9  9  500  600  8/10/93  2.36438  1 
1250  3  9  9  500  700  5/18/91  .13151  1 
9  2  9  9  500  800  7/8/93  2.27397  1 
9  2  9  9  500  600  8/30/91  .41644  1 
99  0  9  9  9  9  6/14/92  1.20822  1 
9  2  9  9  600  600  9/28/93  2.49863  1 
9  2  9  9  600  600  2/1/96  4.84384  1 
9  1  9  9  500  600  3/31/96  5.00548  9 
9  2  9  9  600  600  11/16/93  2.63288  1 
9  1  9  9  600  700  8/8/91  .35616  1 
9  2  9  9  500  600  9/18/93  2.47123 
99  0  9  9  9  9  3/21/96  4.97808  1 
99  0  9  9  9  9  5/18/94  3.13425  1 
9  2  9  9  500  700  6/29/92  1.24932  1 
1250  2  9  9  500  700  10/3/91  .50959  1 295 
33  34  35  36  37  38  39  40 
99  99  99  99  99  99  99  99 
9/14/92  10  2  1.46027  3/30/94  6  4  3.00000 
10/4/94  13  3  3.51507  3/17/95  12  4  3.96438 
9/25/95  10  1  4.49041  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
7/28/93  10  4  2.32877  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
9/8/94  3  3  3.44384  99  99  99  99 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
7/1/93  8  3  2.25479  99  99  99  99 
10/2/93  14  3  2.50959  99  99  99  99 
7/24/91  3  2  .31507  99  99  99  99 
8/29/95  9  1  4.41644  99  99  99  99 
1/6/94  6  3  2.77260  99  99  99  99 
4/22/93 
11/7/94 
8 
7 
3 
4 
2.06301 
3.60822 
99 
2/17/96 
99 
7 
99 
3 
99 
4.88767 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99 
8/10/93  10  4  2.36438  99  99  99  99 
5/18/91  3  4  .13151  99  99  99  99 
7/8/93  10  1  2.27379  99  99  99  99 
8/30/91  4  3  .41644  99  99  99  99 
6/14/92  3  2  1.20822  99  99  99  99 
9/28/93  10  2  2.49863  99  99  99  99 
2/1/96  13  1  4.84384  99  99  99  99 
99  99  99  99  99  99  99  99 
11/16/93  6  4  2.63288  99  99  99  99 
8/8/91  3  4  .35616  99  99  99  99 
9/18/93  12  3  2.47123  99  99  99  99 
3/21/96  10  2  4.97808  99  99  99  99 
5/18/94  6  2  3.13425  99  99  99  99 
6/29/92  2  3  1.24932  99  99  99  99 
10/3/91  13  4  .50959  99  99  99  99 296 
41  42  43  44  45  46  47  48  49 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  2 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  0 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99  1 
99  99  99  99  99  99  99  99 